12Th World Congress of Biological Psychiatry 14 – 18 June 2015 • Athens, Greece Megaron Athens International Conference Centre

Final Programme

WFSBP Congress 2015 12th World congress of Biological Psychiatry 14 – 18 june 2015 • athens, greece Megaron Athens International Conference Centre

www.wfsbp-congress.org organised by: World Federation of Societies of Biological Psychiatry

hosted by the hellenic Society for the advancement of Psychiatry and related Sciences 12th World congress of Biological Psychiatry

WFSBP Congress 2015 Smartphone aPP the congress @ your fi ngertips !

get it now for your

q iPhone q iPad q iPodTouch q Android

Quickly fi nd your way through the most up-to-date congress schedule of scientifi c sessions.

Further information is given at www.wfsbp-congress.org/app. WFSBP 2015 Table of Contents

Page Page

2 invitation to the 12th World congress 91 Final Programme of Biological Psychiatry 91 Congress Information System 91 Wireless Lan / WiFi 3 about WFSBP 91 Technical Exhibition about the WFSBP congress 2015 91 WFSBP Congress APP 4 Congress Administration 92 Speakers Centre 4 WFSBP Executive Committee 92 Poster Exhibition 4 Honorary Committee 92 Best Poster Awards 4 International Scientifi c Programme Committee 92 Programme Changes 5 National Presidents 92 Snack Bars / Venue Restaurant 6 Local Organizing Committee 92 Cloakroom 6 WFSBP Administrative Meetings 93 Cash Machine 93 First Aid 7 Floorplan 93 Mobile Phones 9 WFSBP awards and grants 93 Currency 93 Visa 10 Format descriptions 93 Offi cial Italian Agency 11 Scientifi c information 93 Insurance 11 CME Accreditation 93 Force Majeure 12 Opening Ceremony 93 General Conditions 13 Scientifi c Programme Overview 93 Climate 13 Structure of the Scientifi c Programme 92 Housing 93 Athens Information Counter Scientifi c Programme 94 How to get to the Megaron Athens 23 Saturday, 13 June and Sunday, 14 June 2015 International Conference Centre 24 Monday, 15 June 2015 94 Car Park 42 Tuesday, 16 June 2015 94 Taxis 58 Wednesday, 17 June 2015 94 Safety 74 Thursday, 18 June 2015 94 City of Athens congress information 95 exhibition Floor Plan / exhibitors list 91 Congress Venue 91 Congress Registration Counter 96 acknowledgements 91 Name Badges 97 industry Sessions 91 Congress Language 91 Certifi cate of Attendance / CME Certifi cate 98 list of chairpersons, authors and co-authors

WFSBP gloBal headQuarterS congreSS and exhiBition oFFice Zum Ehrenhain 34

22885 Barsbüttel, Germany Phone: +49 – 40 – 670 882 90 Fax: +49 – 40 – 670 328 82 91 Hamburg Offi ce Email: [email protected] Hanser & Co GmbH www.wfsbp.org Zum Ehrenhain 34 22885 Barsbüttel, Germany Phone: +49 – 40 – 670 88 20 congreSS venue Fax: +49 – 40 – 670 32 83 Megaron Athens International Conference Centre Email: wfsbp2015@cpohanser.de Leoforos Vasilissis Sofi as and Kokkali 1 www.wfsbp-congress.org Athens 115 21, Greece www.maicc.gr WFSBP 2015 Invitation to the 12th World Congress of Biological Psychiatry

Dear Colleagues,

It is our privilege and special pleasure to welcome you to the 12th World Congress of Biological Psy chiatry. The World Federation of Societies of Biological Psychiatry (WFSBP) has chosen Athens for its World Congress in June 14th –18th 2015; therefore, the hosting society (Hellenic Society for the Advancement of Psychiatry and Related Sciences) is very thankful.

Constantin R. Today, it is easy to envision a future where psychiatric diagnosis will be based on understanding funda Soldatos mental defects in thinking, emotional processing, and motivational systems. Psychiatry is now well positioned to take advantage of the major advances achieved in the last few decades in neurobiology and cognitive sciences and to build on them. WFSBP with its unique complementarity between basic neuroscientists and clinical psychiatrists, coming from various cultural and geographical backgrounds, is an important tool for the future of psychiatry.

During the 12th World Congress of Biological Psychiatry, worldwide opinion leaders will share with us the recent innovations in their respective fields which impact on diagnosis, treatment and quality of life of our patients. High scientific level sessions have been organized: plenary lectures, symposia, interactive Florence Thibaut workshops and debates, while a good number of WFSBP Task Forces will actively participate in the scientific programme through the presentation of Treatment Guidelines they currently publish. Also, young scientists will present their recent findings through free communications and posters presentations. Moreover, the scientific programme of the present congress includes certain novel components such as a round table on the topic “Drug discovery in neuroscience: Why is big pharma reluctanct to continue investing?”, and three educational sessions on basic research issues, pharmacological treatments, and brain stimulation methods.

We are looking forward to welcome you in Athens, the heart of European culture and civilization, and to receive you according to the traditional Greek hospitality. Finally, we wish you a joyous and fruitful congress participation and hope that you will take home unforgettable memories and inspiration for your research and everyday clinical practice.

Thank you for joining us!

Prof. Constantin R. Soldatos Prof. Florence Thibaut Congress President and Chair of the International Chair of the Local Organizing Committee Scientific Programme Committee

2 WFSBP 2015 About wfsbp

Founded in 1974, the World Federation of Societies of Bi The Principle Objectives of WFSBP are: ological Psychiatry is a non-profit world wide organisation U To foster and encourage scientific research and advance composed of 63 National Societies of Biological Psychiatry ment in the field of Biological Psychiatry and Individual Members representing professionals from over U To improve the quality of training spanning all the biolo 70 countries. gical psychiatry sciences U To promote education and achieve the highest level of With this multitude of countries represented in its world- knowledge and understanding within the field wide community, the World Federation has built an inter U To provide information and guidance to all institutions, national network of over 4,000 opinion leaders, the majo societies or individuals with an interest in biological psy rity of which are key opinion-leaders in the practice of chiatry Biological Psychiatry. U To establish, build, and maintain solid collaboration with international and national organisations related to biolo WFSBP members per continent gical psychiatry

Educational activities, regional, international and world con n 4,8% n 2,2 % n 0,4 % gresses, the interactive website www.wfsbp.org, and The n 1,2 % World Journal of Biological Psychiatry build the World n 8,6 % Federation’s portfolio and insure its world-wide influence. The development of world-wide treatment guidelines is one of WFSBP’s main areas of international leadership.

WFSBP Members per field of activity

n Clinicians 88 % n Researchers 12 %

n 26 % n 56,8 %

As of May 2015 n Europe n Africa n Asia n Middle East n South America n Australia n North America

As of May 2015

Year after year, more and more professionals choose to join the World Federation’s Biological Psychiatry arena and enjoy its exclusive educational and networking opportunities. In the coming years WFSBP is looking forward welcoming new eminent member societies from different parts of the world.

3 WFSBP 2015 About the wfsbp Congress 2015

Congress Administration Members of ISPC The 12th World Congress of Biological Psychiatry will be C. A. Altamura, Italy* organised by the World Federation of Societies of M. Bauer, Germany Biological Psychiatry (WFSBP) A. Benyamina, France* M. Berk, Australia* J. Bobes, Spain WFSBP Executive Committee C. L. Bowden, USA President (2013 – 2015) J. Bradford, Canada Constantin R. Soldatos, Greece P. Brambilla, Italy Vice President (2013 – 2017) M. Bras, Croatia Tudor Udristoiu, Romania M. S. Buchsbaum, USA Past President (2013 – 2015) D. Castle, Australia Florence Thibaut, France E. Ceskova, Czech Republic President Elect (2013 – 2015) J. Ciprian-Ollivier, Argentina Masatoshi Takeda, Japan P. Cosyns, Belgium Secretary (2013 – 2017) P. Courtet, France* Lakshmi N. Yatham, Canada B. Dean, Australia Treasurer (2013 – 2017) K. Fountoulakis, Greece Martin Hatzinger, Switzerland S. Frangou, UK Vice Secretary (2013 – 2017) W. Gaebel, Germany Ladislav Hosak, Czech Republic F. Duarte Garcia, Brazil Vice Treasurer (2013 – 2017) W. F. Gattaz, Brazil* Victoria Valdez, Ecuador M. George, USA B. Glenthoj, Denmark Honorary Committee (HC) P. Gorwood, France Jules Angst, Switzerland G. M. Goodwin, UK Jose Luis Ayuso, Spain A. Grace, USA Tetsuo Fukuda, Japan H. Grunze, UK Gerardo Heinze, Mexico A. Halaris, USA Florian Holsboer, Germany A. Hasan, Germany* Jeffrey Lieberman, USA C. Hiemke, Germany Julien Mendlewicz, Belgium E. Holsboer-Trachsler, Switzerland Hans-Jürgen Möller, Germany W. G. Honer, Canada Robin Murray, UK R. Kahn, The Netherlands Ahmed Okasha, Egypt S. Kasper, Austria Mitsumoto Sato, Japan T. Kato, Japan Göran Sedvall, Sweden J. Kane, USA Michael Trimble, UK J. Kennedy, Canada H. R. Kranzler, USA R. Lanzenberger, Austria International Scientific Programme V. Larach, Chile Committee (ISPC) A. Lopez Mato, Argentina Florence Thibaut, France Chair C. Lyketsos, USA Peter Falkai, Germany Co-Chair R. McCarley, USA Shigenobu Kanba, Japan Co-Chair M. Maes, Belgium Lakshmi N. Yatham, Canada Co-Chair H. Mayberg, USA Michel Bourin, France Secretary A. Kant Mital, India E. Mohan Das, India

* Special correspondents of ISPC Core Group 4 WFSBP 2015 About the wfsbp Congress 2015

N. Müller, Germany D. Gorelick, USA X. Yu, China* T. Murai, Japan G. Hajak, Germany M. Zanarini, USA Ch. Pantelis, Australia S. Heckers, USA* J. Zohar, Israel G. Papadimitriou, Greece Y. Hirayasu, Japan T. Paparrigopoulos, Greece* E. Hollander, USA O. Pogarell, Gemany J. Horacek, Czech Republic National Presidents R. Post, USA* A. Jablensky, Australia A. Corrales, Argentina M. Rapaport, USA C. Katona, UK A. Boyajyan, Armenia M.S. Reddy, India* W. Kaye, USA J. Marksteiner, Austria P. Riederer, Germany L. Konopka, USA S. Claes, Belgium R. Rupprecht, Germany C. Krieg, Germany N. D. Noya-Tapia, Bolivia T. Saito, Japan T. Kudo, Japan A. Kucukalic, Bosnia-Herzegovina M. Sarchiapone, Italy J. Soo Kwon, Korea* P. Abreu, Brazil N. Sartorius, Switzerland S. Lamy, France O. Atanasova Mikova- A. Schmitt, Germany M. Leboyer, France Demireva, Bulgaria T. G. Schulze, Germany* M. Lejoyeux, France R. R. Lam, Canada S. Seedat, South Africa* M. So Lee, Korea E. Olea, Chile A. Seretti, Italy B. Leonard, Ireland J. Franco, Columbia E. Serfaty, Argentina Y. Levkovitz, Israel R. Castro, Costa Rica L. Siever, USA P. Mc Gorry, Australia M. Jakovljevic, Croatia N. Stefanis, Greece* P. Mc Guire, UK L. Hosak, Czech Republic J. Steiner, Germany A. Malafosse, Switzerland G. Wegener, Denmark T. Suhara, Japan J.-L. Martinot, France F. Solis de Mendez, M.Takeda, Japan H. Y. Meltzer, USA Dominican Republic J. Tellez-Vargas, Colombia A. Meyer-Lindenberg, Germany V. Valdez de Vuibert, Ecuador N. Venizelos, Sweden Z. Nahas, Lebanon A. Okasha, Egypt J. Waddington, Ireland D. Nutt, UK M. Meija Pena, El Salvador A. Weinstein Israel J. Ospina-Duque, Colombia J. Harro, Estonia P. Whybrow, USA N. Ozaki, Japan P. Courtet, France Y. Zervas, Greece* G. Parker, Australia S. Herpertz, Germany L. Pezewas, Austria C. R. Soldatos, Greece Consultants to the ISPC S. G. Potkin, USA H. Soto Chavez, Guatemala G. Alexopoulos, USA M. Rapaport, USA M. Aguilar Lopez, Honduras C. Arango, Spain* E. Richelson, USA S.-W. Tang, Hong Kong E. Baca Garcia, Spain J. Rybakowski, Poland C. Banki, Hungary E. Belfort, Venezuela D. Rujescu, Germany R. Nagpal, India A. Bozkurt, Cyprus H. Sackeim, USA A. J. Tanra, Indonesia N. Boutros, USA P. Salgado Pineda, Spain D. Gothelf, Israel P. Boyer, France T. Schläpfer, Germany M. Maj, Italy A. Burns, UK L. Schneider, USA T. Nishikawa, Japan R. Castilla-Puentes, USA C. Schulz, USA M. Assimov, Kazakhstan M. Cetkovich-Bakmas, Argentina E. Seifritz, Switzerland C. Uk Lee, Korea Y. Hwa Chou, Taiwan W. W. Shen, Taiwan B. Kupca, Latvia H. Correa, Brazil L. Siever, USA C. Baddoura, Libanon J. Costa e Silva, Brazil D. St. Clair, UK B. Stefanovski, Macedonia P. Cosyns, Belgium M. Taleb, France/Algeria S. Krishnaswamy, Malaysia J. de Buitelaar, The Netherlands T. Taneli, USA D. Moussaoui, Marocco M. Dierick, Belgium J. Treasure, UK G. Villanueva Colin, Mexico B. Dubois, France N. A. Uranova, Russia H. Lovdahl, Norway P. Gejman, USA J. Van Os, The Netherlands M. Amin, Pakistan A. Germanavicious, Lithuania D. Velakoulis, Australia G. Da Costa, Panama A. H. Glassman, USA E. Vieta, Spain L. Villalba, Paraguay

5 WFSBP 2015 About the wfsbp Congress 2015

E. Galli, Peru M. Ramklint, Sweden Honorary Members A. Wichniak, Poland M. Hatzinger, Switzerland N. Angelopoulos I. Liappas J. Relvas, Portugal Ch.-Y. Liu, Taiwan S. Beratis M. Livaditis T. Udristoiu, Romania P. Udomratn, Thailand A. Botsis M. Madianos S. Mosolov, Russia B. Taneli, Turkey G. Christodoulou A. Mailis N. Maric Bojovic, Serbia A. V. Kalueff, Ukraine I. Giouzepas Y. Papakostas L. Vavrusova, Slovakia G. Bouza, Uruguay C. Ierodiakonou A. Rabavilas S. Seedat, South Africa J. Ibáñez-Domínguez, G. Kaprinis G. Trikkas M. Bernardo, Spain Venezuela A. Karavatos J. Tsiantis V. Kontaxakis E. Tzebelikos A. Liakos N. Vaidakis

LOCAL ORGANIZING COMMITTEE (LOC) Administrative Meetings Chair: C. R. Soldatos By invitation only Honorary Chair: C. Stefanis WJBP Editorial Board Meeting General Members Monday, 15 June 2015 D. Anagnostopoulos M. Malliori 12:45 – 14:00, Conference Room 4 C. Androutsos V. Mavreas E. Angelopoulos G. Moussas WFSBP Individual Membership Section Meeting N. Bergiannaki G. Nimatoudis Tuesday, 16 June 2015 P. Bitsios M. Panagiotakopoulou 12:30 – 13:30, MC 2 Room G. Diakogiannis G. Papadimitriou D. Dikeos G. Papageorgiou WFSBP Task Force Meeting A. Douzenis C. Papageorgiou Tuesday, 16 June 2015 C. Fokas T. Paparrigopoulos 12:30 – 14:30, Conference Room 4 K. Fountoulakis E. Patsouris G. Garyfalos A. Politis WFSBP Standing and Operational A. Gena C. Psarros Committees Meeting F. Gourzis P. Sakkas Tuesday, 16 June 2015 J. Hatzimanolis M. Samakouri 14:30 – 16:30, Conference Room 4 S. Kaprinis N. Smyrnis G. Karantanos P. Skapinakis WFSBP Council Meeting A. Karkanias N. Stefanis Wednesday, 17 June 2015 G. Kolaitis C. Touloumis 12:30 – 13:30, MC 3 Room S. Kotsopoulos E. Varsou A. Koumoula A. Vgontzas WFSBP General Assembly H. Lazaratou Y. Zervas Wednesday, 17 June 2015 M. Liakopoulou N. Zilikis 13:30 – 15:00, MC 3 Room

6 WFSBP 2015

Ground Level | Floorplan

Trianti Hall

Cloak- to -1 Level room e Skalkotas Hall e MC 2 Room e MC 3 Room e MC 3.3 Room e MC 3.2 Room (Speakers Centre)

Kokkali Room

Atrium Coffee Breaks Poster Exhibition

Exhibition Poster Exhibition

Muses Foyer

Mitropoulos Hall

upstairs Conference rooms 1 + 4

Allegro Restaurant

Registration

q Congress Entrance / Entrance B left from Main Music Hall Entrance

7 WFSBP 2015

Floorplan | Level –1

MC 3 Session Room

MC 3.4 R SessionMC R 2 oom oom

Conerence Suite 2

Foyer to Ground Level e Trianti Hall MC 3.3 e Kokkali Room Session e Room Exhibition MC 3.2 e Poster Exhibition Speakers Centre

Skalkotas Hall

to Ground Level e Entrance e Registration e Mitropoulos Hall e Conference Room 1 + 4

8 WFSBP 2015 WFSBP Awards and Grants

WFSBP AWARDS WFSBP Award for Excellence in Education The Executive Committee will distribute several prizes to The WFSBP Award for Excellence in Education is to acknow honour distinguished scientists for their continuous excellence ledge outstanding and innovative education in biological in clinical and basic research. The awards will be delivered psychiatry including the implementation of new interactive during the Opening Ceremony of the Congress on Sunday, media. The WFSBP Award for Excellence in Education is 14 June 2015. The best poster awards will be delivered open to all WFSBP members who have improved education during the Closing Ceremony on Thursday, 18 June 2015. in all fields of Psychiatry.

Awardees 2015: WFSBP Lifetime Achievement Award in Biologi- Professor Philippe Courtet, France cal Psychiatry Professor Konstantinos Fountoulakis, Greece The WFSBP Lifetime Achievement Award in Biological Psy chiatry is intended for senior research scientists (MD, PhD The World Journal of Biological Psychiatry or equivalent) whose lifework has significantly influenced Excellence in Publication Prize today‘s field of biological psychiatry. This award is open to The World Journal of Biological Psychiatry (WJBP) is the members and non-members of the WFSBP official journal of the WFSBP (2013 Impact Factor: 4.225). Awardee 2015: The Chief Editor Prof. Siegfried Kasper awards the 2015 Professor Janusz Rybakowski, Poland WJBP Excellence in Publication Prize to Prof. Heinz Grunze for his outstanding input to the scientific impact of the jour nal: four of his WFSBP Treatment Guidelines on Bipolar WFSBP Research Award Disorder are among the top ten of the journal’s most cited The WFSBP Research Award is intended for WFSBP members papers of all time. This range of influence depicts the high (MD, PhD or equivalent) whose current scientific work has quality of his work, which is based on systematic reviews had an important impact in the field of clinical and / or basic and thorough evaluation of up-to-date literature. research in the area of biological psychiatry. Awardee 2015: Awardee 2015: Professor Heinz Grunze, United Kingdom Professor Rupert Lanzenberger, Austria

WFSBP Young Investigator Awards for the ten WFSBP Award for Excellence in Mentorship Best Posters (under 40 year-old) The WFSBP Award for Excellence in Mentorship is to ack An application for the Young Investigator Award is not neces nowledge outstanding performance in providing guidance sary. All posters will be evaluated at the congress. The awards and mentorship to colleagues involved in clinical / research will go to those presentations that not only provide evidence work in Biological Psychiatry. This Award is also intended to of innovative research, but are also well presented. acknowledge long standing leadership in educational pro grams related to Biological Psychiatry. WFSBP Educational Grants Awardees 2015: WFSBP is offering an Educational Grant for young investiga Professor E. Mohandas, Inda tors (under 40 year-old) to attend the WFSBP biennial con Professor Bilgen Taneli, Turkey gress and the special WFSBP educational sessions. Special educational sessions have been developed and are only open to educational grant winners.

9 WFSBP 2015 Format Descriptions

Opening Lecture Educational Grant Sessions The Opening Lecture will be held during the Opening These sessions are especially designed for young researchers Ceremony on 14 June 2015. (under 40 year-old) which were pre-selected via an appli cation process. Herewith the WFSBP is promoting education for talented young researchers. Interactional and practical Plenary Lectures learning is in the focus of these sessions. The educational Plenary Lectures are 45-minute sessions held by renowned grant sessions are not open to other congress delegates. experts. The speakers have been chosen from among the most prominent researchers in the respective field. Guided Poster Tours Poster Exhibition Symposia The poster exhibition is located in the Muses Foyer on ground Symposia were selected, covering basic, clinical, interface and level of the Megaron. conceptual topics of Biological Psychiatry. Symposia are orga nized and chaired by the experts whose proposals were ac Posters are allocated to 26 guided poster tours (P-01 to P-26). cepted by the International Scientific Programme Committee. Posters will be changed daily and are on display for the entire day of the according poster tour. They will be sorted by topics and will be numbered within those topics. The Workshops poster exhibition is open to all registered delegates: Workshops are highly interactive sessions with an educatio nal focus. This format is especially designed to give specific Poster exhibition times for P-01 to P-06 regions a platform for presentation and networking. Monday, 15 June 2015 09:00 – 17:00 Guided Poster Tours 12:45 – 14:15

Debates Poster exhibition times for P-07 to P-13 Debates are intended to offer a platform for a lively, yet Tuesday, 16 June 2015 09:00 – 17:00 balanced discussion on controversial issues. A moderator Guided Poster Tours 12:45 – 14:15 (chairperson) and two speakers (one proponent and one Poster exhibition times for P-14 to P-20 opponent) state their opinions on different subjects. Wednesday, 17 June 2015 09:00 – 17:00 Guided Poster Tours 12:45 – 14:15 Round Table Poster exhibition times for P-21 to P-26 The round table is a platform for scientists and industry re Thursday, 18 June 2015 09:00 – 17:00 presentatives to discuss current and controversial issues. Guided Poster Tours 12:45 – 14:15

WFSBP Treatment Guidelines Sessions Best Poster Awards WFSBP Treatment Guidelines Sessions are 90-minute sessi All posters will be evaluated on site by the WFSBP Prize ons with an educational focus. They centre on the WFSBP Committee. The best poster of each poster tour will be mo Treatment Guidelines and include brief presentations by ved to the best poster area in the Muses Foyer where they individual panel members, followed by lively and informative are displayed through-out the congress. Out of these the 10 discussion. This session type provides for substantial audience best posters of young investigators under 40 years will be participation and should be highly interactive. awarded with a poster prize. The awards will be handed out during the Closing Ceremony on Thursday, 18 June 2015. Free Communications Authors were invited to submit abstracts on their latest re search findings. All submitted abstracts were reviewed and the best were selected and allocated to Free Communication Sessions.

10 WFSBP 2015 Scientific Information

The underlying topics of the congress are as follows:

T1 Addictive Disorders T24 Neurophysiology T2 Antidepressants: Basic / Clinical T25 Obsessive-Compulsive Disorders: Basic / Clinical T3 Antipsychotics: Basic / Clinical T26 Oncopsychiatry T4 Anxiety Disorders: Basic / Clinical T27 Pain: Basic / Clinical T5 Anxiolytics: Basic / Clinical T28 Panic Disorders: Basic / Clinical T6 Bipolar Disorders: Basic / Clinical T29 Personality Disorders: Basic / Clinical T7 Childhood & Adolescent Disorders: Basic / Clinical T30 Pharmacoeconomics T8 Cognitive Neuroscience T31 Pharmacogenetics T9 Dementia: Basic / Clinical T32 Pharmacology T10 Depression: Basic / Clinical T33 Posttraumatic Stress: Basic / Clinical T11 Eating Disorders: Basic / Clinical T34 Pregnancy, post partum and new born: Basic / Clinical T12 Emergency Psychiatry T35 Premenstrual Syndrome: Basic / Clinical T13 Epidemiology T36 Psychogeriatrics T14 Ethics and Psychiatry T37 Psychoneuroimmunology T15 Forensic Psychiatry T38 Psychopathology T16 Genetics T39 Psychosurgery T17 Hypnotics: Basic / Clinical T40 Schizophrenia: Basic / Clinical T18 Liaison Psychiatry T41 Sexual Disorders: Basic / Clinical T19 Mental Retardation or Chromosomal Aberrations: T42 Sleep Disorders: Basic / Clinical Basic / Clinical T43 Somatoform Disorders: Basic / Clinical T20 Molecular Neurobiology T44 Stimulation Methods (ECT, TMS, VNS, DBS) T21 Mood Stabilisers: Basic / Clinical T45 Stress: Basic / Clinical T22 Neuropathology T46 Suicide: Basic / Clinical T23 Neuroimaging: Genetic, Functional, Structural T47 Violence: Basic / Clinical

CME Accreditation The '12th World Congress of Biological Psychiatry' is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net. The ’12th World Congress of Biological Psychiatry’ is designated for a maximum of (or ‘for up to’) 23 hours of European external CME credits. Each medical specialist should claim only those credits that he/she actually spent in the educational activity. Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMAcredit can be found at www.ama-assn.org/go/internationalcme Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada. EACCME credits Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity. The EACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day and 6 ECMECs for a full-day event.

11 WFSBP 2015 Opening Ceremony

Sunday, 14 June 2015 Beginning: 18:00

Master of Ceremony Professor Dimitris Dikeos, Greece

OPENING ADDRESS Professor Constantin R. Soldatos, WFSBP President

WELCOME ADDRESSes Georgios Kaminis, Mayor of Athens Professor Dimitris Nanopoulos, President of the Academy of Athens Professor Georgios Zografos, Vice Rector of the University of Athens

Presentation of Distinctions and Awards

Distinctions presented by Professor Constantin R. Soldatos Professor Florence Thibaut, France, being pronounced WFSBP Honorary President Professor Lakshmi Yatham, Canada, being presented with Presidential Commendation

Awards presented by Professor Florence Thibaut Professor Janusz Rybakowski, Poland / WFSBP Lifetime Achievement Award in Biological Psychiatry Professor Rupert Lanzenberger, Austria / WFSBP Research Award Professor E. Mohandas, India / WFSBP Award for Excellence in Mentorship Professor Bilgen Taneli, Turkey / WFSBP Award for Excellence in Mentorship Professor Philippe Courtet, France / WFSBP Award for Excellence in Education Professor Konstantinos Fountoulakis, Greece / WFSBP Award for Excellence in Education

Prize presented by Professor Siegfried Kasper Professor Heinz Grunze, United Kingdom The World Journal of Biological Psychiatry Excellence in Publication Prize

Music by the Athens Municipality Choir

OPENING LECTURE “Risk and resilience for psychosis and autism: Do developmental brain changes matter?” Speaker: Professor Christos Pantelis, Australia/Greece Chair: Professor Constantin R. Soldatos, Greece Co-chair: Professor Tudor Udristoiu, Romania

The Opening Ceremony is followed by a Networking Reception in the Megaron Athens International Conference Centre.

12 WFSBP 2015

Saturday and Sunday, 13 –14 June 2015 | Scientific Programme Overview

Saturday, 13 June 2015

Eginition Psychiatric Hospital PCS-01 13:00 – 16:00 Neuroinflammation, neuroprogression, and neuroplasticity: An integrative approach towards understanding psychiatric disorders

Place: Eginition Psychiatric Hospital, University of Athens, 72-74 Vassilissis Sofias Ave, Athens Auspices: 1st Department of Psychiatry, University of Athens Medical School Free of charge for all registered congress delegates. Congress registration must be done online beforehand: www.wfsbp-congress.org The confirmation of congress registration must be shown in order to attend the session.

Sunday, 14 June 2015

Trianti Hall – Megaron Athens International Conference Centre

16:00 – 17:30 SA-01 Industry sponsored symposium

Opening Ceremony including OL-01: 18:00 – 19:30 Risk and resilience for psychosis and autism: Do developmental brain changes matter?

Structure of the Scientific Programme The scientific programme is structured by day, by format and within format it is sorted by time. All presenters are listed by name and the title of their presentation. The different formats are highlighted in different colours in order to recognize them throughout the programme:

Formats – Colour Legend

WS – Workshops RT – Round Table

PL – Plenary Lectures TG – Treatment Guideline Sessions

P – Poster Presentations FC – Free Communications

S – Symposia ES – Educational Grant Sessions

D – Debates SA – Satellite Symposia

13 WFSBP 2015

Scientific Programme Overview | Monday, 15 June 2015

Hall Trianti Mitropoulos Skalkotas MC 3 MC 2 Time

8:30 S-01 S-02 S-19 S-04 S-05 Advances in child A better use of antipsy Serotonin and Alcohol, nicotine and Sex differences in the psychiatry research chotics to improve the neuroplasticity metamphetamine neurobiology of fear 9:00 prognosis of schizo addiction, progress at and anxiety: A trans phrenia basic and clinical fronts lational approach 9:30

10:00 PL-01 DSM, ICD and RDoc and the future of 10:30 psychiatric diagnosis

Break 11:00 RT-01 S-52 S-38 TG-01 S-08 Drug discovery in Identifying biomarkers New challenges in Task Force on Bipolar Behavioral addictions: of treatment outcome psychoactive sub Disorders: Improving Diagnosis, co-morbi 11:30 neuroscience: Why is big pharma reluctant to in depression: Canadian stances and addictions longitudinal treatment dity and neurobiology continue investing? network for biomarker treatments for bipolar disorders integration in depres including mixed states 12:00 sion guidelines

12:30 Break

13:00 FC-03 FC-04 FC-05 FC-06 Antidepressants Dementia Genetics Eating / Sleeping / Perso nality Disorders 13:30

14:00

14:30 Break

15:00 S-11 S-12 TG-02 S-13 S-14 Biological overlaps Epigenetic acquisitions Task Force Identifying the biologi Neuron-Glia inter between schizophrenia in mood disorders: Im on Genetics cal targets of treatment actions and neuro 15:30 and autism spectrum plication for pathophy response to neuromo psychiatric disease: disorders: Neuroima siology and treatment dulation in resistant Implications for novel ging and neurophysi psychiatric disorders therapeutics 16:00 ology

16:30 FC-09 WS-01 WS-02 WS-03 Depression Lithium phobia: Mood disorders and Neurocognitive and 17:00 Science or superstition? bipolar spectrum: How functional impairment SA-02 to get over diagnostic in mood disorders Industry sponsored problems symposium 17:30

18:00

18:30

14 WFSBP 2015

Monday, 15 June 2015 | Scientific Programme Overview

Hall Kokkali Conference Room 1 MC 3.3 Muses Foyer Time

FC-01 FC-02 8:30 Schizophrenia Depression Registration (Mitropoulos Foyer) 07:30 – 18:00 9:00

Technical Exhibition 09:00 – 17:00 9:30

Poster Exhibition 10:00 09:00 – 17:00

10:30

Break S-09 S-10 11:00 Major psychopathology D-amino acids and during adolescence and D-amino acid oxi 11:30 early adulthood: The dase (DAAO) based dynamic developmental modulation of NMDAR interplay between pro neurotransmission: Dia 12:00 tective and risk factors gnostic and therapeutic implications 12:30 Break

Guided Poster Tours 13:00 Forum-01 FC-07 Achieving interaction Neuroimaging P-01 – P-06 12:45 – 14:15 among Greek scientists 13:30 involved in Biological Psychiatry worldwide ES-01 14:00 Session 1 on basic 14:30 research issues Break

S-15 FC-08 15:00 Convergent approaches Antipsychotics to impulsivity: The role 15:30 of noradrenaline in ADHD and Parkinson‘s disease 16:00

WS-04 WS-05 16:30 Evaluation and manage Role of aldosterone ment of youth with and mineralocorticoid 17:00 autism spectrum disor receptor function in ders and co-morbid be emotion-regulation havioral and neurologic 17:30 symptoms

18:00

18:30

15 WFSBP 2015

Scientific Programme Overview | Tuesday, 16 June 2015

Hall Trianti Mitropoulos Skalkotas MC 3 MC 2 Time

8:30 S-16 S-17 S-18 S-03 S-20 Biological and clinical Recent advances in Metabotropic glu Novel mechanisms of Nitric oxide, glutamate aspects of mood dis understanding and tamate receptors action of antidepres and schizophrenia: 9:00 orders with psychotic treating psychiatric in drug and alcohol sant treatment New insights features disorders in pregnancy dependence and postpartum 9:30

10:00 PL-02 Off label use in 10:30 psychiatry

Break 11:00 D-01 S-21 S-22 TG-03 S-23 Are children CANMAT clinical Biomarkers in Guidelines on Depres Latency to pharmaco guidelines for bipolar psychiatric disorders sion: Globalization or logical treatments in 11:30 overmedicated? disorders 2013: localization psychiatric disorders: The evolution continues Epidemiological, biological and clinical 12:00 aspects

12:30

13:00 Break

13:30 SA-03 Industry sponsored symposium 14:00

14:30

15:00 S-26 S-27 TG-04 S-28 S-29 Neuroimaging and risk Therapeutic drug moni Task Force on Paraphi Glutamatergic mecha Alpha4beta2-nicotinic for schizophrenia toring, pharmacogene lic Disorders: Paraphilia nisms in schizophrenia: acetylcholine recep 15:30 tics and brain imaging treatment for adults From ketamine to tors in schizophrenia: methods as tools for and adolescents genetic models Implications for improving pharmaco smoking cessation and 16:00 therapy therapeutics

16:30 WS-18 FC-13 WS-06 WS-07 WS-08 Treating opioid de Depression Transcranial magnetic Metabolic disturbances Pathways associating in schizophrenia: Epi 17:00 pendence: The future stimulation studies of stress to the neurobio of treatment tailoring neurophysiology, neu demiology, pathophy logy of suicide siology and antipsycho and managing risk for roplasticity, and neuro tics – towards clinical 17:30 patients on substitute cognition in psychiatric application of genetic opioid therapies disorders risk models and new treatment strategies 18:00

18:30

16 WFSBP 2015

Tuesday, 16 June 2015 | Scientific Programme Overview

Hall Kokkali Conference Room 1 MC 3.3 Muses Foyer Time

FC-10 FC-11 8:30 Addiction Child and Adolescent Registration (Mitropoulos Foyer) Psychiatry 08:00 – 18:00 9:00

Technical Exhibition 09:00 – 17:00 9:30

Poster Exhibition 10:00 09:00 – 17:00

10:30

Break S-24 S-25 11:00 Oxytocin and social Sleep, spindles, and cognition: From social schizophrenia 11:30 attachment and reward to novel treatments for autism 12:00

12:30

Break Guided Poster Tours 13:00 P-07 – P-13 12:45 – 14:15 13:30

ES-02 14:00 Session 2 on pharmacological 14:30 treatment

S-30 FC-12 15:00 Clinical neurochemistry Schizophrenia in the early diagnosis of 15:30 dementia disorders

16:00

WS-09 WS-10 16:30 Biological approaches Patient‘s response to toward clarifying hetero treatment: A neurobio 17:00 geneities of obsessive- logical approach compulsive disorder 17:30

18:00

18:30

17 WFSBP 2015

Scientific Programme Overview | Wednesday, 17 June 2015

Hall Trianti Mitropoulos Skalkotas MC 3 MC 2 Time

8:30 S-31 S-32 S-33 S-34 S-35 Novel biomarkers Biological markers of Translational psychiatry Cross species stu Clinical applications and in mood disorders: cognitive deficits and in mood disorders and dies of psychedelic technical foundations of 9:00 Opportunities for negative symptoms in suicide drugs – relevance to transcranial Direct Cur translation into clinical schizophrenia psychiatric disorders rent Stimulation (tDCS), practice a non-invasive brain 9:30 stimulation therapy, in psychiatric disorders 10:00 PL-03 Neuropsychiat ric syndromes of later 10:30 life: Implications ...

Break 11:00 D-02 S-36 S-37 TG-05 S-07 Behavioral addictions – Brain imaging and treat Immunogenetics: Task Force on Noso Anxiety disorders – cli ment response Exploring new territory logy: Psychopatholo nical and biological 11:30 normality or deviance? in schizophrenia gy – past, present and markers in diagnosis future and treatment 12:00

12:30

13:00 Break

13:30 SA-04 Industry sponsored symposium 14:00

14:30

15:00 S-41 S-42 TG-06 S-43 S-44 Resolving the missing Computational, cogni Task Force on Schizo Sleep and neuroplasti Inflammation and link between physical tive and pharmacolo phrenia city: Clinical implica mitochondrial 15:30 and mental pain: Basic, gical connectomics: tions for depression dysfunction: clinical, and translatio Towards understanding Relevance to nal approaches mechanisms of psy depression 16:00 chosis

16:30 FC-18 WS-16 WS-11 WS-12 WS-13 Brain Stimulation Development of Treatment of schizo Task force recommen Interaction between 17:00 Therapies biological markers for phrenia: Personalized dations for the manage neurobiological and differential diagnosis of tailoring to meet ment of comorbidity ethno cultural factors dementia in physiolo patients needs in major depressive in PTSD treatment 17:30 gical and biochemical disorder and bipolar response, recovery strategies disorder and resilience. Is there a link? 18:00

18:30

18 WFSBP 2015

Wednesday, 17 June 2015 | Scientific Programme Overview

Hall Kokkali Conference Room 1 MC 3.3 Muses Foyer Time

FC-14 FC-15 8:30 Addiction Anxiety Disorders Registration (Mitropoulos Foyer) 08:00 – 18:00 9:00

Technical Exhibition 09:00 – 17:00 9:30

Poster Exhibition 10:00 09:00 – 17:00

10:30

Break S-39 S-40 11:00 Molecular and genetic Advances in repetitive substrates underpin Transcranial Magnetic 11:30 ning diagnosis of major Stimulation (rTMS) as depression treatment for psychiatric disorders 12:00

12:30

Break Guided Poster Tours 13:00 P-14 – P-20 12:45 – 14:15 13:30

14:00

14:30

FC-16 FC-17 15:00 Liaison Psychiatry Depression / Psycho pharmacology 15:30

16:00

WS-14 WS-15 16:30 Suicide and behavioral A Latin American addiction in Korea: contribution to bipolar 17:00 Searching for the bio disorders psychosocial basis in the fast changing society 17:30

18:00

18:30

19 WFSBP 2015

Scientific Programme Overview | Thursday, 18 June 2015

Hall Trianti Mitropoulos Skalkotas MC 3 MC 2 Time

8:30 S-45 S-46 S-47 S-48 S-49 Advances in genetics The latest international Defining and re- Understanding Psychobiology of men‘s of affective disorders findings regarding TMS defining the boundaries psychiatric disorders: mental health 9:00 for treating depression of psychotic disorders Recent advances in using neuroimaging postmortem research 9:30

10:00 PL-04 Neurobiological correlates of fear and 10:30 anxiety and ...

Break 11:00 D-03 S-51 S-06 TG-07 S-53 Should anxiety dis Molecular determinants Major controversies for Task Force on Addictive The impact of tobacco of suicide the treatment of bipolar Disorders: Biological and cannabis use on 11:30 orders be treated with medication? disorders treatments of sub psychosis liability and stance use disorders: illness long term out Recent developments come: Epidemiological 12:00 and findings evidence across Europe and Australia 12:30 Break

13:00 FC-20 FC-21 FC-22 FC-23 Schizophrenia Schizophrenia Schizophrenia Depression 13:30

14:00

14:30 Break

15:00 S-56 S-57 S-58 S-59 S-60 Development of bi Central role of glial Diagnostic and prog Dysregulation of tyrosi Neural oscillations: omarkers for neuro cells in the pathogene nostic stratification ne transport influence Translational research 15:30 psychiatric disorders: sis of schizophrenia of affective disorders dopamine function and in psychiatry State-of-the-art and based on inflammation cause cognitive deficits challenges ahead biomarkers and immu in schizophrenia 16:00 ne related neurotrans mitter pathways 16:30

17:00 Closing Ceremony

17:30

20 WFSBP 2015

Thursday, 18 June 2015 | Scientific Programme Overview

Hall Kokkali Conference Room 1 MC 3.3 Muses Foyer Time

S-50 FC-19 8:30 The importance of Anxiety Disorders Registration (Mitropoulos Foyer) 08:00 – 17:00 pharmacovigilance in 9:00 psychiatric inpatient ES-03 populations Session 3 Poster Exhibition on brain stimulation 09:00 – 17:00 9:30 methods

10:00

10:30

Break S-54 S-55 11:00 Recent research data in New insights of clinical, electroconvulsive thera neurobiological and ge 11:30 py and how they inform netic aspects in mental state of the art clinical illness practice 12:00

12:30 Break

Guided Poster Tours 13:00 FC-24 FC-25 Bipolar Disorder Violence P-21 – P-26 12:45 – 14:15 13:30

14:00

14:30 Break

S-61 FC-26 15:00 A paradigm shift in Pharmacogenetics studies of affective 15:30 disorders

16:00

16:30

17:00

17:30

21 We organize your success

CPO HANSER SERVICE is specialist in the ﬁ eld of Conference, Event, Destination and Association Management organizing events of any size throughout Germany and also abroad for more than 30 years.

CONFERENCE – EVENT – DESTINATION – ASSOCIATION MANAGEMENT – IT SOLUTIONS

We offer you:

n the best congress organization n state-of-the-art online solutions n electronic abstract handling n CME accreditation handling n effective congress technology n sponsoring and exhibition acquisition and management n ﬁ nance management n professional tax solutions n creative event programs n websites and apps n graphic design n association management

BERLIN HAMBURG GLOBIT HAMBURG Paulsborner Straße 44 Zum Ehrenhain 34 Am Akku 7 14193 Berlin 22885 Barsbüttel 22885 Barsbüttel fon +49-30-300 669 0 fon +49-40-670 882 0 fon +49-40-670 882 0 fax +49-30-305 73 91 fax +49-40-670 32 83 fax +49-40-670 32 83 Email: [email protected] Email: [email protected] Email: [email protected] www.cpo-hanser.de WFSBP 2015

Saturday, 13 June / Sunday, 14 June 2015 | Scientific Programme

Saturday, 13 June 2015 Sunday, 14 June 2015

OL-01 Opening Ceremony Place Eginition Psychiatric Hospital, University of Athens 18:00 – 19:30 Trianti Hall 72-74 Vassilissis Sofias Ave, Athens Opening Lecture Chair: Constantin R. Soldatos, Greece Auspices Co-Chair: Tudor Udristoiu, Romania 1st Department of Psychiatry, University of Athens Medical School OL-01-001 Risk and resilience for psychosis and autism: Do develop- Free of charge for all registered congress delegates. mental brain changes matter? Congress registration must be done online beforehand: Christos Pantelis, Australia www.wfsbp-congress.org Please see page 12. The confirmation of congress registration must be shown in order to attend the session. SA-01 industry sponsored Symposium 16:00 – 17:30 Trianti Hall PCS-01 Pre-Congress Symposium see page 97. 13:00 – 16:00 eginition Psychiatric Hospital Neuroinflammation, neuroprogression, and neuroplasticity: An integrative approach towards understanding psychiatric disorders Chair: Angelos Halaris, USA Co-Chair: Michael Maes, Thailand

PCS-01-001 From activated immune-inflammatory pathways to neuroprogression Michael Maes, Thailand PCS-01-002 Molecular mechanisms by which early life stress increases vulnerability to mental health disorders Carmine Pariante, United Kingdom PCS-01-003 Molecular mechanisms of neuroprogression Jussi Jokinen, Sweden PCS-01-004 Prevention of neuroprogression after a first episode of mania Michael Berk, Australia PCS-01-005 Central and peripheral inflammatory markers in mood disorders and suicide Ghanshyam Pandey, USA PCS-01-006 Inflammation control reverses treatment restistance in bipolar depression Angelos Halaris, USA Discussant: Elias Angelopoulos, Greece

23 WFSBP 2015

Scientific Programme | Monday, 15 June 2015

PL-01 Plenary lecture S-02-003 Relapse prevention and long-acting injectable antipsycho 10:00 – 10:45 Trianti Hall tics in early phases of schizophrenia Chair: Lakshmi Yatham, Canada Eduard Parellada, Spain S-02-004 PL-01-001 Interest of guidelines to improve the everyday use of anti DSM, ICD and RDoc and the future of psychiatric diagnosis psychotics: Methodological, and implementation aspects Mario Maj, Italy Pierre-Michel Llorca, France

T7: Childhood & Adolescent Disorders: Basic / Clinical T24: Neurophysiology S-01 Symposium S-19 Symposium 08:30 – 10:00 Trianti Hall 08:30 – 10:00 Skalkotas Hall Advances in child psychiatry research Serotonin and neuroplasticity Chair: Joseph Biederman, USA Chair: Rupert Lanzenberger, Austria Co-Chair: Gagan Joshi, USA Co-Chair: Christoph Kraus, Austria

S-01-001 S-19-001 Are autistic traits clinically meaningful? Effects of serotonin on neurostimulation induced cortical Joseph Biederman, USA plasticity S-01-002 Walter Paulus, Austria Resting state functional connectivity analysis of social net- S-19-002 works in adolescents and young adults with high-function- Serotonin and neuroplasticity ing autism spectrum disorder Eero Castren, Finland Gagan Joshi, USA S-19-003 S-01-003 Serotonin and neuroplasticity investigated in vivo with Resting state functional connectivity in a longitudinal study neuroimaging of ADHD children grown up Christoph Kraus, Austria Mai Uchida, USA S. Kasper, R. Lanzenberger S-01-004 S-19-004 Memantine in the treatment of adults with ADHD Neural plasticity in the etiology and therapy of psychiatric Thomas Spencer, USA disorders Tilo Kircher, Germany

T3: Antipsychotics: Basic / Clinical

S-02 Symposium T1: Addictive Disorders 08:30 – 10:00 Mitropoulos Hall S-04 Symposium A better use of antipsychotics to improve the prognosis 08:30 – 10:00 MC 3 Room of schizophrenia Alcohol, nicotine and metamphetamine addiction, pro- Chair: Miquel Bernardo, Spain gress at basic and clinical fronts Co-Chair: Philippe Courtet, France Chair: Yousef Tizabi, USA S-02-001 Co-Chair: Rosario Moratalla, Spain Pharmacogenetic of antipsychotics, as a tool to improve S-04-001 response to cognitive remediation Alcohol and nicotine interactions: Implications for drink- Roberto Cavallaro, Italy ing-smoking co-morbidity S-02-002 Yousef Tizabi, USA Advantages of long-acting injectable antipsychotics (in S-04-002 everyday life) Metamphetamine damage of dopaminergic neurons and Dieter Naber, Germany motor consequences Rosario Moratalla, Spain

24 WFSBP 2015

Monday, 15 June 2015 | Scientific Programme

S-04-003 S-52-003 Imaging and clinical intervention in metamphetamine ad- Genese: Pharmacogenetic response to antidepressant diction treatment in the general population treated for depression Hamed Ekhtiari, Iran Nicolas Ramoz, France S-04-004 Y. Le Strat, P. Courtet, P. Gorwood Clinical intervention in drinking-smoking co-morbidity S-52-004 Bo Söderpalm, Sweden CANBIND – Update on the progress so far A. deBejczy, E. Lof, L. Walther, A. Isaksson, J. Guterstam, Sidney Kennedy, Canada A. Hammarberg, G. Asanovska, J. Franck

T1: Addictive Disorders T4: Anxiety Disorders: Basic / Clinical S-38 Symposium S-05 Symposium 11:00 – 12:30 Skalkotas Hall 08:30 – 10:00 MC 2 Room New challenges in psychoactive substances and addic- Sex differences in the neurobiology of fear and anxiety: tions treatments A translational approach Chair: Amine Benyamina, France Chair: Mohammed Milad, USA Co-Chair: Franco Tagliaro, Italy Co-Chair: Oliver Wolf, Germany S-38-001 S-05-001 Clinical efficacy of high dose of baclofen in reducing alcohol Sex-dependent vulnerability and response of brain circuits consumption in affective disorders and treatment: Evidence from pre- Philippe Jaury, France clinical models S-38-002 Ioannis Sotiropoulos, Portugal Impact of chronic cannabinoid adolescent exposure on S-05-002 prefrontal structure and function Sex differences: Gonadal hormone modulation of fear ex- Therese Jay, France tinction G. Le Pen, M.-O. Krebs, J. Renard Lisa Maeng, USA S-38-003 S-05-003 New challenges for forensic toxicology from the “New Psy- Stress and emotional learning in humans: Does sex make choactive Substances” a difference? Franco Tagliaro, Italy Oliver Wolf, Germany S-38-004 C. Merz Acute human effects of synthetic cannabinoids: How are S-05-004 they related to cannabinoid receptor ligand properties? Influence of estrogen on the neural correlates of fear ex- David Gorelick, USA tinction across species Kelimer Lebron-Milad, USA

T1: Addictive Disorders S-08 Symposium T10: Depression: Basic / Clinical 11:00 – 12:30 MC 2 Room S-52 Symposium Behavioral addictions: Diagnosis, co-morbidity and 11:00 – 12:30 Mitropoulos Hall neurobiology Identifying biomarkers of treatment outcome in depres- Chair: Aviv Weinstein, Israel sion: Canadian network for biomarker integration in de- Co-Chair: Marc Potenza, USA pression Chair: Sidney Kennedy, Canada S-08-001 Co-Chair: Gregor Hasler, Switzerland Hypersexuality: Obsession or addiction? Florence Thibaut, France S-52-001 S-08-002 Biomarkers and the future of treatment in depression A personal status, legal, economic and psychological com- Madhukar Trivedi, USA parison of types of adult male gamblers S-52-002 Pinhas Dannon, Israel Discovering endophenotypes in major depression Gregor Hasler, Switzerland

25 WFSBP 2015

Scientific Programme | Monday, 15 June 2015

S-08-003 S-10-002 Does food addiction exist? D-aspartate based modulation of NMDAR neurotransmis- Marc Potenza, USA sion: Clinical implication S-08-004 Alessandro Usiello, Italy Exercise addiction – brain and behavior S-10-003 Aviv Weinstein, Israel D-amino acid oxidase (DAAO) based modulation of NMDAR M. Gavriel, Y. Weinstein neurotransmission: Therapeutic implication Hsien-Yuan Lane, Taiwan S-10-004 D-amino acid oxidase (DAAO) activator levels in peripheral T7: Childhood & Adolescent Disorders: Basic / Clinical blood: Diagnostic implication S-09 Symposium Chieh-Hsin Lin, Taiwan 11:00 – 12:30 Kokkali Room H.-Y. Lane Major psychopathology during adolescence and early adulthood: The dynamic developmental interplay between protective and risk factors T23: Neuroimaging: Genetic, Functional, Structural Chair: Paolo Brambilla, Italy S-11 Symposium Co-Chair: Jair C. Soares, USA 15:00 – 16:30 Trianti Hall S-09-001 Biological overlaps between schizophrenia and autism Grin2b mediates susceptibility to affective problems in spectrum disorders: Neuroimaging and neurophysiology children and adolescents Chair: Serge Mitelman, USA Maria Nobile, Italy Co-Chair: Monte Buchsbaum, USA S-09-002 Developmental imaging and cognitive markers of pediatric S-11-001 Parkinson‘s disease Neural correlates in autism spectrum disorders and schiz- Jair C. Soares, USA ophrenia S-09-003 Junko Fukushima, Japan Functional imaging markers of psychosis during adoles- T. Miyamoto, A. Toyomaki, N. Hashimoto, I. Kusumi cence S-11-002 Vaibhav Diwadkar, USA Positron emission tomography in patients with schizophre- S-09-004 nia and autism spectrum disorders Risk and protective factors for psychopathology detected Marie-Cécile Bralet, France in the Mannheim Study of Children at Risk (MARS) S-11-003 Katrin Zohsel, Germany Srgap3-/ mice present a neurodevelopmental disorder with M. Laucht schizophrenia-related and autism-related intermediate phenotypes: Implications for psychiatry Robert Waltereit, Germany

T3: Antipsychotics: Basic / Clinical S-11-004 MRI and diffusion tensor imaging assessment in patients S-10 Symposium with schizophrenia and autistic disorder 11:00 – 12:30 Conference Room 1 Monte Buchsbaum, USA S. Mitelman D-amino acids and D-amino acid oxidase (DAAO) based modulation of NMDAR neurotransmission: Diagnostic and therapeutic implications Chair: Kenji Hashimoto, Japan Co-Chair: Hsien-Yuan Lane, Taiwan

S-10-001 Preclinical study of D-serine signaling in schizophrenia Kenji Hashimoto, Japan

26 WFSBP 2015

Monday, 15 June 2015 | Scientific Programme

T16: Genetics T20: Molecular Neurobiology S-12 Symposium S-14 Symposium 15:00 – 16:30 Mitropoulos Hall 15:00 – 16:30 MC 2 Room Epigenetic acquisitions in mood disorders: Implication Neuron-Glia interactions and neuropsychiatric disease: for pathophysiology and treatment Implications for novel therapeutics Chair: Carlo Altamura, Italy Chair: Thomas Sedlak, USA Co-Chair: Jean-Pierre Mothet, France S-12-001 Biological targets for epigenetic modulations in psychiatric S-14-001 disorders D-serine and glycine in gliotransmission: Synaptic and Nicolas Ramoz, France extra-synaptic targets S-12-002 Jean-Pierre Mothet, France Epigenetic regulation of BDNF gene in bipolar vs. unipolar M. Le Bail, S. Sacchi, l. Pollegioni, J.-M. Billard depressive disorders S-14-002 Bernardo Dell´Osso, Italy Neuron-astrocyte interactions – a critical juncture where S-12-003 gene-environment interactions increase risk of psychiatric Epigenetic mechanisms and endocannabinoid signaling: disease A putative treatment target for psychiatric disorders? Mikhail Pletnikov, USA Mauro Maccarrone, Italy S-14-003 Relationship between inflammatory cytokines, oxidative stress and astrogliosis markers and prefrontal grey matter volume in schizophrenia subgroups T44: Stimulation Methods (ECT, TMS, VNS, DBS) Vibeke Catts, Australia S-13 Symposium Y. Zhang, S. Fillman, J. Wong, S. Fung, C. Shannon Weickert 15:00 – 16:30 MC 3 Room S-14-004 Interplay of neurons and glia for glutamate and glutathione Identifying the biological targets of treatment response cycling – new avenues to target excitatory neurotransmis- to neuromodulation in resistant psychiatric disorders sion abnormalities in neuropsychiatric disorders Chair: Zafiris Daskalakis, Canada Thomas Sedlak, USA Co-Chair: Aristotle Voineskos, Canada

S-13-001 Neurophysiological and symptomatic changes induced by T8: Cognitive Neuroscience magnetic seizure therapy in depression Zafiris Daskalakis, Canada S-15 Symposium S-13-002 15:00 – 16:30 Kokkali Room Cognitive, structural and connectivity changes from re- Convergent approaches to impulsivity: The role of nor petitive magnetic stimulation to the prefrontal cortex in adrenaline in ADHD and Parkinson‘s disease schizophrenia Chair: Ulrich Müller, United Kingdom Aristotle Voineskos, Canada Co-Chair: Angie Kehagia, United Kingdom Z. J.Daskalakis, D. Blumberger, N. Neufeld, C. Hawco, T. Rajji S-13-003 S-15-001 ECT-induced changes in functional connectivity in treatment The involvement of the noradrenergic system in impulsivity resistant depression associated with ADHD and Parkinson’s disease Georgios Petrides, USA Manfred Gerlach, Germany M. Argyelan, S. Kaliora S-15-002 S-13-004 PET imaging of the noradrenergic system in ADHD and Neurobiological predictors of response to dorsolateral pre- Parkinson’s disease frontal cortex repititive transcranial magnetic stimulation Rupert Lanzenberger, Austria in depression S-15-004 Daniel Blumberger, Canada Noradrenergic modulation of impulsivity in Parkinson’s disease Angie Kehagia, United Kingdom

27 WFSBP 2015

Scientific Programme | Monday, 15 June 2015

T6: Bipolar Disorders: Basic / Clinical T32: Pharmacology TG-01 WFSBP Treatment Guidelines RT-01 Round Table 11:00 – 12:30 MC 3 Room 11:00 – 12:30 Trianti Hall Task Force on Bipolar Disorders: Improving longitudinal Drug discovery in neuroscience: Why is big pharma re- treatment for bipolar disorders including mixed states luctant to continue investing? guidelines Chair: Lakshmi Yatham, Canada Chair: Siegfried Kasper, Austria Co-Chair: Shigenobu Kanba, Japan Co-Chair: Heinz Grunze, United Kingdom Discussants: Carlos A. Zarate, USA TG-01-001 Michel Bourin, France Bipolar mixed state guideline development Raimund Buller, Denmark Heinz Grunze, United Kingdom Maeda Kenji, Japan Sanjeev Pathak, USA TG-01-002 Matcheri S. Keshavan, USA Long term illness trajectories and their management Eduard Vieta, Spain TG-01-003 Multistate outcome and persistent benefit analysis T6: Bipolar Disorders: Basic / Clinical Charles L. Bowden, USA WS-01 Workshop 16:30 – 18:00 Skalkotas Hall

T16: Genetics Lithium phobia: Science or superstition? Chair: Digvijay Goel, New Zealand TG-02 WFSBP Treatment Guidelines Co-Chair: Mohan Isaac, Australia 15:00 – 16:30 Skalkotas Hall WS-01-001 Task Force on Genetics Lithium: Science or superstition? Chair: Dan Rujescu, Germany Digvijay Goel, New Zealand Co-Chair: Mick C. O‘Donovan, United Kingdom WS-01-002 TG-02-001 Lithium: The magic ion Genomics of schizophrenia: Results from the largest as- Shailesh Kumar, New Zealand sociation study so far WS-01-003 Mick C. O‘Donovan, United Kingdom Lithium vs. sodium valproate: Understanding the dilemma TG-02-002 Rajesh Nagpal, India The genetics of schizophrenia: Back to family studies WS-01-004 Lynn Delisi, USA Lithium: The way forwards TG-02-003 Mohan Isaac, Australia Genetics of intermediate phenotypes: Focus on cognition Dan Rujescu, Germany TG-02-004 Clinical application of psychiatric pharmacogenetic testing James Kennedy, Canada

28 WFSBP 2015

Monday, 15 June 2015 | Scientific Programme

T6: Bipolar Disorders: Basic / Clinical T7: Childhood & Adolescent Disorders: Basic / Clinical WS-02 Workshop WS-04 Workshop 16:30 – 18:00 MC 3 Room 16:30 – 18:00 Kokkali Room Mood disorders and bipolar spectrum: How to get over Evaluation and management of youth with autism spec- diagnostic problems trum disorders and co-morbid behavioral and neuro- Chair: Giuseppe Tavormina, Italy logic symptoms Co-Chair: Nicolas Zdanowicz, Belgium Chair: Adelaide Robb, USA Co-Chair: Peter Daniolos, USA WS-02-001 Bipolarity during the adolescence: When do we treat them? WS-04-001 Nicolas Zdanowicz, Belgium Multidisciplinary team evaluation of youth with autism D. Jacques, C. Reynaert Peter T. Daniolos, USA WS-02-002 WS-04-002 Depression and work related stress problems, with notes Treatment of disruptive behavior and aggression in autism of comparative law Adelaide Robb, USA Marilisa Amorosi, Italy WS-04-003 R. Pettinelli Recognition and management of epilepsy in autism WS-02-003 William Gaillard, USA Depressive disorders and resilience WS-04-004 Sandro Elisei, Italy Use of telehealth to increase accessibility of evidence-based R. Quartesan, S. Anastasi, N. Verdolini intervention for children with PDD WS-02-004 Todd Kopelman, USA Evaluation of cases reports of bipolar spectrum mixed states: A diagnostic-therapeutic approach Giuseppe Tavormina, Italy T10: Depression: Basic / Clinical WS-05 Workshop

T8: Cognitive Neuroscience 16:30 – 18:00 Conference Room 1 WS-03 Workshop Role of aldosterone and mineralocorticoid receptor function in emotion-regulation 16:30 – 18:00 MC 2 Room Chair: Mike Franklin, United Kingdom Neurocognitive and functional impairment in mood dis- Co-Chair: Alan Kim Johnson, USA orders Chair: Sagar Parikh, Canada WS-05-001 Co-Chair: Roumen Milev, Canada Aldosterone in stress related depression models Mike Franklin, United Kingdom WS-03-001 WS-05-002 Neurocognitive deficits in mood disorders: Biological un- Sodium deficiency and mood:T he brain renin-angioten- derpinnings sin-aldosterone system in the craving for salt and in an- Benicio Frey, Canada hedonia WS-03-002 Alan Kim Johnson, USA Clinical assessment of neurocognition: The basis for im- WS-05-003 proved clinical outcomes Aldosterone and mineralocorticoid function as predictors Michael Berk, Australia of antidepressant response WS-03-003 Matthias Buettner, Germany Neurocognitive and functional outcomes in bipolar dis- WS-05-004 orders The role of mineralocorticoid receptors in emotional re Serge Beaulieu, Canada gulation in borderline personality disorder WS-03-004 Katja Wingenfeld, Germany Neurocognitive and functional outcomes in depression Arun Ravindran, Canada

29 WFSBP 2015

Scientific Programme | Monday, 15 June 2015

Forum-01 Forum ES-01-006 Meta-analysis of treatments for anxiety disorders 13:00 – 14:30 Kokkali Room Borwin Bandelow, Germany Achieving interaction among Greek scientists involved ES-01-007 in Biological Psychiatry worldwide Structural, functional and molecular brain imaging in psy- Chair: Nikos C. Stefanis, Greece chiatry Co-Chair: Antonis Politis, Greece Rupert Lanzenberger, Austria Secretaries: Alexander Hatzimanolis, Greece ES-01-008 Rigas Soldatos, Greece How to get grants and publish papers Presenters: V. Brakoulias, Australia Siegfried Kasper, Austria P.T. Daniolos, USA M. Filiou, Germany A. Halaris, USA C. Lyketsos, USA FC-01 Free Communications M. Mavrikaki, USA 08:30 – 10:00 Kokkali Room K. Patas, Germany Schizophrenia C. Pantelis, Australia Chair: Brian Dean, Australia G. Petrides, USA Co-Chair: Nikos C. Stefanis, Greece C. Phassouliotis, Australia Y. Trakadis, Canada FC-01-001 D. Velakoulis, Australia Social brain activity during theory of mind in first episode N. Venizelos, Sweden psychosis: Comparison with healthy controls and link to symptoms Discussion among all participants Cali Bartholomeusz, Australia E. Ganella, S. Whittle, A. Abu-Akel, K. Allott, A. Thompson, P. McGorry, E. Killackey, C. Pantelis, S. J. Wood FC-01-002 ES-01 Educational Session Genetic influences on multivariate cognitive endopheno- 14:00 – 18:00 MC 3.3 Room types of positive symptom schizophrenia Session 1 on basic research issues Narayan R. Mutalik, India Chairs: Florence Thibaut, France H. HN, S. Jain, J. P. John Tudor Udristoiu, Romania FC-01-003 Co-Chairs: Victoria Valdez de Vuibert, Ecuador Ketamine as a model for schizophrenia deficits Anu Kant Mital, India Erica Neill, Australia S. Rossell, C. Morgan, O. Carter, N. Joshua ES-01-001 FC-01-004 What do we learn from genetics (the example of schizo- Prefrontal glutamate and cortical structure in schizophrenia: phrenia) A combined brain metabolic and neuroanatomical study Florence Thibaut, France in antipsychotic naïve patients ES-01-002 Carl Christoph Schultz, Germany What do we learn from genetics (the example of schizo- A. Gussew, I. Nenadic, H. Sauer, S. Smesny phrenia) FC-01-005 Dan Rujescu, Germany Similar age-related decline in cortical activity over fronto- ES-01-003 temporal regions in schizophrenia: A multi-channel near- What do we learn from pharmacology (the example of infrared spectroscopy study anxiolytics mechanism of action) Po Han Chou, Taiwan Michel Bourin, France S. Koike, Y. Nishimura, Y. Satomura, A. Kinoshita, R. Taki- ES-01-004 zawa, K. Kasai Biomarkers in psychiatry Peter Riederer, Germany ES-01-005 What do we learn from meta-analysis Alessandro Serretti, Italy

30 WFSBP 2015

Monday, 15 June 2015 | Scientific Programme

FC-01-006 FC-02-005 Social anhedonia and gamma band oscillations in remit- The patterns of fractional amplitude of low-frequency fluc- ted schizophrenia patients and their first degree relatives: tuations in depression patients: The dissociation between A high resolution eeg study temporal regions and fronto-parietal regions Shreekantiah Umesh, India Chien-Han Lai, Taiwan S. H. Nizamie, N. Goyal Y.-T. Wu FC-01-007 FC-02-006 Sixteen biomarkers for schizophrenia and schizoaffective Cognitive ability in childhood and the chronicity and sui- disorder from a case-control study, yield a clinically-mean- cidality of depression ingful five domain working model with predictive diagnostic Galen Chin-Lun Hung, Taiwan accuracy Stephanie Fryar-Williams, Australia S. Jorg FC-03 Free Communications 13:00 – 14:30 Mitropoulos Hall FC-02 Free Communications Antidepressants Chair: Heinz Grunze, United Kingdom 08:30 – 10:00 Conference Room 1 Co-Chair: Konstantinos Fountoulakis, Greece Depression Chair: Siegfried Kasper, Austria FC-03-001 Co-Chair: John Nimatoudis, Greece (TBC) Stress and antidepressant-induced effects on DNA me thylation and DNA methyltransferase expression in limbic FC-02-001 regions of rats submitted to learned helplessness Predicting treatment outcome in treatment resistant de- Samia Joca, Brazil pression using a large set of 53 clinical and demographic A. Sales predictors and machine learning FC-03-002 Alexander Kautzky, Austria The novel antidepressant spadin: Absence of side effects P. Baldinger, D. Souery, S. Montgomery, J. Mendlewicz, J. and neurogenesis action mechanism Zohar, A. Serretti, R. Lanzenberger, S. Kasper Marc Borsotto, France FC-02-002 J. Veyssiere, C. Devader, S. Moreno, C. Heurteaux, J. Ma- The specific pattern of gray matter alterations in major de- zella, H. Moha ou Maati pressive disorder and panic disorder: A diagnosis-specific FC-03-003 endophenotype model Fluoxetine alleivates behavioral impairments and soluble Chien-Han Lai, Taiwan beta-amyloid production in app/ps1 mice Y.-T. Wu Yanbo Zhang, Canada FC-02-003 J. Wang, Q. Huang, H. Zhang, H. Xu, J. Kong, X.-M. Li Role of melatonin MT1 receptor in melancholic depres- FC-03-004 sion and circadian rhythm: Insights from MT1 receptor Effect of ketamine in patients of treatment resistant de- knockout mice pression Stefano Comai, Canada Bharti Talreja, India R. Ochoa-Sanchez, S. Dominguez-Lopez, F. Rodriguez Bam- S. Reddy bico, G. Gobbi FC-03-005 FC-02-004 Ketamine and 3beta-methoxy-pregnenolone exhibit an The 6-year longitudinal association between telomere antidepressant effect in the endogeneously „depressed“ length & depression and anxiety disorders Wistar-Kyoto rat: A microtubular mechanism? Josine Verhoeven, The Netherlands Jack Prenderville, Ireland P. van Oppen, D. Révész, B. Penninx J. Rouine, M. Campion, S. O‘Mara, M. Bianchi

31 WFSBP 2015

Scientific Programme | Monday, 15 June 2015

FC-03-006 FC-05 Free Communications Seasonal variation of placebo effect in antidepressant cli nical trial: Very preliminary data 13:00 – 14:30 MC 3 Room Joël Gailledreau, France Genetics B. Gailledreau, S. Becque Chair: Carlo Altamura, Italy FC-03-007 Co-Chair: Panagiotis Ferentinos, Greece Pharmacogenetic polymorphisms and antidepressant adverse effects or nonresponse FC-05-001 Rajnish Mago, USA Gene expression profiling of 70 suicide victims with psychosis by using DNA microarray S. Gupta, K. Huhn, R. Shah Arvin Haghighatfard, Iran S. Jokari FC-05-002 FC-04 Free Communications Functional state of c-Fos, c-Jun, and Ier5 transcription fac- 13:00 – 14:30 Skalkotas Hall tors in schizophrenia Roksana Zakharyan, Armenia Dementia G. Mkrtchyan, S. Atshemyan, A. Chavushyan, A. Boyajyan Chair: Masatoshi Takeda, Japan FC-05-003 Co-Chair: Elizabeth Kapaki, Greece The nrg1 polymorphism is a genetic modifier of age at FC-04-001 onset in schizophrenia Regional amyloid burden and intrinsic connectivity net- Shiau Foon Tee, Malaysia works in cognitively normal elderly P. Y. Tang, T. J. Chow Hyun Kook Lim, Republic of Korea FC-05-004 R. Nebes, B. Snitz, A. Cohen, C. Mathis, J. Price, L. Weissfeld, TCF4 gene polymorphism and the risk of schizophrenia in W. Klunk, H. Aizenstein relation to age at onset, gender and family history FC-04-002 Tze Jen Chow, Malaysia Neuronal origin plasma exosomes provide novel biomark- S. F. Tee, P. Y. Tang ers of neuronal intracellular dysfunction in Alzheimer‘s FC-05-005 disease The 5-HTTLPR genotype modulates autonomic reactivity Dimitrios Kapogiannis, USA after pharmacological stress challenge in healthy men M. Mustapic, E. Eitan, A. Boxer, J. Schwartz, E. Abner, R. Agorastos Agorastos, Germany Petersen, B. Miller, E. Goetzl M. Kellner, O. Stiedl, K. Wiedemann, C. Demiralay FC-04-003 FC-05-006 Co-morbid medical conditions in vascular dementia: Genetic variant of FK506 binding protein-5 predicts nega- A matched case-control study tive affectivity in Serbian schizophrenia spectrum patients Ruby Castilla-Puentes, USA Marina Mihaljevic, Serbia M. Habeych S. Andric, T. Mirjanic, I. Soldatovic, I. Novakovic, J. van Os, FC-04-004 N. Maric Effects of serum IL-10 and IL-1ß levels on intestinal endo- FC-05-007 toxemia on Alzheimer‘s disease rat and in Chinese sample Parenting, gender and the polygenic risks for depression of Alzheimer‘s disease patients and healthy controls in adolescents Bai Han, People‘s Republic of China Evelien Van Assche, Belgium F. Wu, H. Li, C. Li, K. Liu, Q. Sun, Y. Gao, L. Ma, X. Shan T. Moons, A. Janssens, S. De Leat, P. Bijttebier, W. Van den FC-04-005 Noortgate, L. Goossens, S. Claes The potential role of nanotechnology in the diagnosis and treatment of Alzheimer‘s disease Jerzy Leszek, Poland J. Zhang

32 WFSBP 2015

Monday, 15 June 2015 | Scientific Programme

FC-06 Free Communications FC-07 Free Communications 13:00 – 14:30 MC 2 Room 13:00 – 14:30 Conference Room 1 Eating / Sleeping / Personality Disorders Neuroimaging Chair: Grigoris Vaslamatzis, Greece Chair: Rupert Lanzenberger, Austria Co-Chair: Eleftheria Varsou, Greece Co-Chair: Nikos Smyrnis, Greece

FC-06-001 FC-07-001 Effect of different REM sleep-suppressing strategies on Serotonin-1A and -2A receptor binding measured by PET in learning and memory consolidation in rats vivo correlates with mRNA expression in postmortem brains Lia Maisuradze, Georgia Arkadiusz Komorowski, Austria N. Lortkipanidze, N. Oniani G. M. James, G. Gryglewski, S. Kasper, R. Lanzenberger FC-06-002 FC-07-002 Central nervous system responses to thermoregulatory Increased cortical gray/white matter intensity contrast in challenge: Differences between lean and obese subjects schizophrenia and bipolar disorder compared to healthy Otto Muzik, USA controls V. Diwadkar Kjetil Nordbø Jørgensen, Norway FC-06-003 S. Nerland, L. Bonaventure Norbom, N. T. Doan, R. Nesvåg, U. White matter changes at the early stages of anorexia ner- K. Haukvik, I. Melle, O. A. Andreassen, L. T. Westlye, I. Agartz vosa in adolescents FC-07-003 Santino Gaudio, Italy Attenuated serotonin transporter binding with increased C. Piervincenzi, F. Carducci, C. C. Quattrocchi age in patients with attention deficit/hyperactivity disorder investigated by pet and [11c]dasb FC-06-004 Optogenetic and dread manipulation of sleep-active neu- Thomas Vanicek, Austria rons: Implications for insomnia H. L. Sigurdardottir, A. Hahn, G. Kranz, M. Spies, A. Kautzky, Peter Shiromani, USA C. Rami-Mark, T. Traub-Weidinger, M. Hacker, M. Mitterhauser, R. R. Konadhod, D. Pelluru, T. Uhde W. Wadsak, S. Kasper, R. Lanzenberger FC-06-005 FC-07-005 Polymorphism-g308a gene tnf-a and sleep disturbance in Genetic modulation of dopamine system and the response open populations men 25-64 years of Siberia (program to methylphenidate: An [18F]FDOPA-PET study who monica-psychosocial) Ingo Vernaleken, Germany Valery Gafarov, Russia I. Schabram, C. Dietrich, O. Winz, S. Mohammadkhani E. Gromova, A. Gafarova, I. Gagulin, D. Panov Shali, K. Henkel, S. Prinz, J. Schmaljohann, G. Gründer, FC-06-006 K. Zerres, F. Mottaghy The imagination of aggressive behavior down-regulates FC-07-006 limbic activation in female patients with borderline per- Involuntary interference in emotion dysregulation: sonality disorder Hyper-modulation of brain networks by the amygdala and Sabine Herpertz, Germany orbitofrontal cortex K. Nagy, F. Mancke, R. Schmitt, A. Gäbel, K. Bertsch Kristy Abraham, USA FC-06-007 V. Diwadkar, P. Soloff Towards best practice outcomes in clozapine therapy in forensic settings Guna Kanniah, New Zealand

33 WFSBP 2015

Scientific Programme | Monday, 15 June 2015

FC-08 Free Communications FC-09 Free Communications 15:00 – 16:30 Conference Room 1 16:30 – 18:00 Mitropoulos Hall Antipsychotics Depression Chair: Yuan Hwa Chou, Taiwan Chair: Angelos Halaris, USA Co-Chair: Charalambos Papageorgiou, Greece Co-Chair: Konstantinos Papageorgiou, Austria

FC-08-001 FC-09-001 Antipsychotic polypharmacy in severe mental disorders: Increased NPY and decreased DPP4 plasma levels are Efficacy and metabolic side effects associated with stress system alterations in children and José M. Pelayo-Terán, Spain adolescents with affective disorders Y. Zapico-Merayo, J. Martínez-Díez, N. Martín-Navarro Yulia Golub, Germany FC-08-002 A. Eichler, F. Canneva, O. Kratz, G. Moll, R. Funke Three-year follow-up after a first episode of psychosis: FC-09-002 Adherence and relapse Risk of cancer after suicide attempt – a nationwide cohort José M. Pelayo-Terán, Spain study in Sweden V. Gajardo-Galán, V. Ortiz-García de la Foz, O. Martí- Jussi Jokinen, Sweden nez-García, M. Gómez, B. Crespo-Facorro F. Mattsson, K. Lagergren, J. Lagergren, R. Ljung FC-08-003 FC-09-004 The effect of aripiprazole on hippocampal volume in Correlation between depression and cardiovascular diseases first-episode psychosis: A one year longitudinal neuro- Peter László, Hungary imaging study K. Schweitzer Martin Lepage, Canada FC-09-005 B. Michael, R. Joober, A. Malla Gamma power and theta-gamma coupling enhancement in FC-08-004 resting state electroencephalogram (EEG) following repet- Reduction of neuroinflammation by antipsychotic treatment itive transcranial magnetic stimulation (rTMS) in patients in a virus model for schizophrenia with treatment-resistant depression (TRD) Hans Klein, The Netherlands Yoshihiro Noda, Canada FC-08-006 R. Zomorrodi, D. Blumberger, Z. J. Daskalakis, M. Nakamura Monitoring antipsychotic drugs in psychiatric patients from FC-09-006 Epirus, northwestern Greece Plasma anti-oxytocin autoantibodies concentration is as- Vassiliki Boumba, Greece sociated with postpartum depression P. Petrikis, L. Patteet, M. Baou, G. Rallis, T. Vougiouklakis, Frederico Garcia, Brazil K. Maudens, V. Mavreas G. de Faria, T. Couto, M. Brancaglion, S. Caligiorne, A. A. Corrêa de Freitas, H. Corrêa FC-09-007 Standardizing and validation of a specialized examination for the assessment of testamentary capacity in patients with dementia: Preliminary results Panagiota Voskou, Greece A. Douzenis, A. Economou, S. Papageorgiou

SA-02 industry sponsored Symposium 17:00 – 18:30 Trianti Hall

see page 97.

34 WFSBP 2015

Monday, 15 June 2015 | Scientific Programme

P-01 Poster Presentation P-01-009 Blockade of D2-like dopamiergic receptor corrects anxie- 12:45 – 14:15 Muses Foyer ty-like behaviour in gonadectomized male rats of middle Addictive Disorders / Anxiety Disorders / Miscellaneous age treated with low dose of testosterone Chair: Thomas Paparrigopoulos, Greece Julia Fedotova, Russia Co-Chair: George Kiosterakis, Greece P-01-010 D-cycloserine-augmented exposure therapy in patients P-01-001 with agoraphobia Functional and structural connectivity in the cingulate cortex Lena Pyrkosch, Germany in the habitual internet game users J. Mumm, J. Plag, T. Fydrich, L. Fehm, A. Ströhle Jihye Choi, Republic of Korea D.-J. Kim, J.-W. Chun, H. Cho P-01-011 Endophenotypes and transcriptional markers of different P-01-002 stress reactivity in two inbred mouse strains Attentional bias and poor inhibitory control as risk factors Klaudia Szklarczyk-Smolana, Poland for relapse in patients diagnosed with bipolar disorder and M. Korostynski, S. Golda, R. Przewlocki alcohol use disorders Marta Marin Mayor, Spain P-01-012 I. Martínez, D. Rentero, L. Hernandez, F. Arias, F. Lopez- Psychiatry and primary care: Obstacles faced by general practitioners in Singapore in managing patients with mental Muñoz, R. Jurado, G. Rubio, M. A. Jimenez Arriero disorders P-01-003 Arnab Kumar Ghosh, Singapore Effects of chronic or acute cocaine on the AMPK system in P. Gangaram, H. Jayaraman the rat frontal cortex and dorsal striatum Shijie Xu, Republic of Korea P-01-013 Effect of SSRIs on gray matter volume in obsessive-com- U. G. Kang pulsive disorder: A prospective study of treatment-naïve P-01-004 patients The peptide origin anxiolytics as possible tools in treatment Janardhanan Narayanaswamy, India of opiate addiction: An experimental study D. Jose, S. M. Agarwal, S. Kalmady, B. Shrinivasa, V. Shivaku- Mark Konstantinopolsky, Russia mar, G. Venkatasubramanian, Y. C. Reddy L. G. Kolik, T. A. Gudasheva P-01-014 P-01-005 Exploring the familiality of obsessive-compulsive symptoms Association between NPY gene polymorphisms and alcohol Vlasios Brakoulias, Australia dependence in Turkish sample Hayriye Akel, Turkey P-01-015 Bipolar disorder (BD) comorbidity in patients with a pri- S. C. Gurel, Y. Ayhan, B. Diclenur Ulug, B. Demir, C. Karaaslan mary diagnosis of obsessive compulsive disorder (OCD) P-01-006 Gayatri Saraf, India The alterations of systemic neuroinflammatory cytokine I. Paul, B. Viswanath, S. Bada Math, Y. C. Reddy levels during early alcohol withdrawal Min Shan Li, Taiwan P-01-016 Increased levels of plasma oxytocin in untreated adult OCD M.-C. Huang patients P-01-007 Donatella Marazziti, Italy The role of serotonin transporter polymorphisms in anxiety S. Baroni, G. Massimetti, L. Dell‘Osso sensitivity: An investigation in a South African adolescent population P-01-017 Sian Hemmings, South Africa A systematic review of the association between the serotonin receptor 2a polymorphisms and obsessive-compulsive R. Benecke, L. Martin, S. Seedat disorder P-01-008 Meir Steiner, Canada Acute restraint and unpredictable chronic mild stress dif- G. Mattina ferentially activate dorsal and median raphe nuclei Milena Viana, Brazil P-01-018 Comorbidity between obsessive compulsive disorder, au- D. A. Lopes, J. A. Lemes, I. C. Céspesdes tism spectrum disorder and alcohol Mikel Ruiz Feliu, Spain C. Campos Mangas, A. B. Rodriguez Aliste, M. Haba Sanchez

35 WFSBP 2015

Scientific Programme | Monday, 15 June 2015

P-01-019 P-02-008 Association between obsessive compulsive disorder and Mood disorders are associated with an increased athero- diogenes syndrome genic index of plasma Mikel Ruiz Feliu, Spain Marta Martin-Subero, Spain C. Campos Mangas, A. B. Rodriguez Aliste, M. Haba Sanchez H. Odebrecht, S. Odebrecht, D. Sabbatini, S. Dodd, M. Berk, M. Maes P-02-009 P-02 Poster Presentation Polarity of first episode and neurocognitive functioning in bipolar disorder 12:45 – 14:15 Muses Foyer Kalliopi Tournikioti, Greece Bipolar Disorders / Depression / Suicide D. Dikeos, A. Douzenis, I. Michopoulos, P. Ferentinos, M. Ale- Chair: Artemios Pehlivanidis, Greece vizaki, C. R. Soldatos Co-Chair: Athanasios Karkanias, Greece P-02-010 The correlation between the clinical symptoms, serum P-02-001 uric acid levels, and quantitative electroencephalography Decreased levels of cerebral lactate in patients with bipolar (QEEG) findings in recently manic patients with bipolarI disorder after treatment with lithium disorder Alana Costa, Brazil Sunmi Kim, Republic of Korea R. Machado-Vieira, M. C. Garcia Otaduy, M. V. Zanetti, R. T. S. Park, Y. Kim, D. Han, K. Min, C. Na de-Sousa, W. F. Gattaz P-02-011 P-02-003 Depression trajectories and the association with metabolic Bipolar misdiagnosis in a 10-year study: How age may adversities among the middle aged adults influence the way bipolarity is perceived in primary care Jaewon Lee, Republic of Korea Andrée Daigneault, Canada E. Y. Kim, S. H. Kim, K. Ha, H. J. Lee, D. H. Yoon, Y.-M. Ahn S. Saury, C. Duclos, J. Paquet, D. Dumont, S. Beaulieu P-02-012 P-02-004 Support vector machine classification for patients with Comparison of cognitive changes between older people major depressive disorder and bipolar disorder using with major depression and those with bipolar disorder near-infrated spectroscopy after two-year follow-up Yukihisa Matsuda, Japan Chih-Chiaing Chiu, Taiwan H. Kihara, K.-i. Watanabe, R. Hashimoto, S. Takemoto, Y. Ka- C.-J. Chang, I.-W. Sun, S.-I. Liu, W.-C. Chiu, M.-L. Lu, C.-H. wasaki Chen, H.-C. Liu P-02-013 P-02-005 A randomized controlled comparison of mri-targeted bilat- Continuous circular cycling in bipolar disorders as a predic- eral and unilateral rtms in treatment resistant depression tor of poor response to short-term antidepressant treatment Daniel Blumberger, Canada Antonio Tundo, Italy L. Thomson, B. Mulsant, T. Rajji, M. Maher, P. Brown, J. Calabrese, L. Proietti, R. de Filippis J. Downar, F. Vila-Rodriguez, P. Fitzgerald, Z. J. Daskalakis, P-02-006 J. Maller Continuous cycling bipolar disorders: Clinical character- P-02-014 istics and response to long-term treatment Basal-ganglia function in major depression – is feed- Antonio Tundo, Italy back-learning impaired in major depression? J. Calabrese, L. Dell‘Osso, L. Proietti, R. de Filippis Sabrina Mörkl, Austria P-02-007 C. Blesl, A. Painold, A. Holl Distinct patterns of amygdala resting state functional con- P-02-015 nectivity in remitted bipolar disorder and major depressive Electroconvulsive therapy changes plasma cytokines and disorder patients kynurenine metabolites in patients with depressive disorder Giannis Lois, Germany Lilly Schwieler, Sweden M. Wessa M. Samuelsson, M. Bhat, M. Frye, I. Schuppe-Koistinen, S. Erhardt

36 WFSBP 2015

Monday, 15 June 2015 | Scientific Programme

P-02-017 P-03 Poster Presentation Parental history of psychiatric diagnoses and unipolar depression: A Danish national register-based cohort study 12:45 – 14:15 Muses Foyer Trine Munk-Olsen, Denmark Schizophrenia / Dementia K. L. Musliner, B. Trabjerg, B. Waltoft, T. Munk Laursen, P. Chair: Charalambos Touloumis, Greece B. Mortensen Co-Chair: Thomas Matsoukas, Greece P-02-018 Serum igG response to 43 food antigens in major depres- P-03-002 sion indicates lower igG response to dairy proteins in de- Cerebrospinal fluid and plasma concentrations of pressed patients Non-Phosphorylated Tau protein as a novel potential biomarker of Alzheimer‘s disease Agata Szulc, Poland Piotr Lewczuk, Germany L. Rudzki, D. Pawlak, N. Waszkiewicz, A. Malus, M. Galecka, N. Lelental, I. Lachmann, A. Perret-Liaudet, J. Kornhuber P. Szlachta, B. Konarzewska P-03-003 P-02-019 Aberrant gray matter structure associated with sleep distur- Aerobic exercise as add-on treatment improves alertness bance in the drug naïve subjects with Alzheimer‘s disease and working memory in depressed patients: Preliminary results from a randomized controlled multicentre-trial Soo Hyun Joo, Republic of Korea Christian Imboden, Switzerland J. Y. Nam, H. K. Lim, I. H. Paik, W. Hahm, C. U. Lee J. Beck, M. Gerber, U. Pühse, E. Holsboer-Trachsler, M. Hat- P-03-004 zinger Development of Abeta42 surrogate marker in peripheral blood P-02-020 Shinji Tagami, Japan Androgen receptor increases resistance to depressive-like phenotypes in chronic unpredictable mild stress through S. Sano, K. Yanagida, T. Kodama, N. Mizuta, T. Tomonaga, maintaining brain-derived neurotrophic factor M. Takeda, M. Okochi Yi-Yung Hung, Taiwan P-03-005 P-02-021 Exploring the effect of adducins genetic variability on cog- Cortical inhibition in the pathophysiology and treatment nition in schizophrenia of major depressive disorder Alessandro Pigoni, Italy Daphne Voineskos, Canada M. Bosia, L. Zagato, N. Casamassima, C. Lorenzi, A. Piro- A. Levinson, D. Blumberger, Z. J. Daskalakis vano, M. Spangaro, E. Smeraldi, P. Manunta, R. Cavallaro P-02-023 P-03-006 Association between plasma brain-derived neutrophic fac- Functional genetic and epigenetic analyses reveal rare mu- tor levels and impulsiveness in recent suicide attempters tations and hypermethylation of the ARC associated with Livia Ambrus, Sweden schizophrenia Å. Westrin Yang-An Chuang, Taiwan M.-C. Cheng, T.-M. Hu, C.-H. Chen, S.-H. Hsu, H.-Y. Tsai P-02-024 Factors associated with suicide completion: A comparison P-03-007 between suicide attempters and completers Oxidative stress and treatment response in schizophrenia: Woong Hahm, Republic of Korea Acute relpase and chronic stable stage S. H. Joo, I. H. Paik Yi-Ling Chien, Taiwan C.-M. Liu, S.-Y. Lin-Shiau, H.-G. Hwu P-02-025 A comparative study of permissive attitudes toward sui- P-03-008 cide in South Korea, Japan, and the U.S.: A cross-national PET study of thalamic dopamine D2-receptors in drug-naive analysis patients with schizophrenia Hyeyoung Kim, Republic of Korea Pauliina Ikonen, Sweden B. Kim, S. S. Lee, C.-j. Baek, Y.-M. Ahn S. Cervenka, K. Collste, H. Fatouros-Bergman, G. Matheson, P. Plaven Sigray, A. Varrone, C. Halldin, L. Flyckt, L. Farde P-02-026 The impact of alcohol problems on depressive symptoms Masaya Tayama, Japan M. Yamamoto, T. Saito

37 WFSBP 2015

Scientific Programme | Monday, 15 June 2015

P-03-011 P-04 Poster Presentation Disrupted frontal-thalamic connectivity as a marker of risk for schizophrenia: Dynamic causal modeling applied to 12:45 – 14:15 Muses Foyer fMRI data collected in vivo Childhood and Adolescent Disorders / Liaison Psychiatry/ Pranav Jagtap, USA Pregnancy V. Diwadkar Chair: Pavlos Sakkas, Greece P-03-012 Co-Chair: Anastasia Koumoula, Greece Identification of rare mutations of postsynaptic scaffolding protein genes associated with schizophrenia using targeted P-04-001 resequencing analysis Role of m2 muscarinic receptors in the development of self Min-Chih Cheng, Taiwan directedness in children and adolescents Y.-A. Chuang, T.-M. Hu, C.-H. Chen, S.-H. Hsu, H.-Y. Tsai, Maria Nobile, Italy S.-M. Tsai M. Bellina, P. Brambilla, S. Mascheretti, M. Garzitto, L. Fornasari, C. Bonivento, R. Giorda, V. Bianchi, P. Colombo, M. Molteni P-03-013 P-04-002 Interaction between memory retrieval and emotion in Convergent changes in fronto-cingulate cortex function and schizophrenic patients structure in adolescent: Multi-modal analyses of fMRI and Sang-Keun Chung, Republic of Korea sMRI data and their implications for neurodevelopment J.-C. Yang models of psychiatric disease P-03-014 Ani Madurkar, USA Interaction of EAATs genotype and clozapine on cognitive V. Diwadkar, A. Burgess remediation outcome P-04-003 Alessandro Pigoni, Italy Latent classes of emotional and behavioral problems in M. Spangaro, M. Bosia, M. Buonocore, A. Pirovano, C. Lo- different samples and their relations to DSM-IV diagnoses renzi, E. Smeraldi, R. Cavallaro Maria Nobile, Italy P-03-016 V. Bianchi, P. Brambila, M. Garzitto, L. Fornasari, P. Colombo, Affective and non-affective first episode psychosis;du p, C. Bonivento, S. Piccin, M. Bellina, A. Tesei, M. Molteni substance abuse and clinical outcome P-04-004 Alba Toll, Spain Clinical management of agitation in child and adolescent A. Mané, D. Bergé, V. Pérez-Solà psychiatric patients P-03-017 Luis San, Spain Antipsychotics prescribing patterns in schizophrenic pa- D. Munoz, M. Pardo, X. Alvarez, B. Sanchez tients with comorbid substance use disorder P-04-005 Gerard Mateu-Codina, Spain Future directions concerning the impact of childhood and M.-R. Roser, F.-M. Adriana, H.-R. Gema, M.-B. Josep, S.-G. adolescent adversities in the field of men‘s mental health: Roberto, C.-S. Maite, C.-R. Víctor, C.-B. Claudio, T.-M. Marta The New York declaration P-03-019 Leo Sher, USA Clinical predictors of a first psychosis in subjects at high T. Rice, Z. Rihmer, J. Golier risk for schizophrenia P-04-006 Maryna Skuhareuskaya, Belarus Genetic polymorphism effect of fto, akt1 and aktip in N. Buyskaya, O. Skugarevsky childhood obesity in a Brazilian population P-03-020 Patricia Pereira, Brazil Familial aggregation of patients with early-onset and V. Sandrim, A. Alvim-Soares, C. Lanna, D. Souza Costa, late-onset schizophrenia and their nonpsychotic relatives V. Belo, L. De Marco, J. Tanus-Santos, M. Romano-Silva, using minor physical anomalies and craniofacial measures D. Miranda Sheng-Hsiang Lin, Taiwan P-04-007 I.-N. Tsai, S.-T. Gan, M.-K. Lu, J.-J. Lin A study on cytogenetic analyses and MECP2 mutation with P-03-022 Gamma-amino butyric acid (GABA) and serotonin in Rett Relationship between membrane fatty acids and cognitive syndrome (RTT) twins symptoms and information processing in individuals at Balachandar Vellingiri, India ultra-high risk for psychosis A. Meyyazhagan, S. Kathanan, B. Balasubramaniam, D. Shanaz, Sung-Wan Kim, Republic of Korea S. Keshavarao M. R. Schafer, M. Berk, S. Rice, K. Allott, C. F. Bartholo- meusz, C. Pantelis, P. McGorry, P. Amminger

38 WFSBP 2015

Monday, 15 June 2015 | Scientific Programme

P-04-008 P-05 Poster Presentation Impact of fibromyalgia and presence of anxious and depressive symptoms 12:45 – 14:15 Muses Foyer María Del Pino Ordovás González, Spain Pharmacological and Brain Stimulation Therapies E. Rodríguez Jiménez, J. Alcalá Partera Chair: George Papageorgiou, Greece P-04-010 Co-Chair: Christos Theleritis, Greece Study about Munchhausen syndrome Mikel Ruiz Feliu, Spain P-05-001 Concentrations of venlafaxine, mirtazapine and citalopram C. Campos Mangas, A. B. Rodriguez Aliste, M. Haba Sanchez in serum and cerebrospinal fluid – a naturalistic approach P-04-012 Sarah Lammertz, Germany A rare case of hematohidrosis with schizophrenia G. Gründer, S. Tauber, T. Veselinovic, C. Hiemke, M. Paulzen Chytanya Ponangi, India P-05-003 M. Gowri Devi Serotonin transporter binding ratios predict outcome and P-04-013 nonadherence to antidepressant in patients with major Fahr‘s syndrome: A case report depression: A naturalistic follow-up study Emilce Blanc, Argentina San-Yuan Huang, Taiwan M. C. Ballarino, O. A. Porta C.-C. Huang, Y.-W. Yeh P-04-014 P-05-004 Functional impairment, religiosity and depression: Beta-arrestin1&2 are inversely affected by antidepressants A mixed-methodology study of spinal cord injury patients through alterations in ERK1/2-regulated transcription in Sri Lanka Sofia Schreiber-Avissar, Israel Arun Ravindran, Canada M. Golan, G. Schreiber S. Xue, S. Arya, A. Embuldeniya, H. Narammalage, T. da Silva, P-05-005 S. Williams The optimal dopamine D2/3 receptor occupancy by P-04-016 antipsychotics in patients with late-life schizophrenia: New onset anxiety disorder in a patient with possible neu- A [11C]-Raclopride PET study rocysticercosis Shinichiro Nakajima, Canada Andrea Bulbena-Cabre, USA D. Mamo, H. Uchida, T. Suzuki, F. Caravaggio, P. Gerretsen, N. Ramos Dunn, R. Gorman Swift T. Rajji, B. Mulsant, B. Pollock, A. Graff-Guerrero P-04-019 P-05-006 „I tried to get a bug out of my ear“: A case report of a pa- Effectiveness and tolerability of high doses of paliperidone tient with delusions of parasitic infestation and the review palmitate in patients with severe schizophrenia of relevant literature Juan J. Fernández-Miranda, Spain Magdalena Spariosu, USA S. Diaz-Fernandez, E. Tubio-Arcos, A. C. Gamon-Cantero D. Coira P-05-007 P-04-020 Serum Orexin-A levels in antipsychotic-treated schizophren- „It‘s all in your head“. The psychiatrist‘s role in the diag- ic patients and their correlation with metabolic profile nosis and management of conversion disorder in medical Po-Yu Chen, Taiwan settings: Case series and literature review M.-C. Huang, L.-L. Hwang, C.-H. Chen, V. Mondelli, C.-C. Magdalena Spariosu, USA Chiu, M.-L. Lu D. Coira

39 WFSBP 2015

Scientific Programme | Monday, 15 June 2015

P-05-009 P-06 Poster Presentation Valerian, melissa, passion flower and their combination STW 32 in experimental models of anxiety 12:45 – 14:15 Muses Foyer Jürgen Müller, Germany Genetics / Cognitive Neuroscience / Neuroimaging S. N. Okpanyi, O. Kelber, C. Kolb Chair: Dimitris Dikeos, Greece P-05-010 Co-Chair: Evgenia Daskalopoulou, Greece Valerian: Safety confirmed J. Müller, Germany P-06-001 Anti-social behaviour neurobiology K. Kraft, O. Kelber, K. Nieber Guillermo Nicolas Jemar, Argentina P-05-011 BDNF gene in bipolar disorder: Case-control association P-06-002 study in South Indian sample and relationship to lithium The effect of cross-sex hormone treatment on resting state treatment response functional connectivity in transsexuals assessed using network-based statistics Ravi Kumar Nadella, India Marie Spies, Austria P. Paul, S. Sen, L. N. Kota, V. Kapur, G. Saraf, B. Viswanath, A. Hahn, G. Kranz, M. Küblböck, H. Allan, S. Ganger, K. Ulrike, M. Purushottam, M. D. Zompo, A. Squassina, S. Jain C. Windischberger, D. Winkler, S. Kasper, R. Lanzenberger P-05-012 Genetic variants in telomerase-pathway genes are associ- P-06-003 ated with antidepressant response The role of peripheral tumor necrosis factor genes in cognitive deficits – preliminary study Sandra Scheuer, Germany Piotr Galecki, Poland T. Brückl, H. Pfister, M. Uhr, S. Kloiber, S. Lucae, F. Wilhelm, M. Talarowska M. Ising P-06-004 P-05-013 Brexpiprazole, a novel serotonin-dopamine activity modu- Transcranial magnetic stimulation at 5Hz as an antide- lator, has the beneficial effects onNMDA related cognitive pressant response accelerator: Clinical and QEEG analysis dysfunction model in mice: Novel object recognition test Jorge Julio González Olvera, Mexico in chronic PCP model E. Reyes Zamorano, J. Ricardo Garcell, E. Miranda-Terres, Noriko Yoshimi, Japan M. d. Lourdes García-Anaya, F. Pellicer-Graham K. Hashimoto, Y. Fujita, Y. Ohgi, T. Futamura, T. Kikuchi P-05-014 P-06-005 Repetitive Transcranial Magnetic Stimulation modifies the Brexpiprazole, a novel serotonin-dopamine activity modu- neural processing of emotional stimuli lator, has the beneficial effects onNMDA related cognitive Virginie Moulier, France dysfunction model in mice: Social recognition test in acute C. Gaudeau, N. Bouaziz, M. Thomas, P. Schenin-King Andri- dizocilpine model anisaina, E. Bertasi, D. Januel Noriko Yoshimi, Japan P-05-015 T. Futamura, T. Kikuchi, K. Hashimoto Clinical effectiveness of electroconvulsive therapy in a uni- P-06-006 versity hospital setting in South Korea Comparison of facial emotion recognition deficits and cere- Hee-Cheol Kim, Republic of Korea bral laterality in patients with schizophrenia versus bipolar Y.-M. Choi, K.-S. Kim disorder, their first degree relatives and healthy controls Rishikesh Behere, India U. Thonse, P. Sharma P-06-007 Social brain activity during theory of mind in first episode psychosis: Comparison with healthy controls and link to symptoms Cali Bartholomeusz, Australia E. Ganella, S. Whittle, A. Abu-Akel, K. Allott, A. Thompson, P. McGorry, E. Killackey, C. Pantelis, S. J. Wood

40 WFSBP 2015

Monday, 15 June 2015 | Scientific Programme

P-06-008 P-06-018 Molecular mechanisms of posttraumatic stress disorder Hypothalamic grey matter volume alterations in alcohol Alma Dzubur Kulenovic, Bosnia and Herzegovina dependence and the effects of the GATA4 genotype: Asso- J. Deckert, K. Domschke, A. Kucukalic, E. Avdibegovic, M. Ja- ciations to relapse kovljevic, D. Babic, F. Agani Evangelos Zois, Germany S. Hoffmann, S. Vollstädt-Klein, H. Nakovics, F. Kiefer P-06-009 Genomewide investigation of copy number variants in P-06-019 relation to tourette syndrome in a Danish cohort Structural brain changes in first episode psychosis – A lon- Shanmukha Sampath Padmanabhuni, Greece gitudinal MRI study A. Juan Ignacio Rodríguez, P. Paschou, Z. Tümer Unn Kristin Haukvik, Norway C. Hartberg, S. Nerland, K. Jørgensen, E. Lange, C. Simon- P-06-010 sen, O. A. Andreassen, I. Melle, I. Agartz The role of neurotrophic system genes and environmental factors in depression and individual differences in per- P-06-020 sonality Structural brain correlates of xenomelia Anastasiya Kazantseva, Russia Bernd Kraemer, Switzerland T. Noskova, S. Koks, T. Traks, S. Malykh, M. Lobaskova, E. Khus- J. Hänggi, L. M. Hilti, P. Brugger nutdinova P-06-021 P-06-011 Altered function of ventrolateral prefrontal cortex in peer Association of CCL11 gene polymorphisms with schizo- verbal abused adolescents phrenia in Korean population Jeewook Choi, Republic of Korea Jong Woo Kim, Republic of Korea S. W. Lee, J. H. Yoo, K. W. Kim, B. Jeong W. S. Kang, J.-W. Paik, J. Choi, Y. J. Kim P-06-022 P-06-012 Analytical q-ball imaging in euthymic patients with bi- Aberrant activation of epigenetic repressive genes is in- polar I disorder volved in the pathophysiology of major depressive disorder Bianca Kollmann, Germany Romain Rey, France J. Houenou, V. Scholz, C. Poupon, M. Wessa J.-R. Teyssier, S. Ragot, J.-C. Chauvet-Gelinier, B. Bonin P-06-023 P-06-013 Childhood physical abuse and neglect predict pituitary Association between GNAL gene polymorphisms and risk gland volume in first episode psychosis patients of schizophrenia in Korean population Christina Phassouliotis, Australia Jong Woo Kim, Republic of Korea S. Kekulawala, B. Garner, L. Phillips, S. Bendall, C. Markulev, W. S. Kang, J. W. Paik, J. Choi, Y. J. Kim P. McGorry, C. Pantelis P-06-015 P-06-024 Associations of white matter hyperintensities with post- Inter-hemispheric transfer leads to hyper-activation of mac- stroke depression: A one year longitudinal study roscopic brain networks in first episode psychosis Kyungyeol Bae, Republic of Korea Karthik Ramaseshan, USA P-06-016 F. Badaoui, E. Penta, M. Bellani, C. Marzi, P. Brambilla, Disruption of thalamofrontal circuitry are linked to neu- V. Diwadkar rocognitive deficits in untreated schizophrenic patients Mingli Li, People‘s Republic of China W. Cheng, W. Deng, Q. Wang, X. Ma, J. Feng, T. Li P-06-017 Acute effects of SSRI and tryptophan depletion on functional connectivity of amygdala in MAOA-high and MAOA-low carriers: A pharmaco-fMRI study Patrick Schelenz, Germany M. Klasen, D. Wolf, K. Zerres, T. Eggermann, A. Eisert, F. Zepf, K. Mathiak

41 WFSBP 2015

Scientific Programme | Tuesday, 16 June 2015

PL-02 Plenary lecture S-17-003 Pregnancy outcomes among women using antipsychotic 10:00 – 10:45 Trianti Hall drugs Chair: Florence Thibaut, France Simone Vigod, Canada S-17-004 PL-02-001 Transcranial magnetic stimulation for pregnant women Off label use in psychiatry with major depressive disorder Guy Goodwin, United Kingdom Deborah Kim, USA

T6: Bipolar Disorders: Basic / Clinical T1: Addictive Disorders S-16 Symposium S-18 Symposium 08:30 – 10:00 Trianti Hall 08:30 – 10:00 Skalkotas Hall Biological and clinical aspects of mood disorders with Metabotropic glutamate receptors in drug and alcohol psychotic features dependence Chair: Thomas Schlaepfer, Germany Chair: Athina Markou, USA Co-Chair: Peter Falkai, Germany Co-Chair: Angela Attwood, United Kingdom S-16-001 S-18-001 Biomarkers associated with psychotic symptoms in major MGluR and mGluR7 activation, and mGluR5 blockade mo depression dulate conditioned behavioral and neurochemical effects Alan Schatzberg, USA of psychostimulants in rats S-16-002 Athina Markou, USA Visualization techniques and psychotic patterns S-18-002 Peter Falkai, Germany Rescue of infralimbic mGluR2 deficit restores control of S-16-003 drug seeking in alcohol dependent rats consistent with Immunological and neuroimaging patterns associated with decreased mGluR2 function in alcoholic patients and al- psychotic dimension in bipolar disorder cohol-dependent rats Massimiliano Buoli, Italy Rainer Spanagel, Germany S-16-004 S-18-003 Pharmacological treatment of psychotic mood disorders Reduction in mGluR5 receptor binding in human smokers Heinz Grunze, United Kingdom and ex-smokers determined by positron emission tomography Gregor Hasler, Switzerland

T34: Pregnancy, post partum and new born: Basic / Clinical S-18-004 Cognitive attentional bias for drug and alcohol-related cues: S-17 Symposium Studies in nicotine and alcohol dependent human subjects 08:30 – 10:00 Mitropoulos Hall Angela Attwood, United Kingdom Recent advances in understanding and treating psychiatric disorders in pregnancy and postpartum Chair: Simone Vigod, Canada T2: Antidepressants: Basic / Clinical Co-Chair: Meir Steiner, Canada S-03 Symposium S-17-001 08:30 – 10:00 MC 3 Room Investigating the phenotypic and genotypic heterogeneity Novel mechanisms of action of antidepressant treatment of postpartum depression in an international perinatal psychiatry consortium Chair: Rainer Rupprecht, Germany Samantha Meltzer-Brody, USA Co-Chair: Mark Rasenick, USA A. Viktorin S-03-001 S-17-002 Lipid rafts and signalling cascades as targets for antide- Preeclampsia and risk of postpartum psychiatric episodes pressants Trine Munk-Olsen, Denmark Rainer Rupprecht, Germany V. Bergink, T. Munk Laursen, B. M. Winther Johannsen, S. Kushner, S. Meltzer-Brody

42 WFSBP 2015

Tuesday, 16 June 2015 | Scientific Programme

S-03-002 S-21-002 The role of lipid rafts for antidepressant mediated G-pro- CANMAT‘s role in developing and implementing guidelines tein signalling for clinical practice Mark Rasenick, USA Sagar Parikh, Canada S-03-003 S-21-003 The role of p-glycoprotein for the effects of antidepressants CANMAT/ISBD guidelines: 2013 update on HPA axis Roumen Milev, Canada Carmine Pariante, United Kingdom R. Milev S-03-004 S-21-004 The cytoskeleton as a target for antidepressants The future of CANMAT/ISBD guidelines Massimiliano Bianchi, Ireland Lakshmi Yatham, Canada

T40: Schizophrenia: Basic / Clinical T20: Molecular Neurobiology S-20 Symposium S-22 Symposium 08:30 – 10:00 MC 2 Room 11:00 – 12:30 Skalkotas Hall Nitric oxide, glutamate and schizophrenia: New insights Biomarkers in psychiatric disorders Chair: Dragos Inta, Germany Chair: Peter Riederer, Germany Co-Chair: Andreas Reif, Germany Co-Chair: Florence Thibaut, France

S-20-001 S-22-001 Nitric oxide and zinc levels in limbic regions in pre- and Biomarkers in schizophrenia post-pubertal rats after neonatal lesions of the ventral hip- Peter Falkai, Germany pocampus S-22-002 Gonzalo Flores, Mexico Biomarkers in ADHD S-20-002 Edna Grünblatt, Switzerland NOS1-NOS1AP interaction at the glutamatergic post-sy S-22-003 napse as a candidate mechanism in the pathogenesis of Biomarkers in alcoholism schizophrenia Toshikazu Saito, Japan Andreas Reif, Germany S-22-004 S-20-003 Biomarkers in Alzheimer‘s disease The glutamate receptor complex in schizophrenia pathogenesis and treatment Markus Schwarz, Germany David Bredt, USA S-20-004 The islands of calleja: The substrate for the glutamate-nitric T13: Epidemiology oxide-dopamine link in schizophrenia? S-23 Symposium Dragos Inta, Germany A. Meyer-Lindenberg, P. Gass 11:00 – 12:30 MC 2 Room Latency to pharmacological treatments in psychiatric disorders: Epidemiological, biological and clinical aspects Chair: Carlo Altamura, Italy T6: Bipolar Disorders: Basic / Clinical S-21 Symposium S-23-002 Assessing latency to pharmacological treatments in psychi- 11:00 – 12:30 Mitropoulos Hall atric disorders: Differences between affective and psychotic CANMAT clinical guidelines for bipolar disorders 2013: disorders The evolution continues Bernardo Dell´Osso, Italy Chair: Lakshmi Yatham, Canada S-23-003 Co-Chair: Roumen Milev, Canada Immunological findings in relation to untreated schizophrenia S-21-001 Elif Weidinger, Germany Guidelines for clinical practice in bipolar disorders? Over- view of the field Konstantinos Fountoulakis, Greece

43 WFSBP 2015

Scientific Programme | Tuesday, 16 June 2015

S-23-004 S-25-002 The effect of prolonged duration of untreated depression Optogenetic studies of the role of the thalamic reticular on antidepressant treatment outcome nucleus in spindles: Implications for schizophrenia Lars Vedel Kessing, Denmark Robert McCarley, USA J. McNally, J. McKenna, R. Strecker, F. Katsuki, R. Brown, S. Thankachan

T7: Childhood & Adolescent Disorders: Basic / Clinical S-25-003 Sleep spindles, magnetic resonance spectroscopy in the S-24 Symposium thalamus and cognitive functioning 11:00 – 12:30 Kokkali Room Reto Huber, Switzerland Oxytocin and social cognition: From social attachment S-25-004 and reward to novel treatments for autism A mathematical model for a sleep spindle and its appli- Chair: Larry Young, USA cation to the quantification of clozapine effects on sleep spindles in schizophrenia Co-Chair: Adam Guastella, Australia Periklis Ktonas, Greece S-24-001 Oxytocin and social attachment: Implications for novel therapies for autism T23: Neuroimaging: Genetic, Functional, Structural Larry Young, USA S-24-002 S-26 Symposium Interactions of oxytocin and serotonin in the striatum me- 15:00 – 16:30 Trianti Hall diate social reward Neuroimaging and risk for schizophrenia Gul Dolen, USA Chair: Lynn Delisi, USA S-24-003 Co-Chair: Marek Kubicki, USA Common polymorphism in the oxytocin receptor gene (OXTR) is associated with human social recognition skills S-26-001 David Skuse, United Kingdom Neuroimaging in people at ultra high risk for psychosis E. Binder, J. Cubells, K. Conneely, I. Lee, A. Lori, L. Young, Matthew Kempton, United Kingdom T. Lehtimaki J. van Os, L. Valmaggia, P. McGuire S-24-004 S-26-002 Oxytocin therapies to treat core social impairments in au- Mechanisms underlying brain changes in early psychosis tism: Clinical treatment trials in toddlers and youth Christos Pantelis, Australia Adam Guastella, Australia V. Cropley, M. Di Biase, S. Wood, A. Zalesky, A. R. Yung, D. Velakoulis, B. Nelson, M. Yücel, A. Lin, L. Phillips, P. McGorry S-26-003 T40: Schizophrenia: Basic / Clinical Early childhood brain development in children at risk for schizophrenia S-25 Symposium John Gilmore, USA 11:00 – 12:30 Conference Room 1 S-26-004 Sleep, spindles, and schizophrenia New white matter biomarkers of schizophrenia risk Chair: Robert McCarley, USA Marek Kubicki, USA Co-Chair: Fabio Ferrarelli, USA O. Pasternak, P. Savadjiev, L. Delisi, L. Seidman, M. Shenton

S-25-001 Sleep spindle deficits point to thalamic reticular nucleus dysfunction in schizophrenia Fabio Ferrarelli, USA G. Tononi

44 WFSBP 2015

Tuesday, 16 June 2015 | Scientific Programme

T32: Pharmacology T40: Schizophrenia: Basic / Clinical S-27 Symposium S-29 Symposium 15:00 – 16:30 Mitropoulos Hall 15:00 – 16:30 MC 2 Room Therapeutic drug monitoring, pharmacogenetics and Alpha4beta2-nicotinic acetylcholine receptors in schiz- brain imaging methods as tools for improving pharma- ophrenia: Implications for smoking cessation and ther- cotherapy apeutics Chair: Christoph Hiemke, Germany Chair: Deepak Cyril D‘Souza, France Co-Chair: Chin Bin Eap, Switzerland Co-Chair: Eden Evins, USA

S-27-001 S-29-001 Pharmacogenetics for improving pharmacotherapies Nicotine dependence treatment in schizophrenia: Evidence Chin Bin Eap, Switzerland for effectiveness of maintenance pharmacotherapy S-27-002 Eden Evins, USA Therapeutic drug monitoring for improving pharmaco- S-29-002 therapies Neuroscience of nicotine addiction vulnerability in schizo Christoph Hiemke, Germany phrenia S-27-003 Andrew Chambers, USA Brain imaging technologies in psychiatry S-29-003 Gerhardt Gründer, Germany In vivo evidence for beta2-nAChR upregulation in smokers with schizophrenia S-27-004 Tools for improving pharmacotherapy in psychiatry: Deepak Cyril D‘Souza, France The opinion of a clinician I. Esterlis, M. Ranganathan, F. Bois, B. Pittman, M. Picciotto, Andreas Conca, Germany L. Shearer, A. Anticevic, J. Carlson, M. Niciu, K. Cosgrove S-29-004 Nicotinic CHRNA4 genotype predicts clinical outcome in schizophrenia and neuroleptic drug treatment response T20: Molecular Neurobiology Georg Winterer, Germany S-28 Symposium 15:00 – 16:30 MC 3 Room Glutamatergic mechanisms in schizophrenia: From ket- T9: Dementia: Basic / Clinical amine to genetic models S-30 Symposium Chair: Peter Gass, Germany 15:00 – 16:30 Kokkali Room Co-Chair: Kazutoshi Nakazawa, USA Clinical neurochemistry in the early diagnosis of demen- S-28-001 tia disorders Ketamine reversal: Towards empirical discovery of antip- Chair: Piotr Lewczuk, Germany sychotics with neuroimaging Co-Chair: Henrik Zetterberg, Sweden Philip Corlett, USA S-28-002 S-30-001 Expression analysis of a NMDA MK-801 rat model identifies Current status and new developments for Alzheimer‘s novel candidate genes for schizophrenia disease biomarkers Dan Rujescu, Germany Kaj Blennow, Sweden S-28-003 S-30-002 Mechanisms of neuronal synchrony deficits inNMDAR -hy- Diagnostic approaches in frontotemporal lobar degener- pofunction-mediated schizophrenia mouse model ation (FTLD) Kazutoshi Nakazawa, USA Markus Otto, Germany K. Nakao S-30-003 S-28-004 Biomarkers for the diagnosis and progression of motor and Inducible genetic mouse models to study the onset of premotor Parkinson‘s disease schizophrenia during late adolescence Brit Mollenhauer, Germany Dragos Inta, Germany S-30-004 H. Elkin, P. Gass Blood biomarkers for neurodegenerative disorders – feasible or too much of a challenge? Henrik Zetterberg, Sweden

45 WFSBP 2015

Scientific Programme | Tuesday, 16 June 2015

T10: Depression: Basic / Clinical T1: Addictive Disorders TG-03 WFSBP Treatment Guidelines WS-18 Workshop 11:00 – 12:30 MC 3 Room 16:30 – 18:00 Trianti Hall Guidelines on Depression: Globalization or localization Treating opioid dependence: The future of treatment Chair: Michael Bauer, Germany tailoring and managing risk for patients on substitute Co-Chair: Raymond W. Lam, Canada opioid therapies Chair: Jacqueline Hudson, Canada TG-03-001 Co-Chairs: Brittany B. Dennis, Canada WFSBP guidelines for unipolar depression Monica Bawor, Canada Emanuel Severus, Germany TG-03-002 WS-18-001 Guidelines for major depressive disorder in Korea The GENetics of Opioid Addiction (GENOA) study: An in- troduction to epidemiologic studies in addiction research Kang Seob Oh, Republic of Korea Jacqueline Hudson, Canada TG-03-003 Global guidelines for psychiatrists, local guideline for ge WS-18-002 neral practitioners – MDD guidelines in Taiwan Risk factors for treatment response among patients with opioid dependence: Understanding the evidence Chia-Yih Liu, Taiwan Monica Bawor, Canada TG-03-004 CANMAT depression guidelines: The next generation of WS-18-003 progress What is the best treatment for opioid addiction? Evi- dence-based practice in addiction medicine Raymond W. Lam, Canada Brittany B. Dennis, Canada

T41: Sexual Disorders: Basic / Clinical T24: Neurophysiology TG-04 WFSBP Treatment Guidelines WS-06 Workshop 15:00 – 16:30 Skalkotas Hall 16:30 – 18:00 Skalkotas Hall Task Force on Paraphilic Disorders: Paraphilia treatment for adults and adolescents Transcranial magnetic stimulation studies of neurophy siology, neuroplasticity, and neurocognition in psychia Chair: Florence Thibaut, France tric disorders Co-Chair: Peer Briken, Germany Chair: Paul Croarkin, USA TG-04-001 Co-Chair: Zafiris J. Daskalakis, Canada The proposed diagnostic criteria of paraphilic disorders for ICD-11 WS-06-001 Overview of transcranial magnetic stimulation studies in Peer Briken, Germany severe psychiatric disorders TG-04-002 Zafiris Daskalakis, Canada WFSBP treatment guidelines on paraphilias WS-06-002 John M. W. Bradford, Canada A review of the use of repetitive Transcranial Magnetic TG-04-003 Therapy in the treatment of chronic pain and borderline Ethical considerations of hormonal treatment of paraphilic personality disorder disorders or sex offenders Shirlene Sampson, USA Paul Cosyns, Belgium WS-06-003 rTMS studies of neurocognition in schizophrenia Stephanie Ameis, Canada T7: Childhood & Adolescent Disorders: Basic / Clinical A. Voineskos, Z. Daskalakis, D. Blumberger D-01 Debate WS-06-004 The neurochemistry of TMS: Magnetic resonance spec- 11:00 – 12:30 Trianti Hall troscopy studies Are children overmedicated? John D. Port, USA Chair: Joseph Biederman, USA Proponent: Maria Nobile, Italy Opponent: Robert Post, USA

46 WFSBP 2015

Tuesday, 16 June 2015 | Scientific Programme

T40: Schizophrenia: Basic / Clinical T25: Obsessive-Compulsive Disorders: Basic / Clinical WS-07 Workshop WS-09 Workshop 16:30 – 18:00 MC 3 Room 16:30 – 18:00 Kokkali Room Metabolic disturbances in schizophrenia: Epidemiology, Biological approaches toward clarifying heterogeneities pathophysiology and antipsychotics – towards clinical of obsessive-compulsive disorder application of genetic risk models and new treatment Chair: Tomohiro Nakao, Japan strategies Co-Chair: Hisato Matsunaga, Japan Chair: Wiepke Cahn, The Netherlands Co-Chair: Bjørn H. Ebdrup, Denmark WS-09-001 Altered frontostriatal connectivity in obsessive-compulsive WS-07-001 disorder Nationwide studies of diabetes in psychiatric populations Takashi Nakamae, Japan René E. Nielsen, Denmark WS-09-002 WS-07-002 Neurobiological heterogeneities of OCD Antipsychotic-induced glucose disturbances: From mice Tomohiro Nakao, Japan to men WS-09-003 Margaret Hahn, Canada Cross-cultural aspects of symptom dimension of OCD G. Remington, M. Guenette, A. Chintoh, A. Giacca, G. Re- Hisato Matsunaga, Japan mington K. Yamanishi, K. Mukai, A. Nakajima, Y. Yamagisawa WS-07-003 WS-09-004 GWAS in antipsychotic-induced weight gain dissecting the Does the neurobiology of obsessions and compulsions CATIE sample differ? Daniel J. Müller, Canada Damiaan Denys, The Netherlands WS-07-004 Antipsychotic-associated dysmetabolism: Glucometabol- ic hormones, cardiovascular risk markers and potential physiological benefits of glucagon-like peptide-1 receptor T8: Cognitive Neuroscience agonist treatment WS-10 Workshop Bjørn H. Ebdrup, Denmark 16:30 – 18:00 Conference Room 1 F. K. Knop, P. L. Ishøy, B. V. Broberg, L. Baandrup, E. Rostrup, B. Fagerlund, H. Lublin, B. Glenthøj Patient‘s response to treatment: A neurobiological approach Chair: Jorge Tellez-Vargas, Colombia Co-Chair: Policarpo Rebolledo, Chile T46: Suicide: Basic / Clinical WS-08 Workshop WS-10-001 Inflammatory and metabolic dysregulation as predictor of 16:30 – 18:00 MC 2 Room antidepressant response Pathways associating stress to the neurobiology of suicide Jorge Tellez-Vargas, Colombia Chair: Leo Sher, USA WS-10-002 Co-Chair: Jorge Ospina-Duque, Colombia Effects of parental anxiety, traumatic events, and hormonal influences on developmental changes in neural circuits WS-08-001 associated with PTSD in children A neurobiological stress-diathesis model of suicidal be- Ruby Castilla-Puentes, USA havior WS-10-003 Leo Sher, USA Pharmacogenetics studies in Latin America WS-08-002 Hernan Silva, Chile Stress and suicide: The role of the hypothalamic-pituitary-adrenal axis WS-10-004 Genetic and psychiatric diagnosis M. Dolores Braquehais, Spain Veronica Larach, Chile WS-08-003 L. Varela Relation between stress, serotonin, and suicide Mushtaq Margoob, India WS-08-004 Oxytocin in suicidal behavior Jussi Jokinen, Sweden

47 WFSBP 2015

Scientific Programme | Tuesday, 16 June 2015

ES-02 Educational Session FC-11 Free Communications 14:00 – 18:30 MC 3.3 Room 08:30 – 10:00 Conference Room 1 Session 2 on pharmacological treatment Child Psychiatry Chair: Lakshmi Yatham, Canada Chair: Eva Ceskova, Czech Republic Co-Chair: David Castle, Australia Co-Chair: Anastasia Koumoula, Greece

ES-02-001 FC-11-001 Pharmacological treatment of anxiety disorders Psychosis: Clinical evaluation of 130 patients for inborn Christer Allgulander, Sweden errors of metabolism ES-02-002 Yannis Trakadis, Canada Pharmacological treatment of unipolar disorders J. Mitchell Michael Bauer, Germany FC-11-002 ES-02-003 Alterations of functional responses to glutamate in human Pharmacological treatment of bipolar disorders neural progenitors in fragile X syndrome Lakshmi Yatham, Canada Maija Castrén, Finland V. S. Achuta, N. Putkonen ES-02-004 Pharmacological treatment of psychotic disorders FC-11-003 Peter Falkai, Germany Perinatal hypoxia differentially regulates the expression of tyrosine hydroxylase in the hypothalamic, midbrain and ES-02-005 pontine catecholaminergic neurons of the human neonate: How to manage metabolic disorders associated to psy- Implications in psychiatry chotropic drugs Maria Panayotacopoulou, Greece David Castle, Australia M. Pagida, A. Konstantinidou FC-11-004 Executive dysfunction in autism spectrum disorders: FC-10 Free Communications A meta-analysis Eleni Demetriou, Australia 08:30 – 10:00 Kokkali Room A. Lampit, A. Guastella Addiction FC-11-005 Chair: Aviv Weinstein, Israel Acute and maintenance electroconvulsive therapy for cat- Co-Chair: Elias Tzavellas, Greece atonia in autism spectrum disorders Lee Wachtel, USA FC-10-001 Methamphetamine induces dopamine neurons degenera- FC-11-006 tion evidenced by silver staining and causes motor defects The effect of support group therapy on parentally bereaved in mice adolescents: A randomized controlled trial Rosario Moratalla, Spain Hesham Abuhegazy, Egypt S. Ares-Santos, N. Granado H. Elkeshishi FC-10-002 FC-11-007 Dopaminergic modulation of value-based decision making Adverse childhood experiences, depressive symptoms, and and subjective well-being food security status: Cross-sectional analysis of mothers Nikolina Skandali, United Kingdom of children under age 4 R. Rutledge, P. Dayan, R. Dolan Mohini Prasad, USA A. Evans, M. Chilton FC-10-003 The glucocorticoid receptor system is altered in cocaine-withdrawn adolescent rats Lucia Caffino, Italy G. Giuseppe, C. Malpighi, C. Michilli, F. Fumagalli FC-10-004 Type of benzodiazepine and clinical presentation of benzodiazepine dependence Olivera Zikic, Serbia V. Djordjevic, J. Kostic, G. Nikolic

48 WFSBP 2015

Tuesday, 16 June 2015 | Scientific Programme

FC-12 Free Communications FC-13 Free Communications 15:00 – 16:30 Conference Room 1 16:30 – 18:00 Mitropoulos Hall Schizophrenia Depression Chair: Wolfgang Gaebel, Germany Chair: Bilgen Taneli, Turkey Co-Chair: Charalambos Touloumis, Greece Co-Chair: Venetsanos Mavreas, Greece

FC-12-002 FC-13-002 Baseline grey matter volume of non-transitioned ultra high Predictors of gestational depression risk cases with and without attenuated psychotic symptoms Mayra Brancaglion, Brazil at long term follow up T. Couto, F. Garcia, R. Nicolato, H. Corrêa Vanessa Cropley, Australia FC-13-003 S. Wood, A. Lin, B. Nelson, R. Reniers, A. Yung, C. Bartholo- Pathogenesis of Cotard‘s syndrome meusz, P. Klauser, D. Velakoulis, P. McGorry, C. Pantelis João Malhadas Martins, Portugal FC-12-003 D. Durães, J. Chainho, A. Paiva Cognitive functions in schizophrenia: A randomized con- FC-13-004 trolled trial of yoga and physical exercise Cognitive function following recovery from a major depres- Triptish Bhatia, India sive episode: Systematic review and meta-analysis S. Mazumdar, J. Wood, F. He, R. Gur, R. Gur, V. Nimgaonkar Maria Semkovska, Ireland FC-12-004 FC-13-006 Clinical course and risk factors for psychotic relapses in Who is who: Depression in attention-deficit/hyperactivity patients diagnosed with delusional disorder: A 24-month disorder in adults – a clinical approach follow-up study Vanessa Vila Nova, Portugal Alexandre González-Rodríguez, Spain J. Martins, C. Cotta O. Molina-Andreu, R. Penadés, A. Pons, R. Catalán, M. Ber- nardo FC-12-005 Microglial activation: A pet study in schizophrenia SA-03 industry sponsored Symposium Vanessa Cropley, Australia 13:30 – 15:00 Skalkotas Hall M. Di Biase, A. Zalesky, G. O´Keefe, J. Olver, B. Baune, P. Amminger, P. McGorry, A. Scott, C. Phassouliotis, I. Everall, see page 97. R. Banati, C. Pantelis FC-12-006 Sub-threshold negative symptoms and brain network sensitivity to emotional salience: Potential predictors of psy- P-07 Poster Presentation chosis in adolescence 12:45 – 14:15 Muses Foyer Harinder Rai, USA V. Diwadkar Addictive Disorders / Anxiety Disorders / Panic Disorders / Stress / Childhood and Adolescent Disorders Chair: Ioanna-Despoina Bergiannaki, Greece Co-Chair: Christos Androutsos, Greece

P-07-001 Increased dorsomedial prefrontal cortex in response to emotional face inducing cognitive conflict in smartphone overusers Chun Ji-Won, Republic of Korea D.-J. Kim, P. Arom, J. Choi

49 WFSBP 2015

Scientific Programme | Tuesday, 16 June 2015

P-07-002 P-07-014 Neurobiological characteristics of teenage internet addic- (Re)Introducing psychodynamics into medical school ed- tion: A resting state EEG study ucation: Regulation focused psychotherapy for children Yunna Kwan, Republic of Korea as a teaching tool I.-J. Lee, D.-B. Yang, S. Choi Timothy Rice, USA L. Hoffman, T. Prout, E. Gaines, F. Oluyadi P-07-003 Simulating alcohol use behavior: Pathophysiology and P-07-015 mechanism of therapeutic measures Children‘s drawings as a window into creativity in play: Ung Gu Kang, Republic of Korea Systematic ratings of disrupted emotionality in human H. S. Kim figure drawings predict creativity in symbolic play Timothy Rice, USA P-07-004 L. Hoffman, N. Derish, E. Gardner-Schuster, C. Christian, Cardiac autonomic dysregulation in opioid-dependent patients: Treatment matters T. Nimroody Sheng-Chang Wang, Taiwan P-07-016 H.-C. Lee, J.-H. Kang, H.-H. Tsou Does prenatal exposure to phthalate alter early neurodevelopment and neurogenesis in rodents? P-07-005 Yeni Kim, Republic of Korea Curcuminoids decreased nicotine self-administration in rats S.-M. Lee, S. Jeon, H.-j. Jeong, S.J. Lee Marina Sagnou, Greece P. Alexiou, A. Markou, M. Pelecanou, X. Li P-07-017 Latrophilin-3 gene and side effect of OROS methylpheni- P-07-006 date in children with attention-deficit/hyperactivity disorder Gender differences in the use of prohibited substances Ki-Hwan Yook, Republic of Korea in prison J. Song, K.-H. Yook, H. J. Hong Oscar Sanz-Garcia, Spain M. P. Ibáñez, A. Muro P-07-018 Effect of emotion regulation training in patients with panic P-07-008 disorder Brain-derived neurotrophic factor (BDNF) Val66Met poly- Sheng-Min Wang, Republic of Korea morphism and plasma levels in road traffic accident sur- vivors H.-K. Lee, Y.-S. Kweon, C.-T. Lee, K.-U. Lee Leigh van den Heuvel, South Africa P-07-019 S. Suliman, S. Hemmings, S. Malan, S. Seedat Methylation effects of early-life stress (ELS) Fabian Streit, Germany P-07-009 Can we predict the treatment response of escitalopram in M. Lang, J. Treutlein, M. Gilles, S. Witt, M. Rietschel, M. social anxiety disorder? Deuschle Karg Seob Oh, Republic of Korea P-07-020 S. Lim Combined effects of social defeat stress and methamphe tamine on behavioral sensitization and dopamine receptor P-07-010 mRNA levels in mice Eye movement desensitization and reprocessing for faci litating post-traumatic growth Yin Cui, Republic of Korea Sang Won Jeon, Republic of Korea H.-M. Jin, T. R. Bagalkot, Y.-C. Chung C. Han, S.-H. Kim P-07-021 Recent – but not early – psychosocial life stress associated P-07-012 with shorter telomere length Identification of chromosomal alteration and association study of NRXN3 gene mutations in autism Josine Verhoeven, The Netherlands Arun Meyyazhagan, India E. Puterman, B. Elzinga, B. Penninx, P. van Oppen B. Balasubramanian, p. Krishnan, D.S.N., S. Keshavarao, B. Vellingiri

50 WFSBP 2015

Tuesday, 16 June 2015 | Scientific Programme

P-08 Poster Presentation P-08-012 Risk fators of recurrence in major depressive disorders 12:45 – 14:15 Muses Foyer Ilyes Marrag, Tunisia Bipolar Disorders / Depression / Suicide K. Hajji, W. Chebbi, R. Ben Soussia, M. Nasr Chair: George Papadimitriou, Greece P-08-014 Co-Chair: Georgios Moussas, Greece Body composition in elderly patients with depression Adam Wysokinski, Poland P-08-001 J. Kazmierski, T. Sobów Compensatory up-regulation of glucose utilizations for mitochondria-related CNS energy insufficiency as an en- P-08-016 dophenotype of bipolar disorders Efficacy of ECT in ultrasound induced depression in rats Cheng-Ta Li, Taiwan Anna Morozova, Russia Y.-M. Bai, P.-C. Tu, M.-H. Chen, W.-C. Lin, H.-C. Lee, J.-C. Z. Eugen, V. P. Chekhonin Hsieh, S.-J. Wang, T.-P. Su P-08-017 P-08-002 Further insights in the mode of action of hypericum perfo- Elucidation of the molecular mechanisms involved in bipo- ratum: The postsynaptic downregulation of ß1-adrenergic lar disorder based on fibroblasts gene expression analysis receptors in rat C6 glioblastoma cells by hyperforin and Marianthi Logotheti, Sweden hyperoside N. Venizelos, O. Papadodima, A. Chatziioannou, R. Kolisis Christiane Kolb, Germany H. Häberlein, D. Jakobs, A. Hage-Hülsmann P-08-004 Dysfunctional bottom-up modulation by the amygdala P-08-019 during episodic memory formation associated with emotion Is serum 25-hydroxyvitamin D associated with depressive dysregulation: fMRI evidence symptoms and suicidal ideation in Korean adults? Megha Jagannathan, USA Sang-Keun Chung, Republic of Korea K. Ramaseshan, R. White, P. Soloff, V. Diwadkar J.-I. Park, J.-C. Yang, T. W. Park P-08-005 P-08-020 Enhanced treatment adherence in bipolar II disorder: Mechanistic understanding of spatial estrogen receptor A 1-year prospective follow-up study using Taiwanese life- beta function during brain development: Implications for chart methodology depressive behavior Kuo-Hsuan Chung, Taiwan Ivan Nalvarte, Sweden S.-Y. Tsai, P.-H. Chen, S.-H. Huang, H. Grunze, J. Scott M. Varshney, J.-A. Gustafsson P-08-006 P-08-021 Prescribing patterns of antidepressants and other drugs in Molecular analyses of the mouse brain exposed to chronic Korean bipolar affective disorder patients mild stress; the relation between depression and physio- Da-ye Baek, Republic of Korea logical dyshomeostasis W. Yoon, J.-s. Lee, Y.-h. Joo Kaoru Ikubo, Japan K. Yamanishi, N. Doe, Y. Watanabe, M. Yoshida, W. Li, P-08-009 H. Okamura, H. Matsunaga, H. Yamanishi Short-term antidepressant treatment of bipolar depression: Are the International Society for Bipolar Disorder‘s P-08-022 Guidelines effective? Thyroid stimulating hormone (tsh) and serum, plasma, Antonio Tundo, Italy and platelet brain-derived neurotrophic factors (bdnf) J. Calabrese, L. Proietti, R. de Filippis during a three month follow-up in patient Hong Jin Jeon, Republic of Korea P-08-010 J. H. Baek, E.-S. Kang, M. Fava, D. Mischoulon, A. Nieren- Study of fMRI activation pattern during associative learning berg, J.-y. Heo, K. w. Kim, I. Yoo, h. Yoo, D. Lee in patients with bipolar disorder Eleonora Maggioni, Italy P-08-023 P. Brambilla, V. Diwadkar, R. A. Paoli, C. Cinnante, E. Caletti, An 8-week open-label flexible-dose study of desvenlafaxine M. Cigliobianco, G. Cabras, F. Triulzi, C. Altamura as monotherapy in the treatment of dysthymia Arun Ravindran, Canada P-08-011 G. Abraham, M. McKay, G. Curran, A. Hassan, J. Ratz, Long-term sertraline treatment increases expression and M. Boucher decreases phosphorylation of glycogen synthase kinase-3b in platelets of patients with late-life major depression Helena Joaquim, Brazil L. Talib, B. Diniz, W. Gattaz

51 WFSBP 2015

Scientific Programme | Tuesday, 16 June 2015

P-08-025 P-09-006 Body mass index of psychiatric patients after a recent su- Cerebral hemodynamics in male schizophrenia patients icide attempt during the trail making test: A functional transcranial dop- Athanassia Papadopoulou, Greece pler sonography study C. Christodoulou, A. Douzenis, R. Gournellis, C. Papageor- Grammato Amexi, Germany giou, M. Markianos S. Egger, J. Ernst, S. Grimm, S. Vetter, E. Seifritz, D. Schüp- bach P-08-026 Suicidal ideation and mental disorders in primary care P-09-007 Narseta Mickuviene, Lithuania EEG characteristics of auditory verbal hallucinations in J. Peceliuniene, V. Kasiulevicius, A. Bunevicius schizophrenia In Won Chung, Republic of Korea J. S. Chang, S. H. Kim, C. S. You, N. Y. Lee, T. Youn, Y. S. Kim P-09-009 P-09 Poster Presentation Epigenetics in schizophrenia and association with anti 12:45 – 14:15 Muses Foyer psychotic response to clozapine: Preliminary findings Schizophrenia Alessandro Pigoni, Italy Chair: Nikos C. Stefanis, Greece M. Bosia, M. Spangaro, C. Lorenzi, A. Pirovano, S. Bonfiglio, Co-Chair: Dennis Velakoulis, Greece G. Barbiera, V. Rossella, D. Cittaro, D. Lazarevic, E. Stupka, V. Maselli, R. Cavallaro P-09-001 P-09-010 Sex-related differences in cerebral laterality between pa- Evaluation of the metabolic parameters of a novel anti tients with schizophrenia and controls psychotic agent „PGW5“ in a rat model of atypical anti Yu Sang Lee, Republic of Korea psychotics induced metabolic side-effect B.-h. Choi Michal Taler, Israel P-09-002 L. Shbiro, I. Vered, A. Weizman, A. Weller, I. Gil-Ad Telomere shortening in the hippocampus is associated with P-09-011 negative symptom-like behavioral deficits and cognitive Frequency of somatic illnesses in patients with schizophre- impairment in schizophrenia nia – age and gender distribution Kazuya Toriumi, Japan Srebrenka Bise, Bosnia and Herzegovina M. Miyashita, T. Ichikawa, M. Arai, I. Nohara, N. Obata, D. Begic, B. Kurtovic, O. Cemalovic A. Kobori, Y. Horiuchi, M. Arai, M. Itokawa P-09-012 P-09-003 Frontal brain activity in the individuals at risk for schizo- A cross sectional study of angular gyrus and supramarginal phrenia: A brain electrical topography study gyrus in patients at first-episode of schizophrenia Aleksandra Aleksandrowicz, Switzerland Paolo Brambilla, Italy F. Hagenmuller, H. Haker Rössler, K. Heekeren, A. Theodori- A. Ferro, R. Roiz-Santiáñez, V. Ortíz-García de la Foz, D. Tor- dou, S. Walitza, W. Rössler, W. Kawohl desillas-Gutiérrez, R. Ayesa-Arriola, N. de La Fuente-González, P-09-013 B. Crespo-Facorro In vivo long-term kinetics by planar imaging studies of P-09-004 radiolabelled N,N-dimethyltryptamine, serotonin and Altered intrinsic connectivity networks between the cer- tryptamine in rabbits ebrum and cerebellum during rest: A clinical ultra-high Jorge Ciprian Ollivier, Argentina risk study A. Vitale, C. Cañellas, M. Vitale, A. Pomilio Minji Bang, Republic of Korea P-09-014 M. Yoon, K. Park, H.-J. Park, S. K. An Increased calcium-independent lipoprotein phospholipase P-09-005 A2 but not protein S100 in patients with schizophrenia BDNF serum levels and Val66Met polymorphism in schi Ante Silic, Croatia zophrenia patients evaluated with MATRICS consensus D. Ostojic, A. Savic, A. Bacekovic, A. Puljic, D. Karlovic cognitive battery Rodrigo Nieto, Chile P-09-015 Inefficient DLPFC recruitment in delusion-prone subjects H. Silva, M. Kukuljan, L. Bustamante, A. Armijo, A. Gonzalez, during a working memory task R. Nachar, C. P. Castaneda, T. Lopez, C. Montes, V. Salinas, Yu Fukuda, Germany V. De Angel T. Katthagen, L. Deserno, F. Schlagenhauf

52 WFSBP 2015

Tuesday, 16 June 2015 | Scientific Programme

P-09-016 P-10 Poster Presentation Inefficient brain network modulations by the responding motor cortex during inter-hemispheric transfer: Pronounced 12:45 – 14:15 Muses Foyer effects of right-hand dominance in chronic schizophrenia Dementia / Psychogeriatrics / Miscellaneous Amanda Martin, USA Chair: Antonis Politis, Greece M. Bellani, K. Ramaseshan, C. Marzi, P. Brambilla, V. Diwadkar Co-Chair: Rigas Soldatos, Greece P-09-018 Investigating serum mean platelet volume in patients with P-10-001 schizophrenia Differences of peripheral inflammatory markers inA lzheim- Murat Beyazyüz, Turkey er‘s disease and mild cognitive impairment E. Soydas Akyol, Y. Albayrak, B. Bilir, N. Albayrak, M. Kuloglu Kang Joon Lee, Republic of Korea H. W. Shin, H. Kim P-09-019 Paliperidone palmitate – Effect on negative, depression/ P-10-002 anxiety, patient functioning and extrapyramidal symptoms Donepezil decreases ß-secretase BACE1 expression in plate- in non-acute schizophrenia patients previously unsuccess- lets of Alzheimer disease patients fully treated with oral aripiprazole Tamires Alves Sarno, Brazil Andreas Schreiner, Germany H. Passarelli Giroud Joaquim, L. Leme Talib, S. R. Hototian, P. Bergmans, P. Cherubin, L. Hargarter W. Farid Gattaz, O. Vicente Forlenza P-09-020 P-10-003 Peroxisome proliferator-activated receptor gamma (PPAR- Donepezil increases iPLA2 activity and inactivates GSK3B gamma) levels in patients with schizophrenia in platelets of Alzheimer‘s Tevfik Kalelioglu, Turkey Leda Talib, Brazil N. Durak, N. Karamustafalioglu, A. Genc, M. Akkus, A. Tas- S. R. Hototian, H. Joaquim, O. Forlenza, W. Gattaz demir, M. Emul P-10-004 P-09-021 Glutamate complex and BDNF concentration of depressive Preliminary study for the effect of open adjunctive molin- patients with cognitive dysfunction done to weight loss in obese and overweight patients with Changsu Han, Republic of Korea schizophrenia H.-k. Yoon, S. Yoon Kyuyoung Lee, Republic of Korea P-10-005 E.-J. Joo Physical exercising is reducing anxiety, depression and P-09-022 memory deficits associated with aM PTP-induced rat model Quality of life and chronic psychiatric diseases of Parkinson‘s disease Ilyes Marrag, Tunisia Alin Ciobica, Romania K. Hajji, W. Chebbi, L. Zarrouk, M. Nasr R. Lefter, M. Paulet, F. Trofin P-09-023 P-10-006 IQ, the urban environment and schizophrenia risk Attentional functions in elderly with and without Attentional Timothea Toulopoulou, Hong Kong Deficit and Hiperactivity Disorder (ADHD): Preliminary results P. B. Mortensen, C. B. Pedersen, V. Ehrenstein, M. Picchioni, Mario Louzã Neto, Brazil L. Petersen M. Klein, A. K. Menezes, T. M. Alves, P-09-024 Reciprocal causation models of superior temporal gyrus P-10-008 and childhood social personality in twin and siblings with A systematic evaluation of impulsive-aggressive behavior of schizophrenia geriatric-psychiatric in-patients using the Staff Observation Aggression Scale-Revision (SOAS-R) Xiaowei Zhang, Myrella Paschali, Germany P. C. Sham, S. S. Cherny, M. Picchioni, R. Murray, T. Toulo- C. Reichmann, D. Kamp, M. Jaenner, T. Supprian poulou P-10-009 P-09-025 Finding high risk patients for delirium in orthopaedic el- Schizophrenia and variations in cognition-associated genes derly patients Roksana Zakharyan, Armenia Jung-Seo Yi, Republic of Korea S. Atshemyan, A. Boyajyan J. J. Kim, N. Hong

53 WFSBP 2015

Scientific Programme | Tuesday, 16 June 2015

P-10-010 P-11-004 The prevalence of bipolar spectrum disorder in elderly Vortioxetine: A meta-analysis of 12 short-term, randomized, patients with recurrent depression placebo-controlled clinical trials for the treatment of major Young-Eun Jung, Republic of Korea depressive disorder Chi-Un Pae, Republic of Korea P-10-011 Libidinal increase induced by memantine C. Han, A. Serretti Jaehyun Kim, Republic of Korea P-11-005 Y. Paik Smoothing spline regression as a modern tool for the analysis of observational data – moderate depression under P-10-012 hypericum extract STW3-VI (900 mg daily) compared to Safety of quetiapine for treatment of geriatric psychosis selective serotonin reuptake inhibitors in routine outpatient Gorana Sulejmanpasic-Arslanagic, Bosnia and Herzegovina treatment S. Fisekovic, A. Kucukalic, S. Ler Juergen Mueller, Germany P-10-013 C. Kolb, O. Kelber, C. Theurer Improving wellness and quality of life of mental health P-11-006 consumers: An eight-year naturalistic evaluation of the St John’s wort: What is the key for the bioavailability of CHU de Québec-IUSMQ Mieux-Être Wellness Program a phytomedicine active in mild to moderate depression? Christian Shriqui, Canada Christiane Kolb, Germany I. Lachance, A. Aubin, S. Bonneville, I. Paradis V. Butterweck, O. Kelber, S. Verjee, H. Abdel-Aziz P-10-014 P-11-007 Comparison of depressive symptoms of the Hamilton Brain state-dependent abnormal LFP activity in the auditory Depression Rating Scale between elderly and non-elderly cortex of a schizophrenia mouse model outpatients with major depressive disorder Kazutoshi Nakazawa, USA Ikki Yoo, Republic of Korea K. Nakao P-11-008 Gender differences regarding prolactin levels, ASEX and P-11 Poster Presentation PANSS scales in schizophrenic patients 12:45 – 14:15 Muses Foyer Christina Kalkavoura, Greece I. Michopoulos, P. Arvanitakis, P. Theodoropoulou, K. Dimo- Pharmacological and Brain Stimulation Therapies poulou, E. Tzebelikos Chair: Elias Angelopoulos, Greece Co-Chair: Styliani Kaliora, Greece P-11-009 Metabolic syndrome risk of antipsychotics: One year fol- P-11-001 low-up study Deficient assessment and reporting of adverse events in Ayse Nur Inci Kenar, Turkey antidepressant clinical trials E. Hanci, K. Saricay Rajnish Mago, USA P-11-010 J. Chaves, S. Kaur Does aripiprazole augmentation reduce prolactine levels P-11-002 and relieves related symptoms in women patients treated Detect neural dynamics across acute, chronic and discon- with amisulpride? tinuation SSRI administration Sarpe Marcel, Romania Shahak Yariv, Israel P. Dan, P. Ruxandra, L. Maria R. Perets, Y. Shohat, R. Paz P-11-011 P-11-003 Therapeutic dose range of valproate-induced hyperam- Involvement of 5-HT1A receptors of the dorsal hippocam- monemic encephalopathy: A case report pus in the anxiogenic effect caused by acute antidepressant Chul Eung Kim, Republic of Korea administration in rats S. Maeng, J. H. Rho Helio Zangrossi Junior, Brazil A. B. Sant’ana do Nascimento, H. H. Vilela-Costa, T. de Andrade

54 WFSBP 2015

Tuesday, 16 June 2015 | Scientific Programme

P-11-012 P-12-004 ABCB1 polymorphism may be related to refractoriness Mentalizing in schizophrenia: Abnormal activation of theory in a sample of mood disorders patients undergoing ECT: of mind areas during implicit perspective taking A pharmacogenetics approach Lisa Mayrhauser, Austria Carolina Prado, Brazil M. Tschernegg, L. A. Nawara, M. Schurz, J. S. Crone, R. Stel- M. van de Bilt, B. Valim de Nicola, L. Rigonatti, S. Rigonatti, zig-Schöler, C. Geretsegger, M. Kronbichler L. Talib, W. Gattaz P-12-005 P-11-013 Neurocognition and serotonin transporter 5-HTTLPR poly Are HTR1A and HTR2A polymorphisms related to treatment morphism in high-risk for psychosis individuals response? A pharmacogenetics study of ECT patients Maryna Skuhareuskaya, Belarus Bruna Nicola, Brazil I. Halayenka C. Prado, M. van de Bilt, L. Rigonatti, L. Talib, S. Rigonatti, P-12-006 W. Gattaz The modulatory role of serotonin in model-based and mo P-11-014 del-free choice behaviour Deep brain stimulation alters expression of blood brain Nikolina Skandali, United Kingdom barrier transporters as a mechanism to enhance CNS drug V. Voon, A. Bruhl, J. Rowe, T. Robbins, B. Sahakian effects P-12-007 Ziad Nahas, Lebanon Co-prescription of antipsychotics with other psychotropics L. Devane, M. Doumit, P. Zhang and medication for somatic disorders: A total population P-11-015 study in Austria Efficacy of repetitive transcranial magnetic stimulation Heinz Katschnig, Austria (rtms) in post traumatic stress disorder (ptsd) and panic F. Endel, C. Strassmayr disorder: A meta-analysis P-12-008 Deepa Nathan, India Genetic ancestry of psychosis in the population of the Cen- M. S. Keshavan tral Valley of Costa Rica P-11-016 Javier Contreras, Costa Rica Longitudinal efficacy of tms treatment in depression R. Barrantes, H. Raventos Oguz Karamustafalioglu, Turkey P-12-009 M. Cevik, O. Tankaya Pattern of gene expression in different stages of schizophrenia: A pilot comparison of human induced pluripotent stem cell-derived neurons with post mortem cerebral cortex Mirko Manchia, Italy P-12 Poster Presentation I. S. Piras, C. C. Zai, J. Kennedy, B. Carpiniello 12:45 – 14:15 Muses Foyer P-12-011 Basic and Clinical Neuroscience / Epidemiology Linkage and association analyses of schizophrenia with Chair: Maria Panayotacopoulou, Greece genetic variations on chromosome 22q11 in Korean po Co-Chair: Margarita Chryssanthou-Piterou, Greece pulation Yu Sang Lee, Republic of Korea P-12-001 K. S. Hong Ketamine as a model for schizophrenia deficits P-12-012 Erica Neill, Australia Polymorphisms in the serotonin transporter gene and the S. Rossell, C. Morgan, O. Carter, N. Joshua risk of stroke: An association study P-12-003 Janne Kaergaard Mortensen, Denmark Emotion processing in schizophrenia patients and their H. Buttenschön, O. Mors, G. Andersen unaffected mothers Natallia Khamenka, Belarus M. Skuhareuskaya, O. Skugarevsky

55 WFSBP 2015

Scientific Programme | Tuesday, 16 June 2015

P-12-013 P-13 Poster Presentation The role of non-coding RNAs in fear extinction Stefanie Malan-Müller, South Africa 12:45 – 14:15 Muses Foyer L. Fairbairn, W. Daniels, M. Jalali Sefid Dashti, E. Oakeley, Neuroimaging / Neurophysiology M. Altorfer, J. Harvey, S. Seedat, J. Gamieldien, S. Hemmings Chair: Nikos Smyrnis, Greece P-12-014 Co-Chair: Sokratis Papageorgiou, Greece Mice, traumatic brain injury, and cognitive effects of en- riched environment P-13-001 Morphological and functional connectivity change of basal Shaul Schreiber, Israel ganglia in amnestic mild cognitive impairment R. Lin, V. Rubovitch, C. Pick Chang Uk Lee, Republic of Korea P-12-015 C. Lee, S.-H. Joo, C. Hahn, H.-K. Lim Gene expression profile of ARP K2 CNV carriers with adult ADHD P-13-002 Neural correlates of hallucinations in bipolar disorder Sarah Kittel-Schneider, Germany Maila Neves, Brazil D. Gersic, M. Frank, C. Lorenz, J. Auer, A. Reif, K.-P. Lesch, F. Garcia, M. Albuquerque, R. Nicolato, F. Silva Neves, F. L. S. Winkler, S. Klebe De Souza Duran, G. Busatto, H. Corrêa P-12-016 Alzheimer‘s disease, Parkinson‘s disease and schizophre- P-13-003 nia are not inflammatory diseases while inflammation is Prediction of depression in youth at high familial risk for recognizable beyond organ borders bipolar disorder using diffusion tensor imaging Michaela Filiou, Germany Rossana Ganzola, Canada A. S. Arefin, P. Moscato, M. Graeber A. McIntosh, T. Nickson, S. Giles, A. Macdonald, J. Suss- mann, S. Duchesne, H. C. Whalley P-12-017 Central nervous system developmental disorder in a case P-13-004 of paranoid schizophrenia. Postmortem pathology Proton magnetic resonance spectroscopy measures relat- Ma Francisca Tristán, Mexico ed to a long-time symptomatic outcome in first-episode schizophrenia R. Sánchez Martínez, S. Toxto Guerrero, G. Vargas Félix, Agata Szulc, Poland M. Manzares Colín, S. Palacios Escalona, L. Reyes Santos, B. Galinska-Skok, E. Tarasow, N. Waszkiewicz, A. Mosiolek E. Alonso Zúñiga, B. Peralta Rodriguez, J. Luna Muñoz, H. Garduño Treviño, H. Cabello Rangel, D. Rembao Bojórquez P-13-005 Regional cerebral glucose metabolism in acute and transient P-12-018 psychosis – comparison with schizophrenia Effects of serum A levels on intestinal endotoxemia among Srinivas Balachander, India Alzheimer‘s disease rats and in chinese sample of Alzheim- er‘s disease patients and healthy controls S. Malhotra, D. Basu, A. Bhattacharya Bai Han, People‘s Republic of China P-13-006 F. Wu, Q. Sun, Y. Gao, L. Ma, X. Shan Reward susceptibility distinctly mediates salience effects on functional connectivity during expectancy and percep- P-12-019 tion condition The effect of antidepressants on the pattern of c-Fos re- Shijia Li, Germany sponse to the tail suspension test in the mouse brain L. R. Demenescu, B. Zhang, A. Kraus, C. Metzger, M. Walter Kentaro Hiraoka, Japan K. Motomura, S. Yanagida, A. Ohashi, S. Kanba P-13-007 Similar white matter but opposite grey matter alterations P-12-020 in schizophrenia and high-functioning autism Cytogenetic study compared with measurements of oxi- Julien Katz, France dative stress and association of PARK2 and PARK6 gene in Parkinson’s disease patients Jayalakshmi Ramalingam, India A. Meyyazhagan, G. Changrathil, M. Iyer, S. Keshavarao, B. Vellingiri

56 WFSBP 2015

Tuesday, 16 June 2015 | Scientific Programme

P-13-008 P-13-013 Studying neuroimaging in patients with first episode of Auditory event-related potentials differentiate patients with acute psychosis. A retrospective study comparing patients schizophrenia and autism spectrum disorders with abnormal neuroimaging results and patients with Yi-Ling Chien, Taiwan normal neuroimaging results M. Hsieh, Y.-H. Sheu, S. Gau, H.-G. Hwu Fengyuan Yao, Singapore P-13-014 J. Rajesh, G. Kunjithapatham, S. P. Lee GABA metabolism and its role in gamma-band oscillatory P-13-009 activity during auditory processing The dorsal prefrontal cortex mediates attention to social Christine Wyss, Switzerland reward in adolescents: Implications for childhood onset D. H. Y. Tse, W. Kawohl, I. Neuner, N. J. Shah psychiatric conditions P-13-015 Vaibhav Diwadkar, USA Auditory P300 event related potentials in acute and tran- B. Chepuri, M. Nobile, K. Ramaseshan, P. Brambilla sient psychosis in remission-comparison with schizophrenia P-13-010 in remission Novel multi-feature vs oddball paradigm in evaluating au- Swapnajeet Sahoo, India ditory change detection in schizophrenia S. Malhotra, D. Basu, M. Modi Michal Jarkiewicz, Poland P-13-016 L. Okruszek, W. Jernajczyk, M. Jarema, A. Wichniak Attentional and sensory gating abnormalities in schizo- P-13-011 phrenia: A neuropsychopharmacologic approach for the The effect of different routes of administration of THC in treatment of schizophrenia rats Leslie Kiraly, Canada Libor Uttl, Czech Republic Z. Elbaz P. Nováková, T. Hložek, L. Kaderábek, F. Tyls, E. Lhotkova, C. Vejmola, T. Palenicek, M. Balikova, D. Ripova P-13-012 The impact of acute cannabis intoxication on eLORETA functional connectivity of the brain Filip Tyls, Czech Republic T. Palenicek, M. Viktorinova, R. Androvicova, M. Fujakova, T. Melicher, M. Brunovsky, J. Horacek

Poster Exhibition Please visit the Poster Exhibition located in the Muses Foyer on the ground level of the Megaron.

Opening hours Monday, 15 June 2015 09:00 – 17:00 Tuesday, 16 June 2015 09:00 – 17:00 Wednesday, 17 June 2015 09:00 – 17:00 Thursday, 18 June 2015 09:00 – 17:00

57 WFSBP 2015

Scientific Programme | Wednesday, 17 June 2015

PL-03 Plenary lecture S-32-002 Negative symptoms in schizophrenia: Main issues in the 10:00 – 10:45 Trianti Hall search for biomarkers Chair: Masatoshi Takeda, Japan Silvana Galderisi, Italy A. Vignapiano, P. Bucci, A. Mucci PL-03-001 Neuropsychiatric syndromes of later life: Implications for S-32-003 the study and treatment of major psychiatric diseases Quantitative analysis of neurophysiological signals as bio- Constantine Lyketsos, USA logical marker of cognitive deficits and negative symptoms in schizophrenia Adam Wichniak, Poland S-32-004 T10: Depression: Basic / Clinical WFSBP-Consensus criteria for neurophysiological biomark- S-31 Symposium ers and endophenotypes of schizophrenia 08:30 – 10:00 Trianti Hall Florence Thibaut, France Novel biomarkers in mood disorders: Opportunities for translation into clinical practice Chair: Bernhard Baune, Australia T46: Suicide: Basic / Clinical Co-Chair: Kenji Hashimoto, Japan S-33 Symposium S-31-001 08:30 – 10:00 Skalkotas Hall A translational perspective on the neurotrophin hypothesis Translational psychiatry in mood disorders and suicide of depression Chair: Julio Licinio, Australia Marc L. Molendijk, The Netherlands Co-Chair: Philippe Courtet, France S-31-002 BDNF and its precursor proBDNF as biomarkers for mood S-33-001 disorders Imaging and cognitive markers of suicidal behavior Kenji Hashimoto, Japan Fabrice Jollant, Canada S-31-003 S-33-002 Apoptosis as new biomarker for mood disorders Omics predictors of suicidal behaviour Yakup Albayrak, Turkey Enrique Baca Garcia, Spain S-31-004 S-33-003 Genetic and serum immune biomarkers in depression The role of neuroinflammation and immunity on suicidality Bernhard Baune, Australia Philippe Courtet, France S-33-004 Serotonin and endocannabinoid system in mood disorders: Animal and clinical studies T40: Schizophrenia: Basic / Clinical Gabriella Gobbi, Canada S-32 Symposium 08:30 – 10:00 Mitropoulos Hall Biological markers of cognitive deficits and negative T32: Pharmacology symptoms in schizophrenia S-34 Symposium Chair: Nash N. Boutros, USA Co-Chair: Adam Wichniak, Poland 08:30 – 10:00 MC 3 Room Cross species studies of psychedelic drugs – relevance to S-32-001 psychiatric disorders Need for assessment batteries to examine cognition in Chair: Franz Vollenweider, Switzerland deficit syndrome patients Co-Chair: Mark A. Geyer, USA Nash N. Boutros, USA K. Gjini, F. Wang, S. Bowyer S-34-001 Behavioral and pharmacological studies of psychedelics in animals Mark A. Geyer, USA

58 WFSBP 2015

Wednesday, 17 June 2015 | Scientific Programme

S-34-002 T23: Neuroimaging: Genetic, Functional, Structural Disruption of thalamocortical activity in psychedelic models in animals S-36 Symposium Francesc Artigas, Spain 11:00 – 12:30 Mitropoulos Hall S-34-003 Brain imaging and treatment response EEG power spectra and connectivity changes as biomarkers Chair: Siegfried Kasper, Austria of psychedelic effects in animal models Co-Chair: Lars Farde, Sweden Tomas Palenicek, Czech Republic S-34-004 S-36-001 Neuroimaging and behavioral studies of cognitive and Multimodal imaging and treatment response in depression emotional effects of serotonergic hallucinogens in humans Siegfried Kasper, Austria Franz Vollenweider, Switzerland S-36-002 R. Krähenmann, E. Seifritz, K. Preller Targets for deep brain stimulation in depression Thomas Schlaepfer, Germany S-36-003 T44: Stimulation Methods (ECT, TMS, VNS, DBS) D2-receptor occupancy and treatment reponse in schizophrenia revisited S-35 Symposium Lars Farde, Sweden 08:30 – 10:00 MC 2 Room S-36-004 Clinical applications and technical foundations of tran- Imaging of the glutamatergic neuroreceptors, a new target? scranial Direct Current Stimulation (tDCS), a non-inva- Erich Seifritz, Switzerland sive brain stimulation therapy, in psychiatric disorders Chair: Andre Brunoni, Brazil Co-Chair: Emmanuel Poulet, France T16: Genetics S-35-001 S-37 Symposium TDCS in psychiatry: Mechanistic foundations and current 11:00 – 12:30 Skalkotas Hall challenges Frank Padberg, Germany Immunogenetics: Exploring new territory in schizophrenia S-35-002 Chair: James Kennedy, Canada TDCS for neuromodulation of decision-making: Implica- Co-Chair: Jennie Pouget, Canada tions for the addictive brain S-37-001 Shirley Fecteau, Canada Common variation does not support involvement of im- S. Fecteau mune loci in schizophrenia S-35-003 Jennie Pouget, Canada Clinical and biological evidence for using TDCS in schiz- V. Goncalves, J. Kennedy, J. Knight ophrenia S-37-002 Jerome Brunelin, France The schizophrenia and bipolar polygenic scores: Associa- E. Poulet tion with clinical and serologic markers S-35-004 Faith B. Dickerson, USA TDCS in major depressive disorder: Results from rand- S-37-003 omized clinical trials and follow-up studies An extreme form of structural variation in the human HLA Andre Brunoni, Brazil locus Steven McCarroll, USA S-37-004 The viral microbiome: The missing link in the pathogenesis of schizophrenia Robert Yolken, USA F. B. Dickerson

59 WFSBP 2015

Scientific Programme | Wednesday, 17 June 2015

T4: Anxiety Disorders: Basic / Clinical T44: Stimulation Methods (ECT, TMS, VNS, DBS) S-07 Symposium S-40 Symposium 11:00 – 12:30 MC 2 Room 11:00 – 12:30 Conference Room 1 Anxiety disorders – clinical and biological markers in Advances in repetitive Transcranial Magnetic Stimula- diagnosis and treatment tion (rTMS) as treatment for psychiatric disorders Chair: Borwin Bandelow, Germany Chair: David Gorelick, USA Co-Chair: Katharina Domschke, Germany Co-Chair: Christos Theleritis, Greece

S-07-001 S-40-001 Patho- and therapy-genetics of anxiety disorders Functional and structural neuroplasticity possibly induced Katharina Domschke, Germany by a series of prefrontal rTMS for major depression S-07-002 Motoaki Nakamura, Japan Childhood anxiety as a precursor of other psychiatric dis- Y. Noda, T. Saeki, S. Hayasaka, T. Izuno, T. Yoshiike, S. Mori- orders in adulthood naga, Y. Hirayasu Christer Allgulander, Sweden S-40-002 S-07-003 Deep transcranial magnetic stimulation in major depres- Efficacy of treatments for anxiety disorders:A meta-analysis sion: From animal models to clinical application Borwin Bandelow, Germany Yechiel Levkovitz, Israel M. Reitt, C. Röver, S. Michaelis, Y. Görlich, D. Wedekind S-40-003 S-07-004 Intermittent theta burst protocol for restricted and repet- The need for new targets in anxiety disorders: From neu- itive behavior on high function autistic spectrum disorder robiology to treatment Marco Marcolin, Brazil Nic J.A. van der Wee, Germany C. Abujadi S-40-004 Neuroplastic effects of standard and deep TMS treatment as measured by EEG in individuals with attention-deficit T10: Depression: Basic / Clinical hyperactivity disorder (ADHD) S-39 Symposium Abraham Zangen, Israel U. Alyagon, H. Shahar, H. Shalev 11:00 – 12:30 Kokkali Room Molecular and genetic substrates underpinning diagnosis of major depression Chair: Yogesh Dwivedi, USA T27: Pain: Basic / Clinical Co-Chair: Dan Rujescu, Germany S-41 Symposium S-39-001 15:00 – 16:30 Trianti Hall MicroRNA-mediated reorganization of gene expression Resolving the missing link between physical and mental networks and its role in depression pathogenesis pain: Basic, clinical, and translational approaches Yogesh Dwivedi, USA Chair: Shigenobu Kanba, Japan S-39-002 Co-Chair: Tim Salomons, United Kingdom Neurotrophic- and GABA-related corticolimbic pathology in depression S-41-001 Etienne Sibille, USA Comorbidity of psychiatric disorders in chronic pain Ryota Hashimoto, Japan S-39-003 DNA methylation in childhood maltreatment and major Y. Yasuda, A. Nakae, H. Yamamori, M. Fujimoto, K. Ohi, depression K. Kou, S. Hagihira, K. Miki, M. Yukioka, M. Takeda Gustavo Turecki, Canada S-41-002 P.-E. Lutz, G. G. Chen, R. Poujol, A. B. Diallo, M. J. Meaney, Microglia as a pain maker in neuropathic pain: Rodent C. Ernst studies Makoto Tsuda, Japan S-39-004 Neuroticism: Role in negative mood states and internalizing S-41-003 depressive conditions Therapeutic and neuroimaging approaches to physical Dan Rujescu, Germany and mental pain Tim Salomons, United Kingdom

60 WFSBP 2015

Wednesday, 17 June 2015 | Scientific Programme

S-41-004 S-43-004 Microglia as a possible key player to bind physical and Sleep-EEG derived biomarkers of depression psychological pain: Translational approach Axel Steiger, Germany Takahiro Kato, Japan M. Adamczyk, E. Friess, M. Pawlowski, M. Uhr M. Ohgodani, M. Hosoi, S. Kanba

T10: Depression: Basic / Clinical T40: Schizophrenia: Basic / Clinical S-44 Symposium S-42 Symposium 15:00 – 16:30 MC 2 Room 15:00 – 16:30 Mitropoulos Hall Inflammation and mitochondrial dysfunction:R elevance Computational, cognitive and pharmacological connecto- to depression mics: Towards understanding mechanisms of psychosis Chair: Michael Berk, Australia Chair: Alan Anticevic, USA Co-Chair: Michael Maes, Thailand Co-Chair: Deanna Barch, USA S-44-001 S-42-001 Differential changes in TNF alpha signalling pathways in Integrating pharmacology, computation and connectivity schizophrenia, major depressive disorders and bipolar to understand schizophrenia onset and progression disorders Alan Anticevic, USA Brian Dean, Australia S-42-002 S-44-002 Connectomics of psychosis: Cross diagnostic similarities, The role of inflammation in the biology and aetiology of differences and relationships to RDoC dimensions depression Deanna Barch, USA Michael Maes, Thailand S-42-003 S-44-003 Neural oscillations in MEG-Data: A translational perspective Novel therapies for depression: Anti-inflammatory treatments Peter Uhlhaas, United Kingdom Michael Berk, Australia S-42-004 Action-based paradigms reveal predictive coding failures in psychotic patients T38: Psychopathology Judith Ford, USA TG-05 WFSBP Treatment Guidelines 11:00 – 12:30 MC 3 Room T10: Depression: Basic / Clinical Task Force on Nosology: Psychopathology – past, present and future S-43 Symposium Chair: Wolfgang Gaebel, Germany 15:00 – 16:30 MC 3 Room Co-Chair: Veronica Larach, Chile Sleep and neuroplasticity: Clinical implications for depression TG-05-001 Psychopathology and neuroscience: A modularity approach Chair: Edith Holsboer-Trachsler, Switzerland Wolfgang Gaebel, Germany Co-Chair: Axel Steiger, Germany TG-05-002 S-43-001 After Jaspers, what else? Animal models of sleep disruption Michael Musalek, Austria Tarja Porkka-Heiskanen, Finland TG-05-003 S-43-002 Gene-environment interaction and psychopathology Sleep and synaptic dysfunction in depression George N. Papadimitriou, Greece Anne Eckert, Switzerland TG-05-004 S-43-003 Teaching psychopathology today Sleep as predictor of emotional regulation in children Veronica Larach, Chile Martin Hatzinger, Switzerland

61 WFSBP 2015

Scientific Programme | Wednesday, 17 June 2015

T40: Schizophrenia: Basic / Clinical WS-16-003 Screening of cognitive impairment and diagnosis of dementia TG-06 WFSBP Treatment Guidelines Katsuya Urakami, Japan 15:00 – 16:30 Skalkotas Hall WS-16-004 Task Force on Schizophrenia CSF biomarkers in differential diagnosis of dementia Chair: Peter Falkai, Germany Toshihisa Tanaka, Japan Co-Chair: Alkomiet Hasan, Germany M. Terada, M. Sato, M. Takeda

TG-06-001 WFSBP Guidelines on the acute treatment of schizophrenia Alkomiet Hasan, Germany T40: Schizophrenia: Basic / Clinical TG-06-002 WS-11 Workshop WFSBP Guidelines on the long-term treatment of schizo 16:30 – 18:00 Skalkotas Hall phrenia Thomas Wobrock, Germany Treatment of schizophrenia: Personalized tailoring to meet patients needs TG-06-003 Chair: Konstantinos Fountoulakis, Greece Treatment guideline for the early phase of schizophrenia/ Co-Chair: Cyril Hoschl, Czech Republic psychosis Eric Chen, People‘s Republic of China WS-11-001 Antipsychotics: Differences and specificity Alessandro Serretti, Italy T1: Addictive Disorders WS-11-002 Information technology aided relapse prevention in schizo D-02 Debate phrenia (itareps) 11:00 – 12:30 Trianti Hall Cyril Hoschl, Czech Republic Behavioral addictions – normality or deviance? F. Spaniel Chair: Florence Thibaut, France WS-11-003 Co-Chair: Victoria Valdez de Vuibert, Ecuador Computer-assisted treatment pathway for schizophrenia: Proponent: Marc Potenza, USA Development and first results in over 200 patients Opponent: Pier Vincenzo Piazza, France Georg Juckel, Germany WS-11-004 The optimization effect in schizophrenia: Why we see different things in everyday clinical practice T9: Dementia: Basic / Clinical Konstantinos Fountoulakis, Greece WS-16 Workshop 16:30 – 18:00 Mitropoulos Hall T10: Depression: Basic / Clinical Development of biological markers for differential diagnosis of dementia in physiological and biochemical WS-12 Workshop strategies 16:30 – 18:00 MC 3 Room Chair: Toshihisa Tanaka, Japan Task force recommendations for the management of Co-Chair: Fernando Maestu, Spain comorbidity in major depressive disorder and bipolar WS-16-001 disorder Magnetoencephalography for diagnose and evaluation of Chair: Roumen Milev, Canada dementia Co-Chair: Serge Beaulieu, Canada Fernando Maestu, Spain WS-12-001 WS-16-002 The comorbidity of mental and bone health: A fracture Functional connectivity in EEG for diagnosis of Alzheimer line ready to break? disease Michael Berk, Canada Leonides Canuet, Spain WS-12-002 Management of patients with comorbid mood and anxiety disorders Roumen Milev, Canada A. Schaffer

62 WFSBP 2015

Wednesday, 17 June 2015 | Scientific Programme

WS-12-003 WS-14-003 Managing substance use in mood disorders Genetic neuroimaging study to find the neurobiology of Serge Beaulieu, Canada depressive disorders WS-12-004 Byungjoo Ham, Republic of Korea Treating bipolar disorder in the real world integrating co- M.-S. Lee morbidity into treatment decisions WS-14-004 Serge Beaulieu, Canada Neurobiology of impulsive behaviors and behavioral addictions Dai-Jin Kim, Republic of Korea J. E. Jeong T33: Posttraumatic Stress: Basic / Clinical WS-13 Workshop

16:30 – 18:00 MC 2 Room T6: Bipolar Disorders: Basic / Clinical Interaction between neurobiological and ethno cultural WS-15 Workshop factors in PTSD treatment response, recovery and resilience. Is there a link? 16:30 – 18:00 Conference Room 1 Chair: Soraya Seedat, South Africa A Latin American contribution to bipolar disorders Co-Chair: Mushtaq Margoob, India Chair: Eugenio Vargas Pena, Paraguay Co-Chair: Guillermo Dorado, Argentina WS-13-001 Contribution of ethno cultural, genetic and biological factors WS-15-001 to increasing or decreasing PTSD treatment response – an Kraepelin model in bipolar disorders Asian experience Jaime Vengoechea, Colombia Mushtaq Margoob, India WS-15-002 D. Mushtaq, H. Mushtaq Addictive disorders and bipolarity WS-13-002 Guillermo Dorado, Argentina Contribution of ethno cultural, genetic and biological fac- WS-15-003 tors to increasing or decreasing a person’s risk for devel- Bipolar II disorders and sudden episodic depression oping PTSD once he or she has been exposed to trauma – an African experience Eugenio Vargas Pena, Paraguay Soraya Seedat, South Africa WS-15-004 Comments on brain-SPECT and bipolar disorders WS-13-003 A model of suicidal behavior among immigrants with PTSD Enrique Galli, Peru Leo Sher, USA WS-13-004 BDNF genetics, serum BDNF, and ethnicity: Implications FC-14 Free Communications for intervening in PTSD 08:30 – 10:00 Kokkali Room Soraya Seedat, South Africa Addiction Chair: Marc Potenza, USA Co-Chair: Ioannis Liappas, Greece T46: Suicide: Basic / Clinical WS-14 Workshop FC-14-001 Non-invasive brain stimulation: A modern approach to 16:30 – 18:00 Kokkali Room improved therapy of nicotin addiction? Suicide and behavioral addiction in Korea: Searching for Andreas J. Fallgatter, Germany the biopsychosocial basis in the fast changing society A. Dieler, M. J. Herrmann, T. Dresler Chair: Chang Uk Lee, Republic of Korea FC-14-002 Co-Chair: Han Yong Jung, Republic of Korea Playing video games while intoxicated Gabriel Thorens, Switzerland WS-14-001 S. Rothen, S. Achab, Y. Khazaal, D. Zullino Crosscultural differences in the attitude toward suicide: Multi-countries comparison study Yong-Min Ahn, Republic of Korea WS-14-002 Postvention program for suicide attempters in Seoul Jong-Woo Paik, Republic of Korea

63 WFSBP 2015

Scientific Programme | Wednesday, 17 June 2015

FC-14-003 FC-15-005 Persistence of psychotic symptoms as an indicator of cog- Hair cortisol and subjective stress in patients with schizo- nitive impairment in methamphetamine users phrenia and bipolar disorder Chih-Ken Chen, Taiwan Lejla Hasandedi, Germany S.-K. Lin, M.-C. Huang, Y.-C. Chen, L.-J. Wang F. Streit, A. Memic, J. Strohmaier, J. Frank, M. Lang, S. H. FC-14-004 Witt, A. Forstner, F. Degenhardt, M. Nöthen, C. Kirschbaum, Addiction: The burden of cyclothymic temperament L. Oruc, M. Rietschel Andreas Erfurth, Austria FC-15-006 G. Sachs, O. Lesch Can body dysmorphic disorder be classifed an obsessive FC-14-005 spectrum disorder? Evidence from neuroimaging Aerobic exercise as treatment for tobacco cravings in college Susan Rossell, Australia students who are quitting smoking B. Buchanan, J. Maller, W. L. Toh, D. Castle Carmen Lara, Mexico M. T. Baez, A. Reyes FC-14-006 FC-16 Free Communications Perceived pain, dissociation and its relation to history of sexual abuse among methadone maintenance and non-ad- 15:00 – 16:30 Kokkali Room dicted patients Liaison Psychiatry Einat Peles, Israel Chair: Ladislav Hosak, Czech Republic Z. Seligman, D. Potik, M. Bloch, A. Sason, S. Schreiber, Co-Chair: Thomas Paparrigopoulos, Greece M. Adelson FC-16-001 Utilization and predictors of post-stroke antidepressant treatment FC-15 Free Communications Janne Kaergaard Mortensen, Denmark 08:30 – 10:00 Conference Room 1 S. P. Johnsen, H. Larsson, G. Andersen Anxiety Disorders FC-16-002 Depressive disorders in patients with coronary heart dis- Chair: Michel Bourin, France ease associated with arterial hypertension and metabolic Co-Chair: Nikos Vaidakis, Greece disorders of carbohydrate and fat metabolism FC-15-001 Alexander Rozin, Russia Patterns of salivary cortisol level in anxiety disorders and E. Schastnyy, N. Garganeeva personality disorders and changes in salivary cortisol level FC-16-003 after psychotherapy Vitamin D supplementation reduces depressive symptoms Edyta Dembiñska, Poland in patients with chronic liver disease K. Rutkowski, K. Tokarz, J. Sobanski, K. Cyranka, L. Muld- Caroline Stokes, Germany ner-Nieckowski, M. Mielimaka F. Gruenhage, C. Baus, D. Volmer, S. Wagenpfeil, M. Rie- FC-15-003 menschneider, F. Lammert Obsessive symptoms and clozapine FC-16-004 Esteban Rodríguez Jiménez, Spain Parkinson‘s disease depression, the pieces of the puzzle: J. Alcalá Partera, M. d. Pino Ordovás González, A. Benito Suggestions for a practical approach Duarte Emmanuelle Pourcher, Canada FC-15-004 FC-16-005 Tau protein is important for stress-driven depressive pa- The role of consultation-liaison psychiatrist in preventing, thology and cognitive deficits identifying and treating Wernicke‘s encephalopathy Ioannis Sotiropoulos, Portugal Magdalena Spariosu, USA S. Lopes, J. Vaz Silva, S. Rodrigues, J. Silva, V. Pinto, N. Ko- D. Coira, C. Wassef, J. Emolo kras, B. Benenk, M. Czisch, O. Almeida, C. Dalla, N. Sousa FC-16-006 Executive dysfunction in psychosis following traumatic brain injury Rachel Batty, Australia A. Francis, N. Thomas, M. Hopwood, J. Ponsford, S. Rossell

64 WFSBP 2015

Wednesday, 17 June 2015 | Scientific Programme

FC-17 Free Communications FC-18-003 Comparative efficacy of intermittent theta-burst versus 15:00 – 16:30 Conference Room 1 conventional 10 Hz left dorsolateral prefrontal rTMS in Depression / Psychopharmacology major depression: A multi-site non-inferiority trial Chair: Janusz Rybakowski, Poland Jonathan Downar, Canada Co-Chair: Constantinos Fokas, Greece D. Blumberger, F. Vila-Rodriguez, K. Dunlop, L. Schulze, P. Giacobbe, S. Kennedy, Z. J. Daskalakis, J. Downar FC-17-001 FC-18-004 Long-term escitalopram blunts autonomic reactivity to Assessing the antidepressant effect of two and three HF- pharmacological stress challenge in healthy men rTMS sessions per day Agorastos Agorastos, Germany Christos Theleritis, Greece M. Kellner, O. Stiedl, K. Wiedemann, C. Demiralay P. Sakkas, T. Paparrigopoulos, C. Tzavara, S. Bonaccorso, FC-17-002 A. Politis, C. R. Soldatos, C. Psarros Effect of short-term escitalopram treatment on neural ac- FC-18-006 tivation during emotional processing Changes in BDNF blood levels after antidepressant treat- Eduard Maron, United Kingdom ment with non-pharmacological therapies: A systematic B. Godlewska, D. Nutt, P. Cowen, P. Matthews, R. Norbury, review and meta-analysis M. Wall Andre Brunoni, Brazil FC-17-003 C. Baeken, R. Machado-Vieira, W. Gattaz, M.-A. Vanderhasselt Antidepressant and neurocognitive effects of single keta- FC-18-007 mine infusion in bipolar depression Non-invasive brain stimulation in psychiatry Janusz Rybakowski, Poland Andreas J. Fallgatter, Germany A. Permoda-Osip, J. Kisielewski, A. Bartkowska-Sniatkowska T. Dresler, A.-C. Ehlis, C. Plewnia FC-17-004 Comparison of the effect of mood stabilizers on prolif- eration and apoptosis of peripheral T lymphocytes from bipolar disorder patients SA-04 industry sponsored Symposium Krzysztof Pietruczuk, Poland 13:30 – 15:00 Skalkotas Hall K. Lisowska, J. Witkowski, K. Grabowski, J. Landowski FC-17-005 see page 97. Psychopharmacotherapy during pregnancy: Therapeutic drug monitoring (TDM) in maternal blood, amniotic fluid and umbilical cord blood Michael Paulzen, Germany P-14 Poster Presentation S. Lammertz, T. Veselinovic, T. Goecke, C. Hiemke, G. Gründer 12:45 – 14:15 Muses Foyer Addictive Disorders / Stress related Disorders / Childhood and Adolescent Disorders FC-18 Free Communications Chair: Ioanna Giannaopoulou, Greece 16:30 – 18:00 Trianti Hall P-14-001 Brain Stimulation Therapies Life skills and substance related knowledge among adoles- Chair: Mark George, USA cent school students in Malaysia Co-Chair: Pavlos Sakkas, Greece Ahmad Hatim Sulaiman, Malaysia M. A. Said, S. Hajar, W. A. Irnee, R. Rashid, M. H. Habil FC-18-002 Deep transcranial magnetic stimulation in major depres- P-14-002 sion: From animal models to clinical application Orexin level in methamphetamine users: Comparison Hilik Levkovitz, Israel between health controls and methamphetamine addicts in Taiwan Wen Yin Chen, Taiwan C.-F. Kao, S.-K. Lin, M.-C. Huang

65 WFSBP 2015

Scientific Programme | Wednesday, 17 June 2015

P-14-003 P-14-015 Prevalence, characteristics and severity of alcohol consump- Women are more likely to develop PTSD following trauma tion among pregnant women in Sabah, Malaysia exposure than men: A prospective study Mas Ayu Said, Malaysia Vasiliki Michopoulos, USA A. H. Sulaiman, N. Ain A. Rothbaum, H. Grinstead, B. Rothbaum, K. Ressler P-14-004 P-14-016 Change of plasma adiponectin level after smoking cessation New medical therapy and the effect mechanism that the Wangyoun Won, Republic of Korea central anticholinergic drug Trihexyphenidyl reduces flash- back in patients with posttraumatic stress disorder (PTSD) P-14-005 Katsumasa Sogou, Japan The development of neurofeedback protocol for the reduction of impulsivity in internet addiction: A case study P-14-017 Sunhye Chung, Republic of Korea A memory is my lighthouse S. Choi Ada Tadevosyan, USA L. Grygoryan P-14-006 The efficacy of the rehabilitation of the dual diagnosis pa- P-14-018 tients Impact of occupational stress on frontotemporal cortical Joanna Zofia Waniek, Poland activity during a verbal fluency test:A near-infrared spectroscopy P-14-007 Wei-Hao Lin, Taiwan Recurrent depression and somatic-vegetative correlates in children P. H. Chou, T.-H. Lan, C.-H. Chan E. Mykhailova, Ukraine P-14-019 T. Proskurina, T. Matkovska, N. Reshetovska Tau missorting as part of glucocorticoid-triggered synaptic pathology P-14-008 Ioannis Sotiropoulos, Portugal Effect of phenytoin and cyclosprine on IL-17 production by gingival fibroblast of adult and child S. Pinheiro, J. Silva, C. Mota, J. Vaz Silva, A. Veloso, V. Pinto, Surena Vahabi, Iran N. Sousa, J. Cerqueira P-14-009 P-14-020 Use of youth restraints in psychiatric care and its impact Decreased medial prefrontal cortex gray matter volume in on organizational climate and culture male conscripts with adjustment disorder Catherine N. Dulmus, USA Kyoung-Sae Na, Republic of Korea D. A. Patterson Silver Wolf, M. Cristalli W. Myung, S. M. Bae, S.-J. Cho P-14-011 P-14-021 The role of dopamine in fear extinction of adolescent rats Health-related quality of life and type d personality in coronary artery disease patients with heart failure: A longitu- Despina Ganella, Australia dinal observational study H. Madsen, L. Lee-Kardashyan, I. Zbukvic, S. Luikinga, Julius Burkauskas, Lithuania R. Coulthard, A. Lawrence, J. H. Kim M. Staniute, J. Brozaitiene, N. Kazukauskiene, N. Mickuvi- P-14-012 ene, R. Bunevicius Methylphenidate use and appearance of peripheral vas- culopathy P-14-022 The effects of high-frequency repetitive transcranial mag- María Del Pino Ordovás González, Spain netic stimulation (rTMS) on occupational stress among R. De Burgos Marín, E. Rodríguez Jiménez health care workers P-14-013 Jaeyoung Ahn, Republic of Korea Prevalence of acute traumatic events in women Y. Kim, S. Y. Park, S. M. Kim, D. H. Han, Y. s. Lee, B. S. Kee, Victoria Valdez de Vuibert, Ecuador C. Na D. Vasquez, D. Rueda, H. Palma, J. Veloz

66 WFSBP 2015

Wednesday, 17 June 2015 | Scientific Programme

P-15 Poster Presentation P-15-010 Affective symptoms as a diagnostic tool in first psychotic 12:45 – 14:15 Muses Foyer episodes Bipolar Disorders / Depression / Antidepressants Marta Arrasate, Spain Chair: Konstantinos Fountoulakis, Greece A. González-Pinto, M. Martínez, I. González, S. Alberich, Co-Chair: Ioannis Michopoulos, Greece F. Mosquera, M. Gutiérrez P-15-011 P-15-001 Bipolar I disorder and the quality of life Combined antidepressant treatment with tranylcypromine Kilani Hajji, Tunisia and s-ketamine in a severely depressed treatment-resistant I. Marrag, M. Nasr patient: A case report Lucie Bartova, Austria P-15-012 S. Vogl, M. Stamenkovic, S. Kasper, M. Willeit Blood-brain barrier dysfunction in bipolar disorder: Less protection to the brain? P-15-002 Benicio Frey, Canada Multi-isotope imaging mass spectrometry reveals hip- J. Patel pocampal protein turnover alterations in response to antidepressant treatment P-15-013 Michaela Filiou, Germany ECT and lithium in old age bipolar depression – cause or C. Webhofer, C. Guillermier, C. Poczatek, M. Wang, C. Turck, treatment of ultra-rapid cycling? C. Lechene Jacqueline Huber, Australia D. Burke P-15-003 The efficacy of aripiprazole augmentation for incomplete P-15-015 response in late-life depression: A retrospective study Neurocognitive remediation therapy for depression: A pilot Hyungseok So, Republic of Korea study H. Chung, J. H. Choi, T. Y. Kim, S.-H. Kang Maria Semkovska, Ireland E. Ahern P-15-004 Results of the depression disorders medical treatment with P-15-016 sertralin in the primary health protection Steroid hormones in the dynamics of therapy of depressive Nebojsa Ilic, Serbia disorders V. Ilic Lyudmila Levchuk, Russia N. Vyalova, G. Simutkin, E. Lebedeva, S. Ivanova P-15-006 Modern view on the issue of bipolar affective disorder P-15-017 (psychopathological characteristics and efficiency of psy- Use of statins in the treatment of depression in patients choeducation in the complex therapy) with acute coronary syndrome Volodymyr Korostiy, Ukraine Sung-Wan Kim, Republic of Korea H. Kozhyna, O. Rezunenko C. Park, Y.-H. Lee, K.-Y. Bae, J.-M. Kim, I.-S. Shin, Y. J. Hong, M. H. Jeong, M. Berk, J.-S. Yoon P-15-007 Neurocognitive impairments in bipolar disorder patients P-15-018 Nozomi Ishisaka, Japan Comparative efficacy of bupropion and duloxetine in depressive disorder due to Parkinson‘s disease P-15-008 Daniel Vasile, Romania Paliperidone for the treatment of bipolar disorder O. Vasiliu, D. G. Vasiliu, F. Androne, F. Vasile Christos Istikoglou, Greece E. Liapis, A. Aivatides, R. Malamou, M. Economou, M. Vas- P-15-019 saliliadou, N. Polofinis, P. Kanellos, I. Liappas, D. Vlissides Depression in the elderly: Description and analyses of four subtypes of geriatric depression P-15-009 Carol Dillon, Argentina A case report – psychiatric sequale following two episodes G. Vazquez, A. Corrales, F. Taragano, R. Allegri of anti-NMDA receptor encephalitis Jun Xiao, Singapore G. Kunjithapatham, E. Wuan

67 WFSBP 2015

Scientific Programme | Wednesday, 17 June 2015

P-15-020 P-16-003 Dynamic interactions between the G protein, galphas, lipid Off-label prescribing of atypical antipsychotics for non-psy- rafts and adenylyl cyclase reveal a potential biomarker for chotic disorders – a significant rise in six years depression and for therapeutic response Marko Saje, Slovenia Mark Rasenick, USA B. Novak Sarotar R. Donati, J. Schappi, C. Czysz P-16-004 P-15-021 Pharmacogenetic of antipsychotics, as a tool to improve Heart rate variability in dysthymia before and after treat- response to cognitive remediation ment with desvenlafaxine Roberto Cavallaro, Italy Arun Ravindran, Canada M. Bosia M. McKay, K. Udupa P-16-005 P-15-022 Diffusion tensor imaging of catatonic and non-catatonic Improved voltammetric determination of neurotransmitters schizophrenia patients as biochemical markers in psychiatric diseases Amir Krivoy, Israel Anton Ciucu, Romania S. Shrot, M. Avrahami, D. Last, Y. Mardor, T. Fischel, D. Guez, A. Gheorghiu C. Hoffman P-15-023 P-16-006 Systematic review of the influence of neurostimulation the Response to clozapine treatment and serum neurotrophins rapies on heart rate variability in major depressive disorder: level among schizophrenia patients A potential predictor of treatment response? Amir Krivoy, Israel Nisha Ravindran, Canada E. Hochman, A. Weizman, S. Hollander, M. Taler M. McKay, Z. J. Daskalakis P-16-007 P-15-024 Sub-threshold negative symptoms and brain network sen- Therapeutic drug monitoring, application into clinical sitivity to emotional salience: Potential predictors of psy- practice chosis in adolescence Maria Radziwon-Zaleska, Poland Harinder Rai, USA M. Skalski, B. Ryszewska-Pokrasniewicz, J. Skrzeszewski, V. Diwadkar E. Drozdowicz P-16-008 P-15-025 Suicide attempt in schizophrenia and first-episode psycho- Use of pharmaco-electroencephalography in the treatment sis: Clinical and biological associations of depression Ahmed Mhalla, Tunisia Michal Skalski, Poland R. Mensi, A. Mrad, I. Azizi, A. Messaoud, W. Douki, F. Najjar, B. Ryszewska-Pokrasniewicz, E. Drozdowicz, J. Skrzeszew- L. Gaha ski, G. Nowak, A. Pilc, M. Radziwon-Zaleska P-16-010 P-15-026 The long-term psychosocial intervention effect on the re- Depression improves after carbon monoxide poisoning duction in hospital stay of patients with schizophrenia Jaisung Noh, Republic of Korea Kyuyoung Lee, Republic of Korea Y. Kwon, M. Cho, S. Kim, S. Hong, M. Jang, S. Son H. J. Oh P-16-011 The prefrontal and anterior cingulate cortices exert exag- gerated modulation during successful cognitive control in P-16 Poster Presentation schizophrenia 12:45 – 14:15 Muses Foyer Nino Papale, USA Schizophrenia / Antipsychotics S. Singh, K. Ramaseshan, A. Omari, R. White, C. Walker, Chair: Venetsanos Mavreas, Greece V. Diwadkar, R. Cho Co-Chair: Emmanuel Rizos, Greece P-16-012 The use of antidepressants in the management of patients P-16-002 with schizophrenia with and without depressive symptoms Different neuroprotection between olanzapine and ari in Greece: Outcomes of the ELPIS study piprazole in rats Christina Kalkavoura, Greece Tudor Udristoiu, Romania S. Kogkas, A. Roussidis, A. Giannopoulou L. Mogoanta, I. Marinescu, D. Marinescu, F. Militaru

68 WFSBP 2015

Wednesday, 17 June 2015 | Scientific Programme

P-16-013 P-16-023 Tolerability, safety and treatment response of flexibly-dosed Investigation of the neurobiology of effort valuation impair- paliperidone palmitate in patients hospitalized for an ex- ments in schizophrenia in a virtual environment acerbation of schizophrenia George Foussias, Canada Andreas Schreiner, Germany I. Siddiqui, C. Hawco, G. Fervaha, S. Saperia, J. Zawadzki, L. Hargarter, M. Lahaye, P. Cherubin K. Zakzanis, A. Wong, O. Agid, G. Remington P-16-015 P-16-024 A role for D-aspartate oxidase in schizophrenia and in Lipid profile in schizophrenia and first-episode psychosis: schizophrenia-related symptoms induced by phencycli- About a Tunisian population dine in mice Ahmed Mhalla, Tunisia Francesco Errico, Italy R. Mensi, A. Messaoud, I. Azizi, W. Douki, F. Najjar, L. Gaha V. D´Argenio, F. Sforazzini, M. Squillace, F. Napolitano, P-16-025 T. Angrisano, D. Vitucci, A. Di Maio, L. Chiariotti, A. de Bar- Long-term improvements in auditory verbal hallucinations: tolomeis, A. Gozzi, A. Usiello Clinician vs. patient perspectives P-16-016 In Won Chung, Republic of Korea Biomarker profiles decode symptoms of psychosis:E vi- S. S.-Hyun Hwang, S. H. Kim, J. S. Chang, H. Y. Jung, Y. S. Kim dence for a new age of biological psychiatry P-16-026 Stephanie Fryar-Williams, Australia Maternal immune activation at the precise times of preg- P-16-017 nancy causes social deficits and decreased prefrontal cortex Characterising language comprehension in schizophrenia BDNF levels in rat offspring and its relationship with language production problems Eliza Koros, Germany Eric Tan, Australia H. Rosenbrock G. Yelland, S. Rossell P-16-028 P-16-018 Peripheral blood markers of dopamine level and oxidative Clinical studies of biomarkers of the indolic hypermethyl- stress in schizophrenia, South India ation in human perception alterations Mahalaxmi Iyer, India Jorge Ciprian Ollivier, Argentina G. Mohan, A. Meyyazhagan, G. Changrathil, S. Keshavarao, A. Vitale, E. Romero, M. Vitale, A. Pomilio D. S.N., B. Vellingiri P-16-019 P-16-029 D-cell hypothesis of schizophrenia: Link of NSC hypothesis Frontal brain activation during emotional stroop task in to dopamine hypothesis individuals at risk for schizophrenia and bipolar disorder Keiko Ikemoto, Japan using functional near-infrared spectroscopy P-16-020 Aleksandra Aleksandrowicz, Switzerland Does cortical thickness act as a mediator between child- F. Hagenmuller, H. Haker Rössler, K. Heekeren, A. Theodori- hood sexual trauma and transition to psychosis in young dou, S. Walitza, W. Rössler, W. Kawohl individuals at ultra-high risk of psychosis? Eleni Ganella, Australia M. Rapado-Castro, S. Whittle, A. Thompson, B. Nelson, A. P-17 Poster Presentation Lin, C. Pantelis, P. McGorry, A. R. Yung, S. J. Wood, C. F. Bartholomeusz 12:45 – 14:15 Muses Foyer P-16-021 Personality Disorders / Violence / Suicide / Forensic Psychiatry Effect of carbonyl stress on cognitive impairment in schi Chair: Athanasios Douzenis, Greece zophrenia patients Co-Chair: George Kiosterakis, Greece Akiko Kobori, Japan S. Hatakeyama, M. Arai, Y. Horiuchi, K. Toriumi, M. Miyas- P-17-001 hita, H. Arai, M. Itokawa A French cohort of paraphilic sex offenders: Preliminary results P-16-022 Sandrine Lamy, France Enhancing cognitive functions in schizophrenia: A rand- V. Olivier, E. Houivet, J. Benichou, H. Delavenne, F. Thibaut omized controlled yoga trial Ruben Gur, India T. Bhatia, S. Mazumdar, J. Wood, F. He, R. Gur, V. Nimgaon- kar, S. Deshpande

69 WFSBP 2015

Scientific Programme | Wednesday, 17 June 2015

P-17-002 P-17-015 Neural processing of erotic adult and naked child pictures Personality traits and fibromyalgia in pedophilic patients and healthy controls María Del Pino Ordovás González, Spain Inka Ristow, Germany E. Rodríguez Jiménez, C. Castaño Díaz S. Li, L. R. Demenescu, M. Walter, H. Walter, K. Beier, B. Schif- P-17-016 fer, J. Ponseti, T. Kruger Cholesterol and inflammatory markers may predict schiz- P-17-003 oid personality traits among Japanese university students Antisocial personality disorder: Neurobiological aspects Noriaki Sagata, Japan and therapeutic approaches K. Hayakawa, T. Kato, M. Ohgidani, M. Watabe, A. R. Teo, Emilce Blanc, Argentina H. Kubo, N. Simokawa, M. Sato-Kasai, S. Ikeda, H. Hori- P-17-004 kawa, M. Tateno, S. Kanba Behavioral improvement in women in prison with ADHD P-17-017 treated with atomoxetine Suicide and testosterone: Neurobiological hypotheses con- Oscar Sanz-Garcia, Spain cerning suicide in young and old men M. P. Ibáñez, A. Muro Leo Sher, USA P-17-009 T. Rice Melatonin levels as a marker of the neuroticism dimension P-17-018 of personality Impact of anxiety and depression on the suicide ide - Armando Luis Morera-Fumero, Spain ation and its correlation with clinical characteristics P. Abreu-Gonzalez, E. Diaz-Mesa in Korean patients with coronary artery disease after percutaneous coronary interventions: An observational P-17-010 cross-sectional study Involuntary interference in emotion dysregulation: Hy- per-modulation of brain networks by the amygdala and Sang Yeol Lee, Republic of Korea orbitofrontal cortex H. J. Lee Kristy Abraham, USA P-17-019 V. Diwadkar, P. Soloff Contemporary patterns of formation of suicidal behavior in patients with depressive disorders P-17-011 Contextual modulation of the connectivity of the brain‘s Volodymyr Korostiy, Ukraine episodic memory pathways by affect: A framework for un- H. Kozhyna, K. Zelenska derstanding emotional dysregulation in psychiatric disease P-17-020 Sonya Sandhu, USA Emotion regulation and adolescent suicide: Proposals for P. Soloff, V. Diwadkar specialist and nonspecialist physician education P-17-012 Leo Sher, USA From anxiolytics to antipsychotics in a patient with a bor- T. Rice derline personality structure P-17-021 Marija Vucic Peitl, Croatia Prevention of homicidal behavior in men with psychiatric J. Proloscic, D. Petric, S. Blazevic Zelic disorders P-17-013 Leo Sher, USA Axis I comorbidity in borderline personality disorder T. Rice M Teresa Bel Villar, Spain P-17-022 I. Frigola de Vehi, V. Fabregat Navarro, R. Borrego Leal, Preventing school shootings: Importance of a developmen- C. Conesa Lopez, A. Corominas Diaz tal approach to at-risk adolescents Timothy Rice, USA P-17-014 Association between neuroticism and 5-HTTLPR L. Hoffman Hernan Silva, Chile J. Villarroel, S. Jerez, C. Montes

70 WFSBP 2015

Wednesday, 17 June 2015 | Scientific Programme

P-18 Poster Presentation P-18-009 Risks of antidepressants during pregnancy – a review 12:45 – 14:15 Muses Foyer Margarida Viana Almeida Coelho, Portugal Dementia / Pregnancy / Psychoneuroimmunology A. R. Carvalho Chair: Angelos Halaris, USA P-18-010 Co-Chair: Maria Anagnostouli, Greece Treating perinatal depression in low and middle-income countries: A systematic review P-18-001 Amy Gajaria, Canada Thalamic shape and cognitive performance in amnestic T. da Silva, A. Ravindran mild cognitive impairment Changtae Hahn, Republic of Korea P-18-011 C.-U. Lee Antipsychotics in pregnancy: Safety and indications Ana Rita Carvalho, Portugal P-18-002 M. Coelho, R. Navarro An exploratory study to reveal the neural basis of visual cognitive dysfunction in Alzheimer‘s disease P-18-013 Taku Yoshida, Japan Cytokine profiles in ultra-high risk and first-episode schizo T. Mori, N. Sonobe, H. Shimizu, T. Matsumoto, S.-i. Ueno phrenia and the effects of aripiprazole treatment Yi-Ling Chien, Taiwan P-18-003 C.-M. Liu, C.-C. Liu, H.-G. Hwu Platelet APP ratio in AD patients treated with donepezil Jessyka Maria de França Bram, Brazil P-18-014 T. Alves Sarno, H. Passarelli Giroud Joaquim, L. Leme Talib, Suicidal patients are deficient in vitaminD , associated with S. R. Hototian, W. Farid Gattaz, O. Vicente Forlenza a pro-inflammatory status in the blood Cécile Grudet, Sweden P-18-004 J. Malm, Å. Westrin, L. Brundin Prevalence of alcohol, tobacco and psychoactive substances in a cohort of 700 pregnant women – GTOX study: Prelim- P-18-015 inary results Altered immune repertoire in major depression Sandrine Lamy, France Kostas Patas, Germany H. Delavenne, E. Houivet, J. Benichou, S. Marret, F. Thibaut A. Willing, A. Agorastos, C. Demiralay, K. Wiedemann, S. Gold P-18-005 P-18-016 Hair steroid analysis in postpartum mothers: An increased Reduced frequency of blood CD8+ T lymphocytes express- ratio of hair cortisol/hair cortisone is associated with post- ing proinflammatory cytokines in mesial temporal lobe partum depression epilepsy patients Thorsten Mikoteit, Switzerland Daniela Rosa, Brazil S. Brand, G. Meinlschmidt, N. Buerki, I. Hoesli, E. Hols- V. Rezende, B. Costa, M. Schutze, F. Mudado, L. Magno, boer-Trachsler M. Vasconcelos, D. Miranda, M. Romano-Silva P-18-006 P-18-018 Alterations of the cortisol and dehydroepiandrosterone in Proinflammatory cytokines and oxidative stress reduces perinatal depression the dopamine precursor tyrosine uptake in human skin Ho-Suk Suh, Republic of Korea fibroblasts: Role of antioxidants as adjuvants R.-S. Ahn, C.-H. Kim, K.-S. Lee Ravi Vumma, Sweden J. Johansson, N. Venizelos P-18-007 Biochemical markers and symptoms of depression in post- P-18-019 partum women Olfactory cravings and cytokine-mediated nociception in Maria Radziwon-Zaleska, Poland vulnerability to substance abuse E. Drozdowicz, J. Skrzeszewski, M. Wielgos, M. Skalski, Tatyana Nevidimova, Russia R. Rodzoch E. Batukhtina, N. Bokhan P-18-008 P-18-021 Postpartum depression is associated with insomnia, de- Biomarkers of brain insulin resistance and neuroimaging creased total sleep time and a lack in NREM S3 sleep du- correlates in early AD ration Dimitrios Kapogiannis, USA Thorsten Mikoteit, Switzerland A. Willette, R. Mullins, M. Mustapic, E. Eitan, M. Mattson, S. Brand, N. Buerki, I. Hoesli, E. Holsboer-Trachsler E. Goetzl

71 WFSBP 2015

Scientific Programme | Wednesday, 17 June 2015

P-19 Poster Presentation P-19-009 Association between depression and polymorphisms of 12:45 – 14:15 Muses Foyer the tryptophan hydroxylase (tph) and the 5,10-methylene- Basic and Clinical Neuroscience / Treatment Methods tetrahydrofolate reductase (mthfr) genes in the Tunisian Chair: Nikolaos Venizelos, Sweden population Co-Chair: Eleytheria Tsalta, Greece Mohamed Amine Sayadi, Tunisia O. Achour, M. H. Saadaoui, A. Mhalla, F. Neffati, A. Omez- P-19-001 zine, W. Douki, A. Bousslama, L. Gaha, F. Najjar, A. Malafosse A pilot study in cytogenetic biomarkers and molecular study P-19-010 of Phospholipase D3 (PLD3) gene in Alzheimer‘s disease Association study of 45 SNPs in Russian patients with Jayalakshmi Ramalingam, India Alzheimer‘s disease A. Meyyazhagan, S. K. Shanmugam, M. Iyer, S. Keshavarao, Anna Bocharova, Russia B. Vellingiri A. Marusin, N. Zhukova, V. Alifirova, I. Zhukova, V. Stepanov P-19-002 P-19-011 Postnatal exposure to moderate noise impaired behavior, Epistastatic interaction study between comt, 5-htr2a and learning and memory in adult female rat nrg1 gene variants on schizophrenia Li-Ho Tseng, Taiwan Shiau Foon Tee, Malaysia C.-Y. Chou, P.-C. Hsu, Y.-J. Ho, J.-F. Hwang, S.-C. Sheen P. Y. Tang, T. J. Chow P-19-003 P-19-012 Role of the neurometabolites in emotional processing Exome sequencing identifies a novel risk variant in a dopa- Dominik Denzel, Germany mine regulation gene in familial schizophrenia M. Walter, L. Demenecu, F. von Düring, L. Colic, S. Li Thelma Bittianda Kuttapa, India P-19-004 J. John, J. Jibin, N. V. L., D. S. N. Spontaneous behavior and oxidative stress of male adult P-19-013 rats exposed to moderate noise Gene expression and psychiatric analysis of 100 Iranian Li-Ho Tseng, Taiwan methamphetamine addicted individuals P.-C. Hsu, I.-L. Chen, C.-Y. Chou, C.-W. Lee Arvin Haghighatfard, Iran P-19-005 P-19-014 fMRI reveals abnormalities in neural processing of reward Prevalence of 22q11.2 deletions in a Chilean population prediction errors in pathological gambling with schizophrenia Martin Kronbichler, Germany Aida Ruiz, Chile T. Eigenberger, P. Schwartenbeck, N. Thon, M. Fauth-Bühler, P. John, R. Murray, E. Miranda, P. Sham, F. Benavides, G. Repetto T. Lemenager, K. Mann, F. M. Wurst P-19-015 P-19-006 Automatic classification of first episode psychosis obtained Depressive symptoms and cognitive functioning in coronary with gray matter thickness artery disease patients: Effect of triiodothyronine Paolo Brambilla, Italy Julius Burkauskas, Lithuania U. Castellani, C. Perlini, V. Marinelli, N. Dusi, M. Bellani, J. Brozaitiene, M. Staniute, R. Bunevicius G. Rambaldelli, A. Lasalvia, M. Ruggeri, L. Squarcina P-19-007 P-19-016 A pilot study in cytogenetic biomarkers and molecular study Basal ganglia imaging (DaTscan): Association with anti of Phospholipase D3 (PLD3) gene in Alzheimer‘s disease psychotic treatment in elderly patients Alagamuthu Karthick Kumar, India Panagiota Fexi, Greece S. Suresh Kumar, B. Balamurali Krishnan, V. Balachandar, N. Kokras, C. Siarkos, E. Katritzoglou, D. Pappa, G. Limouris, K. Sasikala A. Politis P-19-008 P-19-017 Analysis of chromosomal abnormalities and ube3a gene Changes in brain volume and cognitive function in middle mutation in angelman syndrome (as) coimbatore popu- adulthood: A framework for investigating neurodegenera- lation tion in schizophrenia Padmavathi Viji, India Rizwan Ahmed, USA A. Meyyazhagan, S. Keshavarao, B. Vellingiri M. Bellani, G. Rambaldelli, R. White, V. Diwadkar, P. Brambilla

72 WFSBP 2015

Wednesday, 17 June 2015 | Scientific Programme

P-19-019 P-20-002 Differential modulation by working memory performance Relationship between dopaminergic genes polymorphisms on regional brain activation in schizophrenia patients and metabolic syndrome components in schizophrenic Leila Shayegan, Germany patients treated with antipsychotics Y. Fukuda, T. Katthagen, L. Deserno, J. Kaminski, F. Schla- Aurora Arrue, Spain genhauf N. Basterreche, M. I. Zamalloa, A. Arnaiz, O. Olivas, A. Sa- rasola, U. Picaza, E. Zallo, A. Barreiro, M. Garcia, N. Olaza- P-19-020 Gray matter and white matter structural changes in obses- bal, F. J. Garcia, M. Zumárraga sive compulsive disorder from the aspect of heterogeneity P-20-003 Keisuke Ikari, Japan Brain delivery of insulin boosted by intranasal coadminis- T. Nakao, K. Okada, S. Hirokuni, K. Murayama, S. Honda, tration with cell-penetrating peptides M. Kuwano, S. Yamada, O. Togao, A. Hiwatashi, S. Kanba Mariko Takeda, Japan N. Kamei, T. Shingaki, Y. Kanayama, Y. Watanabe P-19-021 Investigating the predictive value of brain metabolism in P-20-004 the identification of laterality in temporal lobe epilepsy: The neuroprotective role of rivastigmine during the treat- A pattern classification approach ment with amitriptyline on animal model Manuel Schutze, Brazil Dragos Marinescu, Romania D. Rosa, M. Mamede, B. Costa, D. Miranda, M. Brammer, T. Udristoiu, L. Mogoanta, I. Marinescu M. Romano-Silva P-20-005 P-19-023 Cognition-enhancing and anxiety-like behavior of the novel Neuroanatomical correlates of schizo-obsessive disorder 1,4-dihydropiridine derivative in female Alzheimer‘s disease Dhanya Raveendranathan, India model-mice J. Narayanaswamy, S. Kalmady, G. Venkatasubramanian, Baiba Jansone, Latvia Y. C. Reddy I. Kadish, T. van Groen, U. Beitnere, A. Plotniece, K. Pajuste, V. Klusa P-20-006 Right side transcranial magnetic stimulation for the treat- P-20 Poster Presentation ment of anxious depression 12:45 – 14:15 Muses Foyer Daniela White, USA Pharmacology / Stimulation Methods K. Mcdermott Chair: Yannis Zervas, Greece P-20-008 Co-Chair: Nikos Kokras, Greece Cognitive function of an adolescent patient with schizophrenia treated with modified electroconvulsive therapy: P-20-001 A case report SLC1a1 gene polymorphism and SRI response association Rie Kuge, Japan in obsessive compulsive disorder A. Yokota, Y. Morino, J. Ozaki, Y. Kikuchi, T. Ookura Tulika Shukla, India R. Jabeen Taj, M. J. K. Kulkarni, B. Viswanath, M. Purushot- tam, Y. C. Reddy, S. Jain, P. H. Shetty, T. Kandavel

73 WFSBP 2015

Scientific Programme | Thursday, 18 June 2015

PL-04 Plenary Lecture S-46-003 Combining TMS with CBT or medications to boost response 10:00 – 10:45 Trianti Hall Michael Thase, USA Chair: Martin Hatzinger, Switzerland S-46-004 PL-04-001 The latest advances in understanding TMS antidepressant Neurobiological correlates of fear and anxiety and their neurobiology clinical implications Shinsuke Kito, Japan Kerry Ressler, USA

T40: Schizophrenia: Basic / Clinical T16: Genetics S-47 Symposium S-45 Symposium 08:30 – 10:00 Skalkotas Hall 08:30 – 10:00 Trianti Hall Defining and re-defining the boundaries of psychotic Advances in genetics of affective disorders disorders using neuroimaging Chair: George N. Papadimitriou, Greece Chair: Christos Pantelis, Australia S-45-001 Co-Chair: Eva Meisenzahl, Germany Update on genetics of affective disorders S-47-001 Dimitris Dikeos, Greece Decomposing schizophrenia into intermediate imaging S-45-002 phenotypes identified by multiple system mapping Pharmacogenetics of antidepressants Henrik Walter, Germany Alessandro Serretti, Italy S-47-002 C. Fabbri Identifying neuroanatomical signatures of schizophrenia S-45-003 phenotypes using novel imaging methods Organization and administration of a multinational project Christos Davatzikos, USA on pharmacogenetics S-47-003 Daniel Surrey, Belgium Stratifying schizophrenia according to outcome using MRI- S-45-004 based pattern classification methods Overview of the field and critical appraisals Paola Dazzan, United Kingdom Thomas Schulze, Germany S-47-004 Commonalities and differences between schizophrenia and neurodegenerative disorders elucidated by neuroimaging T44: Stimulation Methods (ECT, TMS, VNS, DBS) Dennis Velakoulis, Australia S-46 Symposium 08:30 – 10:00 Mitropoulos Hall T22: Neuropathology The latest international findings regardingTM S for treating depression S-48 Symposium Chair: Paul Fitzgerald, Australia 08:30 – 10:00 MC 3 Room Co-Chair: Mark George, USA Understanding psychiatric disorders: Recent advances S-46-001 in postmortem research New data on acute phase treatments – dosing paradigms, Chair: Brian Dean, Australia improving speed of response, coil designs Co-Chair: Elizabeth Scarr, Australia Paul Fitzgerald, Australia Z. J. Daskalakis S-48-001 Structural and molecular alterations of the hippocampus S-46-002 in schizophrenia How durable are TMS antidepressant effects? New data Peter Falkai, Germany Mark Demitrack, USA S-48-002 Roles for immune-regulated genes and neurotransmitter receptors in the pathophysiology of psychiatric disorders Brian Dean, Australia

74 WFSBP 2015

Thursday, 18 June 2015 | Scientific Programme

S-48-003 S-50-004 The syndrome of schizophrenia: Progress towards potential Polypharmacy in psychiatry – a risk factor for adverse biomarkers events? Elizabeth Scarr, Australia Anastasios Konstantinidis, Austria S-48-004 Autophagy as future treatment target for schizophrenia: Lessons from activity-dependent neuroprotective protein T46: Suicide: Basic / Clinical Illana Gozes, Israel S-51 Symposium 11:00 – 12:30 Mitropoulos Hall T38: Psychopathology Molecular determinants of suicide S-49 Symposium Chair: Ghanshyam Pandey, USA Co-Chair: John Mann, USA 08:30 – 10:00 MC 2 Room Psychobiology of men‘s mental health S-51-001 Imaging studies of suicidal behavior neural circuitry Chair: Leo Sher, USA John Mann, USA Co-Chair: Zoltan Rihmer, Hungary S-51-002 S-49-001 Neuroinflammatory markers in suicide brain: Focus on The WFSBP Men‘s Mental Health Task Force: Rationale for cytokine receptors and toll-like receptors a neuroendocrine-focused approach to men‘s mental health Ghanshyam Pandey, USA Timothy Rice, USA S-51-003 S-49-002 Epigenomic basis for astrocyte abnormalities in suicidal Depression in men: Clinical and phenomenological aspects behavior Wolfgang Rutz, Sweden Gustavo Turecki, Canada S-49-003 S-51-004 Suicide in men: Hormonal and neurobiological correlates Role of microRNAs in the etiology and treatment of depres- Zoltan Rihmer, Hungary sive disorder and suicide S-49-004 Yogesh Dwivedi, USA Testosterone, violence and homicide Leo Sher, USA T6: Bipolar Disorders: Basic / Clinical S-06 Symposium T32: Pharmacology 11:00 – 12:30 Skalkotas Hall S-50 Symposium Major controversies for the treatment of bipolar disorders 08:30 – 10:00 Kokkali Room Chair: Gustavo Vazquez, Argentina The importance of pharmacovigilance in psychiatric Co-Chair: Eduard Vieta, Spain inpatient populations S-06-001 Chair: Stefan Bleich, Germany Novel treatments for bipolar disorders Co-Chair: Anastasios Konstantinidis, Austria Eduard Vieta, Spain S-50-001 S-06-002 Systematic pharmacovigilance in psychiatry – Is it necessary? Optimal duration of atypical antipsychotic therapy for Sermin Toto, Germany maintenance treatment S-50-002 Lakshmi Yatham, Canada Suicidality during antidepressant treatment in a psychiatric S-06-003 inpatient population Neuroprotective potential of mood stabilizers Susanne Stübner, Germany Michael Berk, Australia S-50-003 S-06-004 Restless legs syndrome induced by psychotropic treatment Use of antidepressants in bipolar disorders Konstantinos Papageorgiou, Austria Gustavo Vazquez, Argentina A. Konstantinidis, S. Toto, R. Grohmann, S. Kasper L. Tondo, A. Forte, v. Selle, R. Baldessarini

75 WFSBP 2015

Scientific Programme | Thursday, 18 June 2015

T40: Schizophrenia: Basic / Clinical S-54-003 Differential response to ECT between unipolar and bipolar S-53 Symposium depression 11:00 – 12:30 MC 2 Room Pascal Sienaert, Belgium The impact of tobacco and cannabis use on psychosis S-54-004 liability and illness long term outcome: Epidemiological Ketamine plus electroconvulsive therapy: Synergistic effects evidence across Europe and Australia in the treatment of depression? Chair: Nikos C. Stefanis, Greece Styliani Kaliora, USA Co-Chair: David Castle, Australia G. Petrides

S-53-001 Tobacco and cannabis long term impact on physical health and clinical outcomes in schizophrenia. Is discontinuation T40: Schizophrenia: Basic / Clinical of substance use feasible? S-55 Symposium David Castle, Australia 11:00 – 12:30 Conference Room 1 A. Waterreus, V. Morgan, N. Stefanis, A. Sankaranarayanan, S. Mancuso New insights of clinical, neurobiological and genetic S-53-002 aspects in mental illness Substance use brings forward the onset of non-affective Chair: Thomas Schulze, Germany psychosis: Potential biological mechanisms and clinical Co-Chair: Ryota Hashimoto, Japan implications Nikos C. Stefanis, Greece S-55-001 Current genetic approaches to major psychiatric disorders M. Dragovic, B. D. Power, A. Jablensky, D. Castle, V. Morgan Thomas Schulze, Germany S-53-003 Cannabis complexities and why they are important S-55-002 Recent advances in neuroinflammation relevant to schizo Amir Englund, United Kingdom phrenia therapeutics Thomas Weickert, Australia S. Fillman, R. Lenroot, V. Catts, J. Bruggemann, S. Catts, T44: Stimulation Methods (ECT, TMS, VNS, DBS) C. Weickert S-54 Symposium S-55-003 New glia world to psychiatry: Brain function and mental 11:00 – 12:30 Kokkali Room disorders Recent research data in electroconvulsive therapy and Manabu Makinodan, Japan how they inform state of the art clinical practice S-55-004 Chair: Georgios Petrides, USA Intermediate phenotype strategy for discovering disease Co-Chair: Declan McLoughlin, Ireland related gene network Ryota Hashimoto, Japan S-54-001 K. Ohi, M. Ikeda, H. Yamamori, Y. Yasuda, M. Fujimoto, Bitemporal versus high-dose unilateral twice-weekly elec- M. Fukunaga, H. Fujino, Y. Watanabe, N. Iwata, M. Takeda troconvulsive therapy for depression (EFFECT-Dep): A pragmatic, randomised, non-inferiority trial Declan McLoughlin, Ireland S-54-002 T23: Neuroimaging: Genetic, Functional, Structural Antidepressant efficacy ofRUL -Ultra brief pulse ECT: Data S-56 Symposium from phase I of the PRIDE study Charles Kellner, USA 15:00 – 16:30 Trianti Hall M. Husain, R. Knapp, W. V. McCall, G. Petrides, R. Young, Development of biomarkers for neuropsychiatric disor- R. Greenberg, S. McClintock, M. Mueller, J. Prudic, R. Weiner, ders: State-of-the-art and challenges ahead S. Lisanby Chair: Nikolaos Koutsouleris, Germany Co-Chair: Christos Davatzikos, USA

S-56-002 Machine learning biomarkers for individualized outcome prediction in functional psychoses Lena Palaniyappan, United Kingdom S. Guo, G. Deshpande, P. Liddle

76 WFSBP 2015

Thursday, 18 June 2015 | Scientific Programme

S-56-003 T37: Psychoneuroimmunology Genetic markers of autism-spectrum disorders S-58 Symposium Christos Pantelis, Australia E. Skafidas, R. Testa, D. Zantomio, G. Chana, I. Everall 15:00 – 16:30 Skalkotas Hall S-56-004 Diagnostic and prognostic stratification of affective dis- Diagnostic and prognostic imaging markers in neurode- orders based on inflammation biomarkers and immune generative disorders related neurotransmitter pathways Jessica Peter, Germany Chair: Angelos Halaris, USA S. Klöppel Co-Chair: Aye-Mu Myint, Germany

S-58-001 Stratification and outcome prediction of depressed patients T40: Schizophrenia: Basic / Clinical using panels of inflammation biomarkers S-57 Symposium Angelos Halaris, USA 15:00 – 16:30 Mitropoulos Hall S-58-002 Can plasma levels of kynurenines assist in the stratification Central role of glial cells in the pathogenesis of schizo- of mood disorders? phrenia Aye-Mu Myint, Germany Chair: Robert Schwarcz, USA B. Sperner-Unterweger, V. Arolt Co-Chair: Ina Weiner, Israel S-58-003 S-57-001 Inflammation-induced disturbances of neurotransmitter Microglia: A common target for diverse drugs preventing precursor amino acids and their possible role as biomarkers schizophrenia? in depression Ina Weiner, Israel Barbara Sperner-Unterweger, Austria K. Hüfner, A. Oberguggenberger, C. Kohl, S. Geisler, S-57-002 E. Gamper, V. Meraner, J. Egeter, M. Hubalek, B. Beer-Sand- Prenatal elevation of the glia-derived neuromodulator ner, D. Fuchs kynurenic acid: A novel schizophrenia model Robert Schwarcz, USA S-58-004 A. Pocivavsek Biomarker and therapeutic potential of the endocannabinoid system in neuroinflammation-related psychoses S-57-003 Rafael Franco, Spain Inflammatory imbalance in the periphery signalled by G. Navarro, I. Reyes-Resina kynurenines is correlated with wide-spread grey matter decreases in people with schizophrenia Cynthia Shannon Weickert, Australia K. Zavitsanou, C. K. Lim, G. J. Guillemin, R. Lenroot, J. Kind- T40: Schizophrenia: Basic / Clinical ler, V. Catts, S. Catts, J. Bruggemann, T. Weickert S-59 Symposium S-57-004 Astrocytic dopamine modulates neuronal network and 15:00 – 16:30 MC 3 Room cognitive functions in the prefrontal cortex Dysregulation of tyrosine transport influence dopamine Jean-Pierre Mothet, France function and cause cognitive deficits in schizophrenia Chair: Nikolaos Venizelos, Sweden Co-Chair: Lenna Flyckt, Sweden

S-59-001 Aberrant tyrosine transport in fibroblast from patients with schizophrenia and bipolar-I disorders Nikolaos Venizelos, Sweden S-59-002 Aberrant tyrosine transport in fibroblast from patients with schizophrenia – indication of maternal inheritance Lenna Flyckt, Sweden

77 WFSBP 2015

Scientific Programme | Thursday, 18 June 2015

S-59-003 S-61-002 Proinflammatory cytokines and oxidative stress decreases Brain fatty acid metabolism: A promising starting point the dopamine precursor tyrosine uptake in human skin for the translational research of affective and related psy- fibroblasts chiatric disorders Ravi Vumma, Sweden Yoshitaka Tatebayashi, Japan J. Johansson, N. Venizelos S-61-003 S-59-004 Role of immune-to-brain interactions in the pathophysi- A comparative genomic meta-analysis study focused on ology of depression genes and mechanisms involved in amino acid transport Lucile Capuron, France in schizophrenic and bipolar disorder patients S-61-004 Fragiskos Kolisis, Greece Role of sigma 1 receptor in the pathophysiology of de- N. Venizelos, A. Chatziioannou, O. Papadodima, M. Logotheti pression Takashi Kudo, Japan

T24: Neurophysiology S-60 Symposium T1: Addictive Disorders 15:00 – 16:30 MC 2 Room TG-07 WFSBP Treatment Guidelines Neural oscillations: Translational research in psychiatry 11:00 – 12:30 MC 3 Room Chair: Toshiaki Onitsuka, Japan Task Force on Addictive Disorders: Biological treatments Co-Chair: Robert McCarley, USA of substance use disorders: Recent developments and findings S-60-001 Chair: Michael Soyka, Switzerland Neural oscillations: Optogenetic studies in mice Co-Chair: Siegfried Kasper, Austria Robert McCarley, USA T. Kim, S. Thankachan, J. McKenna, J. McNally, J. H. Choi, TG-07-001 R. Strecker, R. Basheer, R. Brown, C. Yang New developments in pharmacotreatment of opioid de- S-60-002 pendence Findings of auditory steady-state responses in psychiatric Michael Soyka, Switzerland disorders TG-07-002 Toshiaki Onitsuka, Japan New evidence-based treatment guidelines for alcohol use S-60-003 disorders Neural dynamics with simultaneous EEG and fMRI mea Karl Mann, Germany surement TG-07-003 Hiroaki Mizuhara, Japan Genetics and pharmacogenetics of alcoholism: Recent S-60-004 developments NMDA-R hypofunctioning and dysregulated high-frequency Victor Hesselbrock, USA oscillations in schizophrenia Peter Uhlhaas, United Kingdom T4: Anxiety Disorders: Basic / Clinical D-03 Debate T10: Depression: Basic / Clinical 11:00 – 12:30 Trianti Hall S-61 Symposium Should anxiety disorders be treated with medication? 15:00 – 16:30 Kokkali Room Chair: Martin Hatzinger, Switzerland A paradigm shift in studies of affective disorders Co-Chair: Ladislav Hosak, Czech Republic Chair: Takashi Kudo, Japan Proponent: Michel Bourin, France Opponent: Borwin Bandelow, Germany S-61-001 Looking for biomarkers of depressive behavior in rats in order to promote closed loop therapeutic interventions Christine Winter, Germany

78 WFSBP 2015

Thursday, 18 June 2015 | Scientific Programme

ES-03 Educational Session FC-19-006 The cumulative effect of childhood trauma on adult mental 09:00 – 13:00 MC 3.3 Room and physical health: Results from the Marine Resiliency Session 3 on brain stimulation methods Study Chair: Mark George, USA Agorastos Agorastos, Germany Co-Chair: Shirley Fecteau, Canada J. O. E. Pittman, A. C. Angkaw, C. M. Nievergelt, S. A. Parisi, D. G. Baker ES-03-001 FC-19-007 TDCS (transcranial Direct Current Stimulation) and TMS The role of increased CRP levels and CRP genetic variation (repetitive Transcranial Magnetic Stimulation) in PTSD Shirley Fecteau, Canada Vasiliki Michopoulos, USA Jerome Brunelin, France T. Jovanovic, K. Ressler Emmanuel Poulet, France Zafiris J. Daskalakis, Canada ES-03-002 Deep brain stimulation FC-20 Free Communications Thomas Schlaepfer, Germany 13:00 – 14:30 Mitropoulos Hall ES-03-003 Schizophrenia ECT (electroconvulsive therapy) Chair: Janusz Rybakowski, Poland Mark George, USA Co-Chair: Elias Angelopoulos, Greece

FC-20-001 A longitudinal study evaluating social cognition of patients FC-19 Free Communications with schizophrenia during the symptomatic and remission 08:30 – 10:00 Conference Room 1 phases Vijaya Lakshmi, India Anxiety Disorders R. Nehra, S. Grover Chair: Soraya Seedat, South Africa Co-Chair: Ioannis Papakostas, Greece FC-20-002 Meta-analysis of cognitive performance in drug-naïve pa- FC-19-002 tients with schizophrenia Sex differences in kappa opioid receptor-mediated negative Helena Fatouros-Bergman, Sweden affective states in rats S. Cervenka, L. Flyckt, G. Edman, L. Farde Maria Mavrikaki, USA FC-20-004 J. Mays, D. Puttick, E. Chartoff Treatment of neurocognitive dysfunction in schizophrenia: FC-19-003 Effects of atypical antipsychotics on emotion processing Mitochondria as pharmacological targets for anxiolytic Gabriele Sachs, Austria treatment A. Erfurth Michaela Filiou, Germany FC-20-005 M. Nussbaumer, L. Teplytska, M. Murphy, R. Landgraf, C. Turck Cognitive function in schizophrenia and its association with FC-19-004 socio-demographics factors A month and 10-year follow-up ptsd study of children Bharti Talreja, India exposed to a mass shooting incident S. Shah, L. Kataria Ruby Castilla-Puentes, USA FC-20-006 T. Falcone, S. Castilla-Puentes, W. Castilla-Puentes, C. San- The impact of genetic counselling for severe mental disor- chez-Russi, I. Gomez Morad, M. Habeych ders: A meta-analysis FC-19-005 Ramona Moldovan, Romania Molecular alterations in neuronal plasticity, immune re- D. Cozman, R. Popp, V. Pop, J. Austin sponse, and apoptosis in posttraumatic stress disorder Anna Boyajyan, Armenia D. Avetyan, L. Hovhannisyan, G. Mkrtchyan

79 WFSBP 2015

Scientific Programme | Thursday, 18 June 2015

FC-21 Free Communications FC-22-002 Evidence for a transient clozapine-mediated gaba regulation 13:00 – 14:30 Skalkotas Hall of mesocorticolimbic and perforant pathway transmission Schizophrenia in schizophrenia Chair: Takashi Kudo, Japan William T. O´Connor, Ireland Co-Chair: George Moussas, Greece S. D. O´Shea FC-22-003 FC-21-001 Familiar risk for psychosis influence the association be- The relationship between optimal plasma concentration tween neuroticism and happy facial emotion recognition of antipsychotics and early treatment response in patients Nadja Maric, Serbia with acute schizophrenia S. Andric, M. Mihaljievic, T. Mirjanic, J. van Os Sergei Potanin, Russia D. Burminskiy, M. Morozova, N. Baymeeva, A. Platova, FC-22-004 Prediction of outcome in the psychosis prodrome using I. Miroshnichenko neuroanatomical pattern classification FC-21-002 Lana Kambeitz-Ilankovic, Germany Comparison of first generation and second generation E. Meisenzahl, C. Cabral, S. von Saldern, J. Kambeitz, P. Fal- long-acting injectable antipsychotics in the treatment of kai, H.-J. Möller, M. Reiser, N. Koutsouleris schizophrenia Shih-Ku Lin, Taiwan FC-22-005 W.-Y. Chen Symptomatic remission and hippocampus volume in schizo phrenia FC-21-004 Yuan Hwa Chou, Taiwan Peony-Glycyrrhiza decoction, an herbal preparation against antipsychotic-induced hyperprolactinemia: From bedside to bench Zhang-Jin Zhang, People‘s Republic of China FC-23 Free Communications FC-21-005 13:00 – 14:30 MC 2 Room Thyroid hormones and schizophrenia Sara Malta Vacas, Portugal Depression M. Constante, M. J. Heitor Chair: Victoria Valdez de Vuibert, Equador Co-Chair: Panos Gregoriou, Greece FC-21-006 Ziprasidone vs. clozapine in the treatment of dually diag- FC-23-001 nosed (DD) patients with schizophrenia and cannabis use Appropriative cycles within in a syllogistic classic T-A-M- disorders: A randomized study space as framework for anxio-affective disorders generating Euphrosyne Gouzoulis-Mayfrank, Germany natural language maybe through thalamo- and insulo-cor- T. Schnell tical loops modulated by mast cells Gottfried R. S. Treviranus, Switzerland FC-23-002 FC-22 Free Communications Meditation as a means of therapy of depression Olesya Zakharova, Russia 13:00 – 14:30 MC 3 Room A. Polunina Schizophrenia FC-23-004 Chair: E. Mohandas, India Sound profile and gene expression:C haracteristics of a rat Chair: Alexandros Vgonzas, Greece model of depression Linda Marie Kai, Denmark FC-22-001 B. Elfving, G. Wegener Different frontal brain activation during verbal fluency test in individuals at risk for schizophrenia and bipolar disorder: A functional near-infrared spectroscopy study Aleksandra Aleksandrowicz, Switzerland F. Hagenmuller, H. Haker Rössler, K. Heekeren, A. Theodori- dou, S. Walitza, W. Rössler, W. Kawohl

80 WFSBP 2015

Thursday, 18 June 2015 | Scientific Programme

FC-23-006 FC-25 Free Communications Attitudes and behavior of healthcare providers at a general hospital towards deliberate self-harm and suicide 13:00 – 14:30 Conference Room 1 Lakshitha Iroshan Ranasinghe, Sri Lanka Violence P. s. Ginige Chair: Philippe Courtet, France FC-23-007 Co-Chair: Athanasios Douzenis, Greece Suicide in military agents in Peru 2010-2012 Freddy Vasquez, Peru FC-25-001 Human aggression: The interaction of MAOA-Genotype, W. Vargas, Y. Nicolas, S. Falconi, V. Vite environment and dopamine Ingo Vernaleken, Germany T. Schlüter, T. Eggermann, C. Dietrich, K. Henkel, M. Decker, FC-24 Free Communications O. Winz, M. Piel, F. Mottaghy, K. Zerres 13:00 – 14:30 Kokkali Room FC-25-002 Impact of childhood abuse on emotion regulation during Bipolar Disorder mother-child-interaction and associated neural correlates Chair: Thomas Schulze, Germany Corinne Neukel, Germany Co-Chair: Dimitris Dikeos, Greece K. Bertsch, A.-L. Zietlow, A. Fuchs, C. Reck, E. Moehler, F. Bermpohl, S. Herpertz FC-24-001 A prospective study of the association of testosterone levels FC-25-004 and future suicide attempts in women with bipolar disorder The possible role of a dysregulation of the endogenous Leo Sher, USA opioid system in antisocial personality disorder (aspd) M. Grunebaum, G. Sullivan, A. Burke, T. Cooper, J. Mann, Borwin Bandelow, Germany M. Oquendo FC-25-005 FC-24-002 Brain anatomy in schizophrenia patients with a history of Gray matter anormalities in childhood maltreated bipolar community violence type I patients: A voxel based morphometric study Unn Kristin Haukvik, Norway Dante Duarte, Brazil A. Jensen, G. B. Storvestre, L. T. Westlye, I. Agartz, I. Melle, M. Neves, F. Neves, R. Nicolato, M. Albuquerque, F. Duran, O. A. Andreassen, M. Jacobsen G. Busatto, C. Humberto FC-25-006 FC-24-003 Clinical and neurosurgical management of treatment-re- Schneiderian first-rank symptoms in bipolar disorder sistant severe violent and aggressive behavior Arindam Chakrabarty, India Ricardo Bueno Vargas, Mexico M. Hernandez Salazar, L. A. Ledesma Torres, O. Meneses FC-24-004 Luna, M. G. Ochoa Madrigal, F. J. Valencia Granados How often do persons with major depression convert to bipolar disorder on prospective follow-up? A systematic review and meta-analysis Aswin Ratheesh, Australia S. Cotton, S. Hetrick, C. Davey, M. Alvarez, P. McGorry, M. Berk FC-24-005 Temperament profile predicts the polarity index of maintenance treatment for bipolar disorder and mixed features major depressive disorder in a naturalistic setting Panagiotis Ferentinos, Greece E. Porichi, C. Christodoulou, D. Margaritis, I. Kotsioumpa, D. Dikeos, A. Douzenis

81 WFSBP 2015

Scientific Programme | Thursday, 18 June 2015

FC-26 Free Communications P-21 Poster Presentation 15:00 – 16:30 Conference Room 1 12:45 – 14:15 Muses Foyer Pharmacogenetics Addictive Disorders / Anxiety Disorders / Stress / Psycho- Chair: Alessandro Serretti, Italy pathology / Childhood and Adolescent Disorders Co-Chair: Despina Sanoudou, Greece Chair: Nikos Vaidakis, Greece Co-Chair: George Konstantakopoulos, Greece FC-26-001 Clinical and genetic markers to predict a rapid and strong P-21-001 weight gain during psychotropic treatment What is „Food Addiction“: The classification issue revisited Frederik Vandenberghe, Switzerland Liliana Castro, Portugal N. Saigi Morgui, A. Delacrétaz, L. Quteineh, M. Gholamre- C. Raposo-Lima zaee, A. von Gunten, P. Conus, C. B. Eap P-21-004 FC-26-002 Varenicline and manic symptoms Impact of HSD11B1 polymorphisms on body mass index Esteban Rodríguez Jiménez, Spain and components of the metabolic syndrome in patients J. Alcalá Partera, M. d. Pino Ordovás González with psychotropic treatments Lina Quteineh, Switzerland P-21-005 F. Vandenberghe, N. Saigi Morgui, A. Délacretaz, E. Choong, Current opinions on alcohol-related aggression M. Gholamrezaee, A. von Gunten, M. Preisig, E. Castelao, Eleftherios Mellos, Greece P. Vollenweider, Z. Kutalik, P. Conus, C. Eap T. Paparrigopoulos, D. Tsaklakidou, D. Panteleakis, D. Ka- raiskos, E. Tzavellas, I. Liappas FC-26-003 Influence of MCHR2 and MCHR2-AS1 genetic polymor- P-21-006 phisms on body mass index in psychiatric patients and in Medical cannabis: Pros and cons subjects from the general population with present or past Dimitrios Panteleakis, Greece atypical depression D. Karaiskos, D. Tsaklakidou, E. Mellos, E. Tzavellas, I. Liap- Aurélie Delacrétaz, Switzerland pas, T. Paparrigopoulos M. Preisig, F. Vandenberghe, N. Saigi-Morgui, L. Quteineh, P-21-007 E. Choong, M. Gholamrezaee, Z. Kutalik, A. von Gunten, Conversion disorder E. Castelao, P. Vollenweider, P. Conus, C. Eap Yacov Rofe, Israel FC-26-004 P-21-008 Influence of weighted genetic risk score on BMI in Swiss Cognitive impairment and global functioning in schizo- psychiatric cohorts phrenic and schizoaffective disorder patients with comorbid Núria Saigi-Morgui, Switzerland anxiety F. Vandenberghe, A. Délacretaz, L. Quteineh, M. Gholamre- Aurora Sabau, Romania zaee, Z. Kutalik, J. M. Aubry, A. von Gunten, P. Conus, C. B. Eap K. Wild, D. Podea FC-26-005 P-21-009 Genetic variation in multi-drug resistance 1 and cat- Salivary cortisol level as a biomarker in anxiety disorders echol-o-methyltransferase genes may influence antipsychotic response in schizophrenia and related disorders Krzysztof Rutkowski, Poland Rosa Catalán, Spain E. Dembinska, K. Tokarz, J. Sobanski, K. Cyranka, L. Muld- A. González-Rodríguez, M. J. Arranz, R. Penadés, B. Gutiér- ner-Nieckowski, M. Mielimaka rez, F. Pérez Blanco, M. Bernardo P-21-010 FC-26-007 C-reactive protein level and psychological function of treat- The need to improve current psychopharmacotherapy be- ment seeking obese patients. A case-control study fore developing new drugs Kavitha Subramaniam, Malaysia Eva Ceskova, Czech Republic W.-Y. Low, K. Chinna, K.-F. Chinna, S. Krishnaswamy M. Mayerova P-21-011 Anxiety: A new clinical neuroconnective phenotype Andrea Bulbena-Cabre, USA A. Bulbena-Vilarrasa

82 WFSBP 2015

Thursday, 18 June 2015 | Scientific Programme

P-21-012 P-21-023 Advancing pharmacological treatment of hoarding disorder Gender differences in persistent delusional disorder: Ret- Vlasios Brakoulias, Australia rospective chart review from a tertiary care centre in India Karishma Kulkarni, India P-21-013 Regulation-focused psychotherapy for children: Illustrations R. Arasappa, K. Prasad, A. Zutshi, P. Chand, M. S. Keshavan, of a research domain criteria-compatible psychodynamic P. Murthy intervention for youth with externalizing behaviors P-21-024 Timothy Rice, USA Hair cortisol and subjective stress in patients with schizo- L. Hoffman phrenia and bipolar disorder P-21-014 Fabian Streit, Germany The therapeutic role of oxytocin in child and adolescent A. Memic, L. Hasandedi, J. Strohmaier, J. Frank, M. Lang, mental health problems S. H. Witt, A. Forstner, F. Degenhardt, M. Nöthen, C. Kirsch- Evdokia Davilla, Greece baum, L. Oruc, M. Rietschel N. M. Voudouri, K. Apostolopoulou, N. Vasilakopoulou, C. Po- P-21-025 lychronidis, D. Georgiadis, E. Tsalamanios Transcriptional activation of non-LTR retrotransposons P-21-015 specific transcripts in rats Depressive disorders at teenagers in places of freedom Somnath Mukherjee, India deprivation K. C. Upadhyaya, D. Sharma Volodymyr Korostiy, Ukraine P-21-026 H. Kozhyna, A. Cherkasova Influence of meditation on the regulatory systems in the P-21-016 human body TS-eurotrain: European wide investigation of the etiology Evgeniy Zakharov, Russia and pathophysiology of gilles de la tourette syndrome and related disorders Ahmad Seif Kanaan, Germany P-22 Poster Presentation N. Forde, P. Paschou 12:45 – 14:15 Muses Foyer P-21-017 Psychiatric aspects of Addison‘s disease (case report in a Bipolar Disorders / Depression / Suicide poster) Chair: Georgios Moussas, Greece Rumyana Trendafilova, Bulgaria Co-Chair: Evgenia Daskalopoulou, Greece Z. Yaneva P-22-002 P-21-018 Use of personality measures and heart rate variability for Preventing school shootings: Importance of a developmen- subthreshold depressive symptoms of bipolar disorder in tal approach to at-risk adolescents remission Timothy Rice, USA Saejeong Lee, Republic of Korea L. Hoffman S. Park, Y. Joo P-21-019 P-22-003 Psychiatric features of body integrity identity disorder A manic episode following sexual enhancement supple- Bernd Kraemer, Switzerland ment use L. M. Hilti, J. Hänggi, P. Brugger Andrea Bulbena-Cabre, USA P-21-021 N. Ramos Dunn, R. Gorman Swift Is it possible to discriminate affective and non affective first P-22-005 episode psychosis based on their verbal pragmatic abilities? Altered auditory steady-state magnetic fields in bipolar Paolo Brambilla, Italy disorders: A source localization study L. Finos, A. Tavano, L. Antonio, G. de Girolamo, A. Fioritti, Oda Yuko, Japan P. Santonastaso, D. Ghigi, M. Miceli, S. Scarone, A. Cocchi, N. Hironaga, H. Shogo, R. Tsuchimoto, T. Maekawa, T. Onit M. Ruggeri, C. Perlini suka, S. Tobimatsu, S. Kanba P-21-022 P-22-006 Psychopathology, ways of copying with stress and quality Designing a new therapeutic intervention for cognitive of life in nursing staff of public hospitals impairments in bipolar disorders: From a theoretical con- Panagiota Voskou, Greece struct to a clinical illustration E. Kararizou, A. Douzenis, M. Economou, M. Ginieri-Cocco- Clémence Isaac, France sis, I. Evdokimidis M.-C. Castillo, S. Braha-Zeitoun, A. Faivre, N. Bouaziz, D. Januel

83 WFSBP 2015

Scientific Programme | Thursday, 18 June 2015

P-22-007 P-22-017 From nails, via the lymphatic cauldron to brain: Mast cells, Comparison of cognitive function between early-onset and their particles and conduits take the lead beyond fluid psy- late-onset depression in euthymic people with late-life choneuroimmunology depression Gottfried R. S. Treviranus, Switzerland Ying Chih Cheng, Taiwan P-22-008 C.-C. Chiu, H.-C. Liu Psychometrical scales in the bipolar I disorder P-22-018 David Alberca, Spain Depression as the first symptom of haemochromatosis N. Corominas Castell Margarita Perez Fominaya, Spain P-22-009 L. Muñoz Lorenzo, A. Rico Román Differential expression of microRNA in peripheral blood P-22-019 of bipolar disorder I manic patient under asenapine and Depression associated to pathological condition risperidone treatment Kristina Zadorina, Ukraine Lim Chor Hong, Malaysia P-22-020 N. Z. Zainal, S. Kanagasundram, Z. Mohamed Looking into terrorists‘ eyes: The sign of lower eye-white P-22-010 enlargement Development of somatogenic depression Enrica Di Rosa, Italy Volodymyr Mykhaylov, Ukraine L. Ricciardi, M. Bologna, B. Demartini, A. Di Rosa A. Kogyna, V. Korostiy P-22-021 P-22-011 Neurofeedback training for depression: A case study Severe post-partum depression with catatonic features Sungwon Choi, Republic of Korea as the presentation of neuropsychiatric systemic lupus H. Lim, S. Jeong erythematosus P-22-022 Adam Wysokinski, Poland Lipidomics as a new tool in diagnosis of neuropsychiatric R. Magierski, M. Partyka, I. Kloszewska disorder P-22-013 Wojciech Rachel, Poland The role of zinc in elder people depression W. Piekoszewski, A. Grela Michal Skalski, Poland P-22-023 J. Skrzeszewski, E. Drozdowicz, B. Ryszewska-Pokrasnie- The impact of clinical and biological factors on dexameth- wicz, K. Mlyniec, G. Nowak, A. Pilc, M. Radziwon-Zaleska asone suppression test result in psychiatric patients after P-22-014 a suicide attempt Therapeutic drug monitoring of depression: Augmentation Athanassia Papadopoulou, Greece by magnesium ions A. Douzenis, C. Christodoulou, R. Gournellis, C. Papageor- Maria Radziwon-Zaleska, Poland giou, M. Markianos B. Ryszewska-Pokrasniewicz, M. Skalski, J. Skrzeszewski, P-22-024 E. Drozdowicz, G. Nowak, A. Pilc Work-related stress and suicidal ideation P-22-015 Policarpo Rebolledo, Chile Efficacy and tolerability of venlafaxine switch in serotonin N. Martini, P. González, C. Rebolledo selective reuptake inhibitors treated patients with partial response Daniel Vasile, Romania O. Vasiliu, D. G. Vasiliu, G. A. Sopterean, R. E. Bratu, F. An drone, F. Vasile

84 WFSBP 2015

Thursday, 18 June 2015 | Scientific Programme

P-23 Poster Presentation P-23-011 Cognitive profile in schizophrenia and bipolar disorder: 12:45 – 14:15 Muses Foyer A study in Chilean patients Schizophrenia Aida Ruiz, Chile Chair: Elias Angelopoulos, Greece M. Martinez, A. Soto, E. Miranda Co-Chair: Dimitra Pappa, Greece P-23-013 Frontal assessment battery (fab). A brief assessment of P-23-001 executive functions in schizophrenic patients Bridging the gap between biochemistry content and sensory John Nimatoudis, Greece process in schizophrenia and schizoaffective psychosis A. Theofilidis Stephanie Fryar-Williams, Australia P-23-014 P-23-002 Paliperidone for the treatment of schizoaffective disorder Development of a novel animal model of clozapine-resistant Christos Istikoglou, Greece schizophrenia: Behavioral and neurobiological character- R. Malamou, E. Liapis, A. Aivatides, M. Economou, M. Vassi- ization liadou, N. Polonifis, P. Kanellos, I. Liappas, D. Vlissides Michal Taler, Israel I. Gil-Ad, I. Tarasenko, A. Weizman, A. Krivoy P-23-016 Reduced negative symptoms may distinguish the clinical P-23-004 profile of patients with psychosis following traumatic brain Frequency and type of somatic diseases in schizophrenic injury from schizophrenia/schizoaffective disorder patients – correlation with antipsychotics treatment Rachel Batty, Australia Dzevad Begic, Bosnia and Herzegovina A. Francis, N. Thomas, M. Hopwood, J. Ponsford, S. Rossell S. Bise, O. Cemalovic, B. Kurtovic P-23-017 P-23-006 Smoking habits in psychotic patients in Greek population Memory deficits in a ketamine-induced rat model of schizo Christos Istikoglou, Greece phrenia E. Liapis, A. Aivatides, M. Economou, M. Vassiliadou, P. Ka- Manuela Padurariu, Romania nellos, N. Polofinis, I. Liappas, R. Malamou, V. Tziora M. Paulet, L. Hritcu, A. Ciobica, R. Lefter, D. Timofte P-23-018 P-23-007 Social cognition in people with schizophrenia as seen in Myelination alterations in an animal model of schizophre- thematic apperception test nia-like symptoms and schizophrenia patients Ladislav Hosak, Czech Republic Michaela Filiou, Germany K. Hosakova, M. Lecbych P. Wood, L. Teplytska, D. Otte, A. Zimmer, C. Turck P-23-020 P-23-008 Treatment in first psychotic episodes: A case report Neurological soft signs might be an endophenotype candidate for patients with deficit syndrome schizophrenia Esteban Rodríguez Jiménez, Spain Murat Beyazyüz, Turkey J. Alcalá Partera, M. d. Pino Ordovás González E. Soydas Akyol, Y. Albayrak, M. Kuloglu P-23-021 International classification of functioning, disability and P-23-009 health (ICF) for schizophrenic patients Re-engineering case management processes to promote patients adherence to treatment Oscar Pino, Spain Margaret Mary Hendricks, Singapore E. Rojo, G. Guilera, J. Gomez-Benito V. K. Swapna, K. L. Yow

85 WFSBP 2015

Scientific Programme | Thursday, 18 June 2015

P-24 Poster Presentation P-24-009 Factors associated with high risk for eating disorders in 12:45 – 14:15 Muses Foyer Korean adolescents Dementia / Oncopsychiatry / Pain / Emergency Psychiatry/ Young-Eun Jung, Republic of Korea Somatoform Disorders / Sexual Disorders / Eating Disor- P-24-010 ders / Sleeping Disorders / Miscellaneous Elevated body temperature: A symptom of malignant neuro- Chair: Christo Christodoulou, Greece leptic syndrome or of a distinct excited delirium syndrome Co-Chair: Anna Pigkou, Greece in the course of the treatment of psychosis Gordana Rubesa, Croatia P-24-001 L. Gudelj, I. Skarpa Usmiani, S. Blazevic Zelic A comparative study of serum Tau protein levels on intestinal endotoxemia among Alzheimer‘s disease rats and P-24-011 in Chinese sample of Alzheimer‘s disease patients and Psychiatric emergency: Factors associated with the decision healthy controls of hospitalization Bai Han, People‘s Republic of China Kilani Hajji, Tunisia F. Wu, Q. Sun, Y. Gao, L. Ma, X. Shan I. Marrag, R. Ben Soussia, L. Zarrouk, M. Nasr P-24-002 P-24-012 Alterations in hippocampal cholinergic system of Samar- The doctor-patient relationship and medication adherence itan rats are similar to those observed in early stages of in chronic psychiatric illness: A mixed-model study Alzheimer‘s disease Gayatri Devasthali, India Zdenka Kristofikova, Czech Republic S. Chakrabarti, A. K. Misra A. Stuchlik, T. Petrasek, M. Skurlova, K. Vales, D. Ripova P-24-013 P-24-003 Devising the neuroscience in clinical adolescent and young A comparative study of serum NO levels on intestinal en- adult psychiatry study dotoxemia among Alzheimer‘s disease rats and in chinese Konstantinos Ioannidis, United Kingdom sample of Alzheimer‘s disease patients and healthy controls R. Kelvin, I. Goodyer Bai Han, People‘s Republic of China P-24-015 F. Wu, Q. Sun, Y. Gao, L. Ma, X. Shan Correlation of psychiatry disorders with full moon and P-24-005 new moon Study on serum BDNF levels on intestinal endotoxemia on Meraj Quadri, India Alzheimer‘s disease rats and in chinese sample of Alzheim- P. Rathi er‘s disease patients and healthy controls P-24-016 Bai Han, People‘s Republic of China Impact of belief in Jinnie and black magic in psychiatric F. Wu, Q. Sun, Y. Gao, L. Ma, X. Shan patients P-24-006 Meraj Quadri, India Associated symptoms with eating disorders among mothers A. Quadri and subjects with ED P-24-018 María Del Pino Ordovás González, Spain Cytokine-behavior links in lewis lung carcinoma (LLC)-bear- E. Rodríguez Jiménez, T. Guijarro Granados, P. Martín Bor- ing mice and effects of a new anticancer agent reguero Anna Tallerova, Russia P-24-007 O. Kuznetsova, S. Nikitin, L. Kovalenko Negative correlation between skin conductance response P-24-019 and the severity in patients with bulimia nervosa Effects of a new 5-pyrimidinol derivative (SNK-411) on Noriko Numata, Japan tumor growth and depressive-like behavior in LLC-bearing Y. Hirano, M. Nakazato mice P-24-008 Olga Kuznetsova, Russia Obesity and eating attitude of medical, surgical and service A. Tallerova, D. Shatsky, S. Nikitin, L. Kovalenko group resident and intern physicians Beomwoo Nam, Republic of Korea J. S. Seo

86 WFSBP 2015

Thursday, 18 June 2015 | Scientific Programme

P-24-020 P-25-002 Translational research of chronic pain patients using human Predictors of weight gain during antipsychotic treatment blood-induced microglia-like (iMG) cells of schizophrenia Masahiro Ohgidani, Japan Adam Wysokinski, Poland T. Kato, M. Hosoi, R. Iwaki, N. Sudo, S. Kanba R. Magierski, I. Kloszewska, T. Sobów P-24-022 P-25-003 Hephaestus revisited: The heritability of lifelong premature Efficacy of quetiapine on psychotic symptoms and congni- ejaculation tion in Parkinson‘s disease Paddy Janssen, The Netherlands Gorana Sulejmanpasic-Arslanagic, Bosnia and Herzegovina F. van der Heijden S. Fisekovic, A. Kucukalic, S. Ler P-24-024 P-25-005 Impact of non-apnea sleep disorders on diabetic control Safety profile and weight gain of treatment with risperidone and metabolic outcome – a longitudinal cohort study in patients with schizophrenia Ying Chuan Hung, Taiwan Alma Bravo-Mehmedbasic, Bosnia and Herzegovina Y.-C. Lin, H.-M. Hsieh, H.-C. Chiu A. Kucukalic, A. Dzubur Kulenovic, S. Kucukalic P-24-025 P-25-006 The quality of life in patients with nonorganic insomnia Psychiatric pharmacogenomics: A stride in human genetics Michal Skalski, Poland and a bridge for individualized treatment A. Król, A. Silka, M. Zarzycki Leslie Kiraly, Canada Z. Elbaz P-24-026 BDNF concentrations in patients with somatization disorder P-25-007 before and after treatment Agmatine rescued ASD like behavior in valproic acid in- Mal Rye Choi, Republic of Korea duced animal model of autism: New implication for the ASD J.-C. Yang, S.-K. Chung, D.-J. Kim, Y.-K. Kim Ji-Woon Kim, Republic of Korea H. Seung, C. s. Choi, H. A. Oh, C. y. Shin P-24-027 1) Psychogenic nonepileptic seizures in an epilepsy center P-25-008 in Colombia: A diagnosis challenge 2) Quality of life in pa- Drug induced body weight gain and metabolic syndrome tients with epilepsy and psychogenic Nnn-epileptic seizures in patient with schizophrenia and bipolar disorder in a Colombian neurological centre Kyungphil Kwak, Republic of Korea Maria Alejandra Velez Aguirre, Colombia T. Kim P-24-028 P-25-009 Acute adjustment disorders: A descriptive study of 93 pa- Influence streptozotocin-induced diabetes on behavioral tients activity of offspring and it‘s correction of afobazole Kilani Hajji, Tunisia Victoria Zabrodina, Russia I. Marrag, W. Chebbi, R. Ben Soussia, M. Nasr E. Shreder, O. Shreder, A. Durnev P-25-010 The interaction between decreased short-term spatial mem- P-25 Poster Presentation ory and increased oxidative stress in a scopolamine-induced rat model of Alzheimer‘s disease 12:45 – 14:15 Muses Foyer Manuela Padurariu, Romania Pharmacological and Brain Stimulation Therapies R. Lefter, A. Ciobica, E. Anton Chair: George Papageorgiou, Greece P-25-011 Co-Chair: Elena Tsiolka, Greece Psychosis as a side effect of raltegravir Jose M. Lopez-Santin, Spain P-25-001 P. Alvaro Seron 30 years after the advent or risperidone – promises and facts about „atypicals“ Matthias Dose, Germany

87 WFSBP 2015

Scientific Programme | Thursday, 18 June 2015

P-25-012 P-26-006 Case report: A patient with restless legs syndrome associat- Epidemiology of PANDAS in children at the Far East of ed with the co-administration of duloxetine and paroxetine Russia Kalliopi Nikolaou, Greece Alina Martynova, Russia R. Gournellis, I. Michopoulos, C. Papazahos, C. Papageor- P-26-007 giou, A. Douzenis Depression and anxiety disorders in child and adolescent P-25-013 populations in low and middle income countries: A review Serotonin syndrome in a patient with autism spectrum Swetha Yatham, Canada disorder A. Ravindran Kalliopi Nikolaou, Greece P-26-009 R. Gournellis, I. Michopoulos, G. Dervenoulas, A. Douzenis Epidemiology of obsessive-compulsory disorders on data P-25-014 of the Far East of Russia Efficacy and safety of electroconvulsive therapy in the first Alina Martynova, Russia trimester of pregnancy: A case of severe manic catatonia A. Shwedova Mirko Manchia, Italy P-26-010 M. Pinna, G. Pillai, P. Salis, G. Minnai Transcultural psychiatry working with migrants in everyday P-25-015 clinical Prolonged postictal delirium following electroconvulsive Solmaz Golsabahi-Broclawski, Germany therapy A. Broclawski Suet Yee Chee, Singapore P-26-011 N. Kathirvel, N. Ravichandran Sex-related differences of relationships between 2nd to 4th P-25-016 digit ratio and EEG coherence in patients with schizophrenia High frequency left prefrontal transcranial magnetic stimu- compared with controls lation (TMS) in the treatment of depressive stupor: A case Yu Sang Lee, Republic of Korea report B.-h. Choi Takashi Hasegawa, Japan P-26-012 A. Takamiya, T. Nakajima, S. Kito Two case-reports providing evidence for a new phenotype of SHANK3 alterations Stéphanie Vesperini, France S. Serret, F. Askenazy, S. Thummler, A. Santos, E. Dor P-26 Poster Presentation 12:45 – 14:15 Muses Foyer P-26-013 Investigating gene pathways involved in the aetiology of Basic Neurosciences / Neuroimaging / Epidemiology / Mis- Gilles de la Tourette syndrome cellaneous John Alexander, Greece Chair: Dimitris Dikeos, Greece F. Tsetsos, P. Drineas, P. Paschou Co-Chair: George Georgantopoulos, Greece P-26-014 The role of genes in the psychotherapeutic treatment of P-26-001 psychiatric disorders (therapygenetics) Development of an algorithm for the differential diagnosis of organic psychotic disorders Niki Maria Voudouri, Greece Olivier Bonnot, France E. Tsalamanios, K. Apostolopoulou, E. Davilla, D. Georgiadis J. Torres Martin, S. Kolb P-26-015 Whole exome sequencing of consanguineous family with P-26-002 psychosis in northwest Algeria Subjective cognition across psychiatric disorders: Gone with the wind? Aïcha Dahdouh Guermouche, Algeria Valerie Tourjman, Canada M. Guipponi, J. Prados, M. Taleb, B. Semaoune, S. Antona- S. Potvin, S. Purdon, A. Djouini rakis P-26-003 Effects of alcohol on decision-making in healthy woman Marina Kunchulia, Georgia P-26-005 Cognitive disorders, associated with epilepsy Volodymyr Korostiy, Ukraine A. Dubenko, M. Ivenskaya

88 WFSBP 2015

Thursday, 18 June 2015 | scientifi c Programme

P-26-016 P-26-023 Screening of marker chromosome and mutational study of Single-event-related changes in oxy-hb during verbal dis- shank3 in adhd patients compared with serotonin level crimination tasks in schizophrenic patients Subramaniam Mohana Devi, India Youhei Ishii, Japan V. Balachandar , M. Arun , K. Sasikala Y. Shoji, K. Morita , R. Fujiki, K. Mori , N. Uchimura P-26-018 P-26-024 resting state functional connectivity pattern-classifi cation as using magnetoencephalography (meg) to evaluate neuro- a tool for the identifi cation of clinical high risk for psychosis cognitive models of auditory verbal hallucinations Maria F. Urquijo, Germany Susan Rossell, Australia L. Kambeitz-Ilankovic , C. Cabral , N. Koutsouleris M. Hughes , W. Woods, S. Lancaster , N. Thomas , P. Michie P-26-019 P-26-025 changes in the oxyhemoglobin levels and reaction time utilizing mutual information analysis to explore the rela- during the game of rock, paper, scissors taking with the tionship between gray and white matter structural pathol- responses after the opponent‘s – comparison between ogies in fi rst episode schizophrenia schizophrenic patients and healthy controls Amanda Lyall, USA Mamoru Sato, Japan P. Savadjiev , E. Del Re , L. O´Donnell , L. J. Siedman , J. Gold- Y. Shoji, K. Morita , Y. Ishii, R. Fujiki , Y. Yamashita , Y. Kato , stein , R. Mesholam-Gately , T. Petryshen , J. Wojcik, R. McCarley , M. Inoue, N. Uchimura M. Shenton , M. Kubicki P-26-021 Single emotional load event-related changes in cerebral oxyhemoglobin using shiritori task in patients with schiz- cloSing ceremony ophrenia: comparison with healthy subjects Yoshihisa Shoji, Japan 16:30 – 17:30 trianti hall K. Morita , R. Fujiki , Y. Ishii, M. Sato , Y. Yamashita, Y. Kato , Chair: Masatoshi Takeda, Japan M. Inoue, N. Uchimura e WFSBP Poster awards P-26-022 presented by the Chair of the ISPC: Single word evoked changes in cerebral oxyhemoglobin Florence Thibaut, France using shiritori task in patients with schizophrenia: com- e invitation to the parison with healthy subjects 13th WFSBP Congress 2017 Copenhagen, Denmark Ryo Fujiki, Japan Y. Shoji , K. Morita, Y. Ishii, M. Sato , Y. Yamashita, Y. Kato , e Farewell message M. Inoue, N. Uchimura

89 EUROPEAN PSYCHIATRIC ASSOCIATION

24th EUROPEAN CONGRESS OF PSYCHIATRY Madrid, Spain 12-15 March 2016 www.epa-congress.org

TOWARDS A COMMON LANGUAGE IN EUROPEAN PSYCHIATRY

JOIN US IN Scan this code with your smart phone www.epa-congress.org Need a code reader for your phone? MADRID http://get.neoreader.com

EPA 2016 PROGRAMME AD 297x210NEW.indd 1 20/03/2015 12:07 WFSBP 2015 Congress Information

congreSS venue Final Programme EUROPEAN PSYCHIATRIC ASSOCIATION Megaron Athens International Conference Centre The Final Programme is inserted in your congress bag.

congress entrance Entrance B, left from main Music Hall entrance co congreSS online® Leoforos Vasilissis Sofi as and Kokkali 1 congress information system Athens 115 21, Greece For the 12th WFSBP Congress 2015, the web based Congress th Information System CO CONGRESS ONLINE® has been installed: www.wfsbp-congress.org 24 congreSS regiStration counter All congress materials will be available at the congress re co congreSS online® will provide information on: gistration located in Mitropoulos Foyer of the Megaron. e Updated scientifi c programme EUROPEAN The Mitropoulos Foyer is located right hand side when e Programme by day entering the congress venue through the congress entrance B e Programme by formats with accepted abstracts on ground fl oor. CONGRESS e Programme by topics with accepted abstracts opening hours e Programme search Sunday, 14 June 2015 12:00 – 19:00 e List of participants (who is who) Monday, 15 June 2015 07:30 – 18:00 e List of exhibitors and sponsors OF PSYCHIATRY e Tuesday, 16 June 2015 08:00 – 18:00 General congress information Madrid, Spain 12-15 March 2016 Wednesday, 17 June 2015 08:00 – 18:00 e City of Athens Thursday, 18 June 2015 08:00 – 17:00 e Travel information www.epa-congress.org e Private mailbox During these hours the congress registration counter can be reached at Phone: +30 – 210 – 7282651 WireleSS lan/Wi-Fi TOWARDS A COMMON LANGUAGE Wireless LAN / WiFi is installed free of charge from Monday, name BadgeS 15 June until Thursday, 18 June 2015 in the Muses Foyer. IN EUROPEAN PSYCHIATRY All participants are kindly requested to wear their name A password is not required in order to access the wireless LAN. badge at all times during the congress including the Opening Ceremony and Welcome Reception. technical exhiBition the colours of the name badge have the following si- The WFSBP Congress will be accompanied by a technical gnifi cance: exhibition taking place in the Muses Foyer, ground fl oor, of Congress delegate: e blue the Megaron Athens International Conference Centre. Coffee Exhibitor: e green bars will be located in the technical exhibition. Staff: e red opening hours Monday, 15 June 2015 09:00 – 17:00 congreSS language Tuesday, 16 June 2015 09:00 – 17:00 The offi cial language of the Congress will be English. Simul Wednesday, 17 June 2015 09:00 – 17:00 taneous translation will not be provided. No simultaneous translation will be provided. WFSBP 2015 aPP congreSS moBile® Get the WFSBP 2015 Congress App for your smart certiFicate oF attendance / cme certiFicateS phone now and experience the congress at your For certifi cates of attendance and CME certifi cates please fi ngertips! Quickly fi nd your way through the most use the terminals located in the registration area. From uptodate congress schedule. Stop carrying 24 June following to the congress you can also print your around piles of paper. Just take the congress with you, where CME certifi cate online at www.wfsbp-congress.org by ac ver and whenever you want! The App is completely free for cessing with your participant number on your badge or with congress participants and provides iPhone/iPad, Android your personal login data of the congress website. Smartphone users at the WFSBP Congress 2015 in Athens with onthego access to the congress. JOIN US IN Scan this code with your smart phone www.epa-congress.org Need a code reader for your phone? MADRID http://get.neoreader.com 91

EPA 2016 PROGRAMME AD 297x210NEW.indd 1 20/03/2015 12:07 WFSBP 2015 Congress Information

The WFSBP 2015 Congress App is powered by GLOBIT’s Poster exhibition times for P-14 to P-20 acclaimed CONGRESS MOBILE® software. Wednesday, 17 June 2015 09:00 – 17:00 Guided Poster Tours 12:45 – 14:15

Poster exhibition times for P-21 to P-26 Thursday, 18 June 2015 09:00 – 17:00 Further information is given at Guided Poster Tours 12:45 – 14:15 www.wfsbp-congress/app.

Interested participants can meet the authors for discussions SPeaKerS centre of their poster presentation during the time of the poster tour. The Speakers Centre is located in Room MC 3.2 at Level 1/ Set-up and dismantling times for posters Conference Suites 2 Foyer. Speakers are asked to hand in Posters need to be set up and dismantled on the day of the their CD ROM or USB stick, containing the PowerPoint pre respective poster tour within the following times: sentation (IBM format or compatible, no multisession) pre ferably one day before but at the latest 90 minutes prior to Set-up: 08:00 – 09:00 the presentation. dismantling: 17:00 – 18:00

The presentation will be transferred to the central congress Posters which have not been removed will be disposed off. server and will be available afterwards on a special congress Poster material to put up the poster is available at the poster notebook in the hall of the presentation. Due to time and service desk in the poster area. technical reasons we kindly ask the speakers not to use their own notebook. Several PC working stations are provided in BeSt PoSter aWardS the speakers centre where speakers can also work on their All posters will be evaluated on site by the WFSBP Prize PC charts in a quiet area. Technical staff will be glad to assist. Committee. The best poster of each poster tour will be mo operated by Estensis GmbH ved to the best poster area in the Muses Foyer where they the Conference Company are displayed throughout the congress. Out of these the 10 best posters of young investigators under 40 years will be opening hours awarded with a poster prize. The awards will be handed out Sunday, 14 June 2015 12:00 – 19:00 during the Closing Ceremony on Thursday, 18 June 2015. Monday, 15 June 2015 07:30 – 18:00 Tuesday, 16 June 2015 08:00 – 18:00 Wednesday, 17 June 2015 08:00 – 18:00 Programme changeS Thursday, 18 June 2015 08:00 – 17:00 The organizers cannot assume liability for any changes in the congress programme due to external or unforeseen circum stances. PoSter exhiBition The poster exhibition is located in the Muses Foyer on ground level of the Megaron. SnacK BarS / venue reStaurant The congress provides snack bars in the exhibition area in Posters are allocated to 26 guided poster tours (P01 to P26). the Muses Foyer. Beverages and snacks can be purchased Posters will be changed daily and are on display for the there. In addition, the Allegro restaurant of the Megaron entire day of the according poster tour. They will be sorted Athens International Conference Centre, next to the congress by topics and will be numbered within those topics. The registration counter, offers cold and warm dishes. poster exhibition is open to all registered delegates:

Poster exhibition times for P-01 to P-06 cloaKroom Monday, 15 June 2015 09:00 – 17:00 A cloakroom can be used free of charge from Sunday, 14 June Guided Poster Tours 12:45 – 14:15 through Thursday, 18 June 2015. Delegates can also store Poster exhibition times for P-07 to P-13 their luggage there. Tuesday, 16 June 2015 09:00 – 17:00 Guided Poster Tours 12:45 – 14:15

92 WFSBP 2015 Congress Information

Cash Machine Force Majeure An ATM/cash machine is located in the passway from the For reasons beyond its control (such as war, strikes, lockouts, congress registration counter to conference room 4 (in the riots or any such civil disturbances, any natural disaster, in foyer of the main Megaron Entrance A). cluding but not limited to earthquakes, floods, droughts and typhoons and any other cause of circumstance of whatsoe ver nature beyond its control) that have an impact on the First Aid arrangements, timetables or planning of the 12th World In case of emergency, please contact the registration counter. Congress of Biological Psychiatry (WFSBP 2015) and its cor responding activities in Athens, WFSBP has the right to im Mobile Phones mediately alter or cancel the activities or events or any of Participants are kindly requested to keep their mobile phones the arrangements, timetables, plans or other items relating turned off while attending the scientific sessions in the mee directly or indirectly thereto. No party involved shall be en ting rooms. titled to any compensation for damages that result from such alteration or cancellation.

Currency The Greek currency is the Euro. The Euro is freely converti General Conditions ble on world currency markets. The exchange rate fluctuates The conditions published in the web will apply. daily depending on the money market. www.wfsbp-congress.org

Visa Climate The entry formalities for Greece vary according to the coun The city of Athens is located in a Mediterranean climate. try of origin. The Ministry of Foreign Affairs of Greece advises The average temperature for the month of June is 28°C/82°F on its website a list of countries that do not and that do re and it can drop down to 20°C/68°F. quire a visa to enter the country. Please visit the website The sun shines 13 hours a day. The sun’s rays are strong and www.mfa.gr it is recommended to use sun-cream and to wear a hat and sunglasses. A bottle of water should be taken with you every Official Italian Agency time you go outside to keep yourself appropriately hydrated. AIM Group International - AIM Education S.r.l. has been In average it rains 4 days in the month of June. appointed as the Italian Official Agency for AIFA submission. Italian pharmaceutical companies which require specific Housing authorization from the Italian Health Ministry have been For the 12th WFSBP Congress in Athens, the hotel accom advised to contact: modation for the participants is managed by our on-site AIM Group International – AIM Education S.r.l. partner company AFEA. Raffaella Figerio / Cristina Ghidoli AFEA S.A. Via G. Ripamonti, 129 l 20141 Milan, Italy 39-41 Lykavittou Str. Phone: +39 – 02 – 56601.288/360 10672 Athens, Greece Fax: +39 – 02 – 70048585 Email: [email protected] Email: [email protected] Phone: +30-210 366 8800 www.aimgroupinternational.com Contact: Martha Kornarou

Booking conditions and information can be found on the Insurance congress website www.wfsbp-congress.org. Please notice that the congress fee does not include insu rance. All participants should arrange for their own insurance. Health and accident insurance is strongly recommended and Athens Information Counter will need to be purchased in the country of origin. An Athens counter is located at the registration counter and open during the congress. Please contact the staff for city information on Athens or reservations.

93 WFSBP 2015 Congress Information

How to get to the Megaron Athens Interna- Safety tional Conference Centre Athens is a city where inhabitants and visitors can safely stroll Airport in the streets at any time of day and night. As a recommen The Athens-Eleftherios Venizelos Airport (ATH) is the inter dation, please do not wear your badge and take your bag as national airport of the city of Athens. It is named after the you might be identified as a tourist. premier Eleftherios Venizelos (1864 – 1936) and is the biggest and most important airport of Greece. The airport functions City of Athens as an intersection for the Middle East and the Balkans. More Located in the very southeast of Europe, Greece – ‚Hellas‘ than 13 million travelers transfer via the ATH yearly. It is – is one of the oldest cultural spot within Europe. With a 25 kilometers away from the city center and part of the total population of around 11,3 million people, more than commune Spata. a third – 4 million people – live in Athens, the Capital. Athens is located in the Attica prefecture, in particular in the Attica Transport between airport and city / between city and basin, which is framed by Mount Aegaleo, Mount Parnitha, Megaron Athens International Conference Centre Mount Penteli and Mount Hymettos. The metro M3 takes about 30 minutes from the airport to the Megaron Athens International Conference Centre (metro Athens has been founded more than 5,000 years ago and station “Megaron Moussikis” on metro line 3, blue line). therefore is – unchallenged – the oldest and most ancient Please visit the website www.ametro.gr for more information capital in Europe. But not only is the age a measure. Nowa about the prices and departure times. days Athens is a very special spot in the world where ancient culture meets the challenges and advantages of todays life.

Car Park This was proved very successfully by the Olympic summer The Megaron Athens International Conference Centre’s games in 2004. Athens has come up with infrastructure, three-level underground parking facility has spaces for facilities and services that meet global standards – so far the 750 cars. It is open every day. The facility is fully signed for 12th World Congress of Biological Psychiatry will become the convenience of drivers and pedestrians, and has 15 de another successful global event in a global environment. dicated spaces for persons with special needs on each level. Next to the most famous sites of Athens, such as the Acro The facility is open from 6 a.m. to 2 a.m. every day. polis, the National Archaeological Museum of Athens, the The charge is EUR 3 for the first three hours, and EUR 1 for Museum of the Acropolis, the Plaka area, also known as the each extra hour. The parking fee is not included in the con god´s neighborhood. Athens is very famous for the attic light, gress registration fee. a unique yellow golden light which has been described sin ce ancient times.

Taxis Also in scientific terms, Greece and especially Athens have Taxis can stop right in front of the Megaron. Even though, much going for: Nine universities are located in Athens. In there is no permanent taxi stand in front of the building, the 20th century, two Nobel Prize of Literature awardees taxis can be stopped with hand signs easily. The appropriate were born in Greece: Odysseas Elytis (1911-1996), received price for a taxi from Athens-Eleftherios Venizelos Airport the prize in 1979 – and Giorgos Seferis (1900-1971), who (ATH) to the Megaron Athens International Conference Cen was the awardee of 1963. tre is approx. EUR 35 – 40.

94 WFSBP 2015 Exhibition floor Plan /Exhibitors List

exhiBition Floor Plan (as per May 2015)

Trianti Hall

Cash Bar

9 Atrium 10 7 13 8 Coffee Area

Poster Area 3 Poster Area 5 6 4 11 12

Cash Bar

technical exhiBition 2 1 opening hours Monday, 15 June 2015 09:00 – 17:00 Tuesday, 16 June 2015 09:00 – 17:00 Entrance/Registration Wednesday, 17 June 2015 09:00 – 17:00

exhiBitor liSt

company Booth no company Booth no

Actelion Pharmaceuticals Ltd. 3 Neuroelectrics 6

Brainsway 7 Neuronetics 13

ECNP – European College of 9 Pharmaserve Lilly S.A.C.I. 1 Neuropsychopharmacology 2015 REMED TMS – TSIMPOS 1B Ferrer 4 Wisepress Ltd. 11 Informa PLC 12 WFSBP 2 Karger Verlag 8 WPA 10 MagVenture A/S 5

95 WFSBP 2015 Acknowledgements

The organizers of the 12th World Congress of Biological Psychiatry gratefully acknowledge the support of the following companies (as per May 2015)

SPonSorS

e Actelion Pharmaceuticals Ltd. e Neuroelectrics

e Brainsway e Neuronetics

e Ferrer e Pharmaserve Lilly S.A.C.L.

e Informa PLC e REMED TMSTSIMPOS

e MagVenture A/S e Sumitomo Dainippon Pharma Co., Ltd.

e MSD K.K. e Wisepress Ltd.

96 WFSBP 2015 Industry Sessions

Sunday, 14 June 2015 Tuesday, 16 June 2015 SA-01 industry sponsored Symposium SA-03 industry sponsored Symposium 16:00 – 17:30 Trianti Hall 13:30 – 15:00 Skalkotas Hall Bipolar disorder as metabolic inflammatory disorder: Managing behavioral emergencies Implications for disease modeling and interventional Chair: Konstantinos Fountoulakis, Greece priorities Chair: Joseph R. Calabrese, USA SA-03-001 Management of behavioral emergencies in Europe: SA-01-001 The French model Bipolar disorder and metabolic disorder: Implications Pierre-Michel Llorca, France of depressive symptoms for cognitive function SA-03-002 Roger S. McIntyre, Canada Experience with inhaled route of administration SA-01-002 in behavioral emergencies Gene expression changes in animal models of mood Andreas Erfurth, Austria disorders: The effect of pharmacological intervention Marco Andrea Riva, Italy supported by an educational grant from Ferrer supported by an educational grant from Sumitomo Dainippon Pharma Co. Ltd. Wednesday, 17 June 2015 SA-04 industry sponsored Symposium

Monday, 15 June 2015 13:30 – 15:00 Skalkotas Hall SA-02 industry sponsored Symposium Could it be Niemann-Pick disease Type C? A differential diagnosis of organic psychoses 17:00 – 18:30 Trianti Hall Chair: Hans-Hermann Klünemann, Germany Orexin receptor antagonist and sleep disorder Chair: Masatoshi Takeda, Japan SA-04-001 Making the correct diagnosis: SA-02-001 How to recognise a rare disease Solving the mysteries of sleep and wakefulness: Hans-Hermann Klünemann, Germany from the discovery of orexin to forward genetics SA-04-002 Masashi Yanagisawa, Japan Identifying disorders with organic psychoses: Revolutionising differential diagnosis supported by an educational grant from MSD K.K. Olivier Bonnot, France SA-04-003 Novel approaches to screening, diagnosis and disease management in NP-C Mark Roberts, United Kingdom

supported by an educational grant from Actelion

97 WFSBP 2015 List of Chairpersons and Presenters

A Anticevic, A...... 45, 61 Barreiro, A...... 73 Bonin, B...... 41 Abdel-Aziz, H...... 54 Antonarakis, S...... 88 Bartholomeusz, C...... 30, 38, Bonivento, C...... 38 Abner, E...... 32 Anton, E...... 87 ...... 40, 49, 69 Bonneville, S...... 54 Abraham, G...... 51 Antonio, L...... 83 Bartkowska-Sniatkowska, A...... 65 Bonnot, O...... 88, 97 Abraham, K...... 33, 70 Apostolopoulou, K...... 83, 88 Bartova, L...... 67 Borrego Leal, R...... 70 Abreu-Gonzalez, P...... 70 Arai, H...... 69 Basheer, R...... 78 Borsotto, M...... 31 Abu-Akel, A...... 30, 40 Arai, M...... 52, 69 Basterreche, N...... 73 Bosia, M...... 37, 38, 52, 68 Abuhegazy, H...... 48 Arasappa, R...... 83 Basu, D...... 56, 57 Bouaziz, N...... 40, 83 Abujadi, C...... 60 Arefin, A. S...... 56 Batty, R...... 64, 85 Boucher, M...... 51 Achab, S...... 63 Ares-Santos, S...... 48 Batukhtina, E...... 71 Boumba, V...... 34 Achour, O...... 72 Argyelan, M...... 27 Bauer, M...... 46, 48 Bourin, M...... 28, 30, 64, 78 Achuta, V. S...... 48 Arias, F...... 35 Baune, B...... 49, 58 Bousslama, A...... 72 Adamczyk, M...... 61 Armijo, A...... 52 Baus, C...... 64 Boutros, N. N...... 58 Adelson, M...... 64 Arnaiz, A...... 73 Bawor, M...... 46 Bowden, C. L...... 28 Adriana, F.-M...... 38 Arolt, V...... 77 Baymeeva, N...... 80 Bowyer, S...... 58 Agani, F...... 41 Arom, P...... 49 Beaulieu, S...... 29, 36, 62, 63 Boxer, A...... 32 Agartz, I...... 33, 41, 81 Arranz, M. J...... 82 Beck, J...... 37 Boyajyan, A...... 32, 53, 79 Agarwal, S. M...... 35 Arrasate, M...... 67 Becque, S...... 32 Bradford, J. M. W...... 46 Agid, O...... 69 Arrue, A...... 73 Beer-Sandner, B...... 77 Braha-Zeitoun, S...... 83 Agorastos, A...... 32, 65, 71, 79 Artigas, F...... 59 Begic, D...... 52, 85 Brakoulias, V...... 30, 35, 83 Ahern, E...... 67 Arun, M...... 89 Behere, R...... 40 Bralet, M.-C...... 26 Ahmed, R...... 72 Arvanitakis, P...... 54 Beier, K...... 70 Brambilla, P...... 26, 38, 41, Ahn, J...... 66 Arya, S...... 39 Beitnere, U...... 73 ...... 51, 52, 53, 57, 72, 83 Ahn, R.-S...... 71 Asanovska, G...... 25 Bellani, M...... 41, 53, 72 Bram, J. M. de França ...... 71 Ahn, Y.-M...... 36, 37, 63 Askenazy, F...... 88 Bellina, M...... 38 Brammer, M...... 73 Ain, N...... 66 Atshemyan, S...... 32, 53 Belo, V...... 38 Brancaglion, M...... 34, 49 Aivatides, A...... 67, 85 Attwood, A...... 42 Bel Villar, M. T...... 70 Brand, S...... 71 Aizenstein, H...... 32 Aubin, A...... 54 Benavides, F...... 72 Braquehais, M. D...... 47 Akel, H...... 35 Aubry, J. M...... 82 Bendall, S...... 41 Bratu, R. E...... 84 Akkus, M...... 53 Auer, J...... 56 Benecke, R...... 35 Bravo-Mehmedbasic, A...... 87 Albayrak, N...... 53 Austin, J...... 79 Benenk, B...... 64 Bredt, D...... 43 Albayrak, Y...... 53, 58, 85 Avdibegovic, E...... 41 Benichou, J...... 69, 71 Briken, P...... 46 Alberca, D...... 84 Avetyan, D...... 79 Benito Duarte, A...... 64 Broberg, B. V...... 47 Alberich, S...... 67 Avrahami, M...... 68 Ben Soussia, R...... 51, 86, 87 Broclawski, A...... 88 Albuquerque, M...... 56, 81 Ayesa-Arriola, R...... 52 Benyamina, A...... 25 Brown, P...... 36 Alcalá Partera, J...... 39, 64, 82, 85 Ayhan, Y...... 35 Bergé, D...... 38 Brown, R...... 44, 78 Aleksandrowicz, A...... 52, 69, 80 Azizi, I...... 68, 69 Bergiannaki, I.-D...... 49 Brozaitiene, J...... 66, 72 Alevizaki, M...... 36 Bergink, V...... 42 Brückl, T...... 40 Alexander, J...... 88 Bergmans, P...... 53 Bruggemann, J...... 76, 77 Alexiou, P...... 50 B Berk, M...... 23, 29, 36, 38, 61, Brugger, P...... 41, 83 Alifirova, V...... 72 Baandrup, L...... 47 ...... 62, 67, 75, 81 Bruhl, A...... 55 Allan, H...... 40 Babic, D...... 41 Bermpohl, F...... 81 Brundin, L...... 71 Allegri, R...... 67 Baca Garcia, E...... 58 Bernardo, M...... 24, 49, 82 Brunelin, J...... 59, 79 Allgulander, C...... 48, 60 Bacekovic, A...... 52 Bertasi, E...... 40 Brunoni, A...... 59, 65 Allott, K...... 30, 38, 40 Bada Math, S...... 35 Bertsch, K...... 33, 81 Brunovsky, M...... 57 Almeida, O...... 64 Badaoui, F...... 41 Beyazyüz, M...... 53, 85 Bucci, P...... 58 Alonso Zúñiga, E...... 56 Bae, K...... 41 Bhatia, T...... 49, 69 Buchanan, B...... 64 Altamura, C...... 27, 32, 43, 51 Baek, C.-j...... 37 Bhat, M...... 36 Buchsbaum, M...... 26 Altorfer, M...... 56 Baek, D.-y...... 51 Bhattacharya, A...... 56 Bueno Vargas, R...... 81 Alvarez, M...... 81 Baeken, C...... 65 Bianchi, M...... 31, 43 Buerki, N...... 71 Alvarez, X...... 38 Baek, J. H...... 51 Bianchi, V...... 38 Buettner, M...... 29 Alvaro Seron, P...... 87 Bae, K.-Y...... 67 Biederman, J...... 24, 46 Bulbena-Cabre, A...... 39, 82, 83 Alves Sarno, T...... 71 Bae, S. M...... 66 Bijttebier, P...... 32 Bulbena-Vilarrasa, A...... 82 Alves, T. M...... 53 Baez, M. T...... 64 Bilir, B...... 53 Buller, R...... 28 Alvim-Soares, A...... 38 Bagalkot, T. R...... 50 Billard, J.-M...... 27 Bunevicius, A...... 52 Alyagon, U...... 60 Bai, Y.-M...... 51 Binder, E...... 44 Bunevicius, R...... 66, 72 Ambrus, L...... 37 Baker, D. G...... 79 Bise, S...... 52, 85 Buoli, M...... 42 Ameis, S...... 46 Balachandar, V...... 72, 89 Bittianda Kuttapa, T...... 72 Buonocore, M...... 38 Amexi, G...... 52 Balachander, S...... 56 Blanc, E...... 39, 70 Burgess, A...... 38 Amminger, P...... 38, 49 Balamurali Krishnan, B...... 72 Blazevic Zelic, S...... 70, 86 Burkauskas, J...... 66, 72 Amorosi, M...... 29 Balasubramaniam, B...... 38, 50 Bleich, S...... 75 Burke, A...... 81 Anagnostouli, M...... 71 Baldessarini, R...... 75 Blennow, K...... 45 Burke, D...... 67 Anastasi, S...... 29 Baldinger, P...... 31 Blesl, C...... 36 Burminskiy, D...... 80 Andersen, G...... 55, 64 Balikova, M...... 57 Bloch, M...... 64 Busatto, G...... 56, 81 Andreassen, O. A...... 33, 41, 81 Ballarino, M. C...... 39 Blumberger, D...... 27, 34, 36, Bustamante, L...... 52 Andric, S...... 32, 80 Banati, R...... 49 ...... 37, 46, 65 Buttenschön, H...... 55 Androne, F...... 67, 84 Bandelow, B...... 30, 60, 78, 81 Bocharova, A...... 72 Buyskaya, N...... 38 Androutsos, C...... 49 Bang, M...... 52 Bois, F...... 45 Androvicova, R...... 57 Baou, M...... 34 Bokhan, N...... 71 Angelopoulos, E...... 23, 54, 79 Barbiera, G...... 52 Bologna, M...... 84 C Angkaw, A. C...... 79 Barch, D...... 61 Bonaccorso, S...... 65 Cabello Rangel, H...... 56 Angrisano, T...... 69 Baroni, S...... 35 Bonaventure Norbom, L...... 33 Cabral, C...... 80, 89 An, S. K...... 52 Barrantes, R...... 55 Bonfiglio, S...... 52 Cabras, G...... 51

98 WFSBP 2015 List of Chairpersons and Presenters

Caffino, L...... 48 Cherkasova, A...... 83 Cotta, C...... 49 Dervenoulas, G...... 88 Cahn, W...... 47 Cherny, S. S...... 53 Cotton, S...... 81 Deserno, L...... 52, 73 Calabrese, J. R...... 36, 51, 97 Cherubin, P...... 53, 69 Coulthard, R...... 66 Deshpande, G...... 76 Caletti, E...... 51 Chiariotti, L...... 69 Courtet, P...... 24, 25, 58, 81 Deshpande, S...... 69 Caligiorne, S...... 34 Chien, Y.-L...... 37, 57, 71 Couto, T...... 34, 49 de-Sousa, R. T...... 36 Campion, M...... 31 Chilton, M...... 48 Cowen, P...... 65 De Souza Duran, F. L...... 56 Campos Mangas, C...... 35, 36, 39 Chinna, K...... 82 Cozman, D...... 79 Deuschle, M...... 50 Cañellas, C...... 52 Chinna, K.-F...... 82 Crespo-Facorro, B...... 34, 52 Devader, C...... 31 Canneva, F...... 34 Chintoh, A...... 47 Cristalli, M...... 66 Devane, L...... 55 Canuet, L...... 62 Chiu, C.-C...... 36, 39, 84 Croarkin, P...... 46 Devasthali, G...... 86 Capuron, L...... 78 Chiu, H.-C...... 87 Crone, J. S...... 55 Diallo, A. B...... 60 Caravaggio, F...... 39 Chiu, W.-C...... 36 Cropley, V...... 44, 49 Diaz-Fernandez, S...... 39 Carducci, F...... 33 Cho, H...... 35 Cubells, J...... 44 Diaz-Mesa, E...... 70 Carlson, J...... 45 Choi, B.-h...... 52, 88 Cui, Y...... 50 Di Biase, M...... 44, 49 Carpiniello, B...... 55 Choi, C. s...... 87 Curran, G...... 51 Dickerson, F. B...... 59 Carter, O...... 30, 55 Choi, J...... 35, 41, 49 Cyranka, K...... 64, 82 Diclenur Ulug, B...... 35 Carvalho, A. R...... 71 Choi, J. H...... 67, 78 Czisch, M...... 64 Dieler, A...... 63 Casamassima, N...... 37 Choi, M. R...... 87 Czysz, C...... 68 Dietrich, C...... 33, 81 Castaneda, C. P...... 52 Choi, S...... 50, 66, 84 Dikeos, D...... 36, 40, 74, 81, 88 Castaño Díaz, C...... 70 Choi, Y.-M...... 40 Dillon, C...... 67 Castelao, E...... 82 Cho, M...... 68 D Di Maio, A...... 69 Castellani, U...... 72 Choong, E...... 82 Dahdouh Guermouche, A...... 88 Dimopoulou, K...... 54 Castilla-Puentes, R...... 32, 47, 79 Cho, R...... 68 Daigneault, A...... 36 Diniz, B...... 51 Castilla-Puentes, S...... 79 Chor Hong, L...... 84 Dalla, C...... 64 Di Rosa, A...... 84 Castilla-Puentes, W...... 79 Cho, S.-J...... 66 Daniels, W...... 56 Di Rosa, E...... 84 Castillo, M.-C...... 83 Chou, C.-Y...... 72 Daniolos, P. T...... 29, 30 Diwadkar, V...... 26, 33, 38, 41, Castle, D...... 48, 64, 76 Chou, P. H...... 30, 66 Dannon, P...... 25 ...... 49, 51, 53, 57, 68, 70, 72 Castren, E...... 24 Chou, Y. H...... 34, 80 Dan, P...... 54 Djordjevic, V...... 48 Castrén, M...... 48 Chow, T. J...... 32, 72 D‘Argenio, V...... 69 Djouini, A...... 88 Castro, L...... 82 Christian, C...... 50 da Silva, T...... 39, 71 Doan, N. T...... 33 Catalán, R...... 49, 82 Christodoulou, C. .... 52, 81, 84, 86 Daskalakis, J...... 34 Dodd, S...... 36 Catts, S...... 76, 77 Chryssanthou-Piterou, M...... 55 Daskalakis, Z. J...... 27, 36, 37, 46, Doe, N...... 51 Catts, V...... 27, 76, 77 Chuang, Y.-A...... 37, 38 ...... 65, 68, 74, 79 Dolan, R...... 48 Cavallaro, R...... 24, 37, 38, 52, 68 Chung, H...... 67 Daskalopoulou, E...... 40, 83 Dolen, G...... 44 Cemalovic, O...... 52, 85 Chung, I. W...... 52, 69 Davatzikos, C...... 74, 76 Dominguez-Lopez, S...... 31 Cerqueira, J...... 66 Chung, K.-H...... 51 Davey, C...... 81 Domschke, K...... 41, 60 Cervenka, S...... 37, 79 Chung, S...... 66 Davilla, E...... 83, 88 Donati, R...... 68 Ceskova, E...... 48, 82 Chung, S.-K...... 38, 51, 87 Dayan, P...... 48 Dorado, G...... 63 Céspesdes, I. C...... 35 Chung, Y.-C...... 50 Dazzan, P...... 74 Dor, E...... 88 Cevik, M...... 55 Chun, J.-W...... 35 Dean, B...... 30, 61, 74 Dose, M...... 87 Chainho, J...... 49 Cigliobianco, M...... 51 de Andrade, T...... 54 Douki, W...... 68, 69, 72 Chakrabarti, S...... 86 Cinnante, C...... 51 De Angel, V...... 52 Doumit, M...... 55 Chakrabarty, A...... 81 Ciobica, A...... 53, 85, 87 de Bartolomeis, A...... 69 Douzenis, A...... 34, 36, 52, Chambers, A...... 45 Ciprian Ollivier, J...... 52, 69 deBejczy, A...... 25 ...... 69, 81, 83, 84, 88 Chana, G...... 77 Cittaro, D...... 52 De Burgos Marín, R...... 66 Downar, J...... 36, 65 Chan, C.-H...... 66 Ciucu, A...... 68 Decker, M...... 81 Dragovic, M...... 76 Chand, P...... 83 Claes, S...... 32 Deckert, J...... 41 Dresler, T...... 63, 65 Chang, C.-J...... 36 Claudio, C.-B...... 38 de Faria, G...... 34 Drineas, P...... 88 Chang, J. S...... 52, 69 Cocchi, A...... 83 de Filippis, R...... 36, 51 Drozdowicz, E...... 68, 71, 84 Changrathil, G...... 56, 69 Coelho, M...... 71 Degenhardt, F...... 64, 83 D‘Souza, D. C...... 45 Chartoff, E...... 79 Cohen, A...... 32 de Girolamo, G...... 83 Duarte, D...... 81 Chatziioannou, A...... 51, 78 Coira, D...... 39, 64 Délacretaz, A...... 82 Dubenko, A...... 88 Chauvet-Gelinier, J.-C...... 41 Colic, L...... 72 de La Fuente-González, N...... 52 Duchesne, S...... 56 Chaves, J...... 54 Collste, K...... 37 Delavenne, H...... 69, 71 Duclos, C...... 36 Chavushyan, A...... 32 Colombo, P...... 38 De Leat, S...... 32 Dulmus, C. N...... 66 Chebbi, W...... 51, 53, 87 Comai, S...... 31 Delisi, L...... 28, 44 Dumont, D...... 36 Chee, S. Y...... 88 Conca, A...... 45 Dell’Osso, B...... 27, 43 Dunlop, K...... 65 Chekhonin, V. P...... 51 Conesa Lopez, C...... 70 Dell’Osso, L...... 35, 36 Durães, D...... 49 Chen, C.-H...... 36, 37, 38, 39 Conneely, K...... 44 Del Re, E...... 89 Durak, N...... 53 Chen, C.-K...... 64 Constante, M...... 80 De Marco, L...... 38 Duran, F...... 81 Chen, E...... 62 Contreras, J...... 55 Demartini, B...... 84 Durnev, A...... 87 Chen, G. G...... 60 Conus, P...... 82 Dembinska, E...... 64, 82 Dusi, N...... 72 Cheng, M.-C...... 37, 38 Cooper, T...... 81 Demenecu, L...... 72 Dwivedi, Y...... 60, 75 Cheng, W...... 41 Corlett, P...... 45 Demenescu, L. R...... 56, 70 Dzubur Kulenovic, A...... 41, 87 Cheng, Y. C...... 84 Corominas Castell, N...... 84 Demetriou, E...... 48 Chen, I.-L...... 72 Corominas Diaz, A...... 70 Demiralay, C...... 32, 65, 71 Chen, M.-H...... 51 Corrales, A...... 67 Demir, B...... 35 E Chen, P.-H...... 51 Corrêa de Freitas, A. A...... 34 Demitrack, M...... 74 Eap, C. B...... 45, 82 Chen, P.-Y...... 39 Corrêa, H...... 34, 49, 56 Deng, W...... 41 Ebdrup, B. H...... 47 Chen, W. Y...... 65 Cosgrove, K...... 45 Dennis, B. B...... 46 Eckert, A...... 61 Chen, W.-Y...... 80 Costa, A...... 36 Denys, D...... 47 Economou, A...... 34 Chen, Y.-C...... 64 Costa, B...... 71, 73 Denzel, D...... 72 Economou, M...... 67, 83, 85 Chepuri, B...... 57 Cosyns, P...... 46 Derish, N...... 50 Edman, G...... 79

99 WFSBP 2015 List of Chairpersons and Presenters

Egeter, J...... 77 Forstner, A...... 64, 83 Gaudeau, C...... 40 Granado, N...... 48 Eggermann, T...... 41, 81 Forte, A...... 75 Gaudio, S...... 33 Greenberg, R...... 76 Egger, S...... 52 Fountoulakis, K. . 31, 43, 62, 67, 97 Gau, S...... 57 Gregoriou, P...... 80 Ehlis, A.-C...... 65 Foussias, G...... 69 Gavriel, M...... 26 Grela, A...... 84 Ehrenstein, V...... 53 Francis, A...... 64, 85 Geisler, S...... 77 Grimm, S...... 52 Eichler, A...... 34 Franck, J...... 25 Gema, H.-R...... 38 Grinstead, H...... 66 Eigenberger, T...... 72 Franco, R...... 77 Genc, A...... 53 Grohmann, R...... 75 Eisert, A...... 41 Frank, J...... 64, 83 Georgantopoulos, G...... 88 Gromova, E...... 33 Eitan, E...... 32, 71 Franklin, M...... 29 George, M...... 65, 74, 79 Grover, S...... 79 Ekhtiari, H...... 25 Franklin, Mike ...... 29 Georgiadis, D...... 83, 88 Grudet, C...... 71 Elbaz, Z...... 57, 87 Frank, M...... 56 Gerber, M...... 37 Gruenhage, F...... 64 Elfving, B...... 80 Frey, B...... 29, 67 Geretsegger, C...... 55 Grünblatt, E...... 43 Elisei, S...... 29 Friess, E...... 61 Gerlach, M...... 27 Gründer, G...... 33, 39, 45, 65 Elkeshishi, H...... 48 Frigola de Vehi, I...... 70 Gerretsen, P...... 39 Grunebaum, M...... 81 Elkin, H...... 45 Fryar-Williams, S...... 31, 69, 85 Gersic, D...... 56 Grunze, H...... 28, 31, 42, 51 Elzinga, B...... 50 Frye, M...... 36 Geyer, M. A...... 58 Gryglewski, G...... 33 Embuldeniya, A...... 39 Fuchs, A...... 81 Gheorghiu (Ciurea), A...... 68 Grygoryan, L...... 66 Emolo, J...... 64 Fuchs, D...... 77 Ghigi, D...... 83 Guastella, A...... 44, 48 Emul, M...... 53 Fujakova, M...... 57 Gholamrezaee, M...... 82 Gudasheva, T. A...... 35 Endel, F...... 55 Fujiki, R...... 89 GholamRezaee, M...... 82 Gudelj, L...... 86 Englund, A...... 76 Fujimoto, M...... 60, 76 Ghosh, A. K...... 35 Guenette, M...... 47 Erfurth, A...... 64, 79, 97 Fujino, H...... 76 Giacca, A...... 47 Guez, D...... 68 Erhardt, S...... 36 Fujita, Y...... 40 Giacobbe, P...... 65 Guijarro Granados, T...... 86 Ernst, C...... 60 Fukuda, Y...... 52, 73 Giannopoulou, A...... 68 Guilera, G...... 85 Ernst, J...... 52 Fukunaga, M...... 76 Giannaopoulou, I...... 65 Guillemin, G. J...... 77 Errico, F...... 69 Fukushima, J...... 26 Gil-Ad, I...... 52, 85 Guillermier, C...... 67 Esterlis, I...... 45 Fumagalli, F...... 48 Giles, S...... 56 Guipponi, M...... 88 Eugen, Z...... 51 Fung, S...... 27 Gilles, M...... 50 Guo, S...... 76 Evans, A...... 48 Funke, R...... 34 Gilmore, J...... 44 Gupta, S...... 32 Evdokimidis, I...... 83 Futamura, T...... 40 Ginieri-Coccosis, M...... 83 Gurel, S. C...... 35 Everall, I...... 49, 77 Fydrich, T...... 35 Ginige, P. s...... 81 Gur, R...... 49, 69 Evins, E...... 45 Giorda, R...... 38 Gussew, A...... 30 Giuseppe, G...... 48 Gustafsson, J.-A...... 51 G Gjini, K...... 58 Guterstam, J...... 25 F Gäbel, A...... 33 Glenthøj, B...... 47 Gutiérrez, B...... 82 Fabbri, C...... 74 Gaebel, W...... 49, 61 Gobbi, G...... 31, 58 Gutiérrez, M...... 67 Fabregat Navarro, V...... 70 Gafarova, A...... 33 Godlewska, B...... 65 Fagerlund, B...... 47 Gafarov, V...... 33 Goecke, T...... 65 Fairbairn, L...... 56 Gagulin, I...... 33 Goel, D...... 28 H Faivre, A...... 83 Gaha, L...... 68, 69, 72 Goetzl, E...... 32, 71 Haba Sanchez, M...... 35, 36, 39 Falcone, T...... 79 Gaillard, W...... 29 Golan, M...... 39 Häberlein, H...... 51 Falconi, S...... 81 Gailledreau, B...... 32 Golda, S...... 35 Habeych, M...... 32, 79 Falkai, P...... 42, 43, 48, 62, 74, 80 Gailledreau, J...... 32 Gold, S...... 71 Habil, M. H...... 65 Fallgatter, A. J...... 63, 65 Gaines, E...... 50 Goldstein, J...... 89 Hacker, M...... 33 Farde, L...... 37, 59, 79 Gajardo-Galán, V...... 34 Golier, J...... 38 Hage-Hülsmann, A...... 51 Farid Gattaz, W...... 53, 71 Gajaria, A...... 71 Golsabahi-Broclawski, S...... 88 Hagenmuller, F...... 52, 69, 80 Fatouros-Bergman, H...... 37, 79 Galderisi, S...... 58 Golub, Y...... 34 Haghighatfard, A...... 32, 72 Fauth-Bühler, M...... 72 Galecka, M...... 37 Gomez-Benito, J...... 85 Hagihira, S...... 60 Fava, M...... 51 Galecki, P...... 40 Gómez, M...... 34 Hahm, W...... 37 Fecteau, S...... 59, 79 Galinska-Skok, B...... 56 Gomez Morad, I...... 79 Hahn, A...... 33, 40 Fedotova, J...... 35 Galli, E...... 63 Goncalves, V...... 59 Hahn, C...... 56, 71 Fehm, L...... 35 Gamieldien, J...... 56 Gonzalez, A...... 52 Hahn, M...... 47 Feng, J...... 41 Gamon-Cantero, A. C...... 39 González, I...... 67 Hajar, S...... 65 Ferentinos, P...... 32, 36, 81 Gamper, E...... 77 González Olvera, J. J...... 40 Hajji, K...... 51, 53, 67, 86, 87 Fernández-Miranda, J. J...... 39 Ganella, D...... 66 González, P...... 84 Ha, K...... 36 Ferrarelli, F...... 44 Ganella, E...... 30, 40, 69 González-Pinto, A...... 67 Haker Rössler, H...... 52, 69, 80 Ferro, A...... 52 Gangaram, P...... 35 González-Rodríguez, A...... 49, 82 Halaris, A...... 23, 30, 34, 71, 77 Fervaha, G...... 69 Ganger, S...... 40 Gooclush, G...... 42 Halayenka, I...... 55 Fexi, P...... 72 Gan, S.-T...... 38 Goodyer, I...... 86 Halldin, C...... 37 Filiou, M...... 30, 56, 67, 79, 85 Ganzola, R...... 56 Goossens, L...... 32 Ham, B...... 63 Fillman, S...... 27, 76 Gao, Y...... 32, 56, 86 Gorelick, D...... 25, 60 Hammarberg, A...... 25 Finos, L...... 83 García-Anaya, M. d. Lourdes ..... 40 Görlich, Y...... 60 Han, B...... 32, 56, 86 Fioritti, A...... 83 Garcia, F...... 34, 49, 56 Gorman Swift, R...... 39, 83 Han, C...... 50, 53, 54 Fischel, T...... 68 Garcia, F. J...... 73 Gorwood, P...... 25 Hanci, E...... 54 Fisekovic, S...... 54, 87 Garcia, M...... 73 Gournellis, R...... 52, 84, 88 Han, D...... 36 Fitzgerald, P...... 36, 74 Gardner-Schuster, E...... 50 Gouzoulis-Mayfrank, E...... 80 Han, D. H...... 66 Flores, G...... 43 Garduño Treviño, H...... 56 Gowri Devi, M...... 39 Hänggi, J...... 41, 83 Flyckt, L...... 37, 77, 79 Garganeeva, N...... 64 Goyal, N...... 31 Hargarter, L...... 53, 69 Fokas, C...... 65 Garner, B...... 41 Gozes, I...... 75 Hartberg, C...... 41 Forde, N...... 83 Garzitto, M...... 38 Gozzi, A...... 69 Harvey, J...... 56 Ford, J...... 61 Gass, P...... 43, 45 Grabowski, K...... 65 Hasan, A...... 62 Forlenza, O...... 53 Gattaz, W...... 51, 53, 55, 65 Graeber, M...... 56 Hasandedi, L...... 64, 83 Fornasari, L...... 38 Gattaz, W. F...... 36 Graff-Guerrero, A...... 39 Hasegawa, T...... 88

100 WFSBP 2015 List of Chairpersons and Presenters

Hashimoto, K...... 26, 40, 58 Huang, S.-Y...... 39 Jaury, P...... 25 Kang, W. S...... 41 Hashimoto, N...... 26 Hubalek, M...... 77 Jayaraman, H...... 35 Kanniah, G...... 33 Hashimoto, R...... 36, 60, 76 Huber, J...... 67 Jay, T...... 25 Kao, C.-F...... 65 Hasler, G...... 25, 42 Huber, R...... 44 Jemar, G. N...... 40 Kapaki, E...... 32 Hassan, A...... 51 Hudson, J...... 46 Jensen, A...... 81 Kapogiannis, D...... 32, 71 Hatakeyama, S...... 69 Hüfner, K...... 77 Jeong, B...... 41 Kapur, V...... 40 Hatzimanolis, A...... 30 Hughes, M...... 89 Jeong, H.-j...... 50 Karaaslan, C...... 35 Hatzinger, M...... 37, 61, 74, 78 Huhn, K...... 32 Jeong, J. E...... 63 Karaiskos, D...... 82 Haukvik, U. K...... 33, 41, 81 Humberto, C...... 81 Jeong, M. H...... 67 Karamustafalioglu, N...... 53 Hawco, C...... 27, 69 Hung, G. C.-Lun ...... 31 Jeong, S...... 84 Karamustafalioglu, O...... 55 Hayakawa, K...... 70 Hung, Y. C...... 87 Jeon, H. J...... 51 Kararizou, E...... 83 Hayasaka, S...... 60 Hung, Y.-Y...... 37 Jeon, S...... 50 Karkanias, A...... 36 Heekeren, K...... 52, 69, 80 Husain, M...... 76 Jeon, S. W...... 50 Karlovic, D...... 52 He, F...... 49, 69 Hu, T.-M...... 37, 38 Jerez, S...... 70 Karthick Kumar, A...... 72 Heitor, M. J...... 80 Hwang, J.-F...... 72 Jernajczyk, W...... 57 Kasai, K...... 30 Hemmings, S...... 35, 50, 56 Hwang, L.-L...... 39 Jibin,J...... 72 Kasiulevicius, V...... 52 Hendricks, M. M...... 85 Hwang, S. S.-Hyun ...... 69 Jimenez Arriero, M. A...... 35 Kasper, S...... 24, 28, 30, 31, Henkel, K...... 33, 81 Hwu, H.-G...... 37, 57, 71 Jin, H.-M...... 50 ...... 33, 40, 59, 67, 75, 78 Heo, J.-y...... 51 Ji-Won, C...... 49 Kataria, L...... 79 Hernandez, L...... 35 Joaquim, H...... 51, 53 Kathanan, S...... 38 Hernandez Salazar, M...... 81 I Joca, S...... 31 Kathirvel, N...... 88 Herpertz, S...... 33, 81 Ibáñez, M. P...... 50, 70 Johansson, J...... 71, 78 Kato, T...... 61, 70, 87 Herrmann, M. J...... 63 Ichikawa, T...... 52 John, J...... 72 Kato, Y...... 89 Hesselbrock, V...... 78 Ikari, K...... 73 John, P...... 72 Katritzoglou, E...... 72 Hetrick, S...... 81 Ikeda, M...... 76 Johnsen, S. P...... 64 Katschnig, H...... 55 Heurteaux, C...... 31 Ikeda, S...... 70 Johnson, A. K...... 29 Katsuki, F...... 44 Hiemke, C...... 39, 45, 65 Ikemoto, K...... 69 Jokari, S...... 32 Katthagen, T...... 52, 73 Hilti, L. M...... 41, 83 Ikonen, P...... 37 Jokinen, J...... 23, 34, 47 Katz, J...... 56 Hirano, Y...... 86 Ikubo, K...... 51 Jollant, F...... 58 Kaur, S...... 54 Hiraoka, K...... 56 Ilic, N...... 67 Joober, R...... 34 Kautzky, A...... 31, 33 Hirayasu, Y...... 60 Ilic, V...... 67 Joo, E.-J...... 53 Kawasaki, Y...... 36 Hirokuni, S...... 73 Imboden, C...... 37 Joo, S. H...... 37 Kawohl, W...... 52, 57, 69, 80 Hironaga, N...... 83 Inoue, M...... 89 Joo, S.-H...... 56 Kazantseva, A...... 41 Hiwatashi, A...... 73 Inta, D...... 43, 45 Joo, Y...... 83 Kazmierski, J...... 51 Hložek, T...... 57 Ioannidis, K...... 86 Joo, Y.-h...... 51 Kazukauskiene, N...... 66 HN, H...... 30 Irnee, W. A...... 65 Jørgensen, K...... 41 Kee, B. S...... 66 Hochman, E...... 68 Isaac, C...... 83 Jorg, S...... 31 Kehagia, A...... 27 Hoesli, I...... 71 Isaac, M...... 28 Jose, D...... 35 Kekulawala, S...... 41 Hoffman, C...... 68 Isaksson, A...... 25 Josep, M.-B...... 38 Kelber, O...... 40, 54 Hoffman, L...... 50, 70, 83 Ishii, Y...... 89 Joshi, G...... 24 Kellner, C...... 76 Hoffmann, S...... 41 Ishisaka, N...... 67 Joshua, N...... 30, 55 Kellner, M...... 32, 65 Holl, A...... 36 Ishøy, P. L...... 47 Jovanovic, T...... 79 Kelvin, R...... 86 Hollander, S...... 68 Ising, M...... 40 Juan Ignacio Rodríguez, A...... 41 Kempton, M...... 44 Holsboer-Trachsler, E...... 37, 61, 71 Istikoglou, C...... 67, 85 Juckel, G...... 62 Kenar, A. N. Inci ...... 54 Honda, S...... 73 Itokawa, M...... 52, 69 Jung, H. Y...... 63, 69 Kenji, M...... 28 Hong, H. J...... 50 Ivanova, S...... 67 Jung, Y.-E...... 54, 86 Kennedy, J...... 28, 55, 59 Hong, K. S...... 55 Ivenskaya, M...... 88 Jurado, R...... 35 Kennedy, S...... 25, 65 Hong, N...... 53 Iwaki, R...... 87 Keshavan, M. S...... 28, 55, 83 Hong, S...... 68 Iwata, N...... 76 Keshavarao, S. ... 38, 50, 56, 69, 72 Hong, Y. J...... 67 Iyer, M...... 56, 69, 72 K Kessing, L. V...... 44 Hopwood, M...... 64, 85 Izuno, T...... 60 Kaderábek, L...... 57 Khamenka, N...... 55 Horacek, J...... 57 Kadish, I...... 73 Khazaal, Y...... 63 Horikawa, H...... 70 Kai, L. M...... 80 Khusnutdinova, E...... 41 Horiuchi, Y...... 52, 69 J Kalelioglu, T...... 53 Kiefer, F...... 41 Hosak, L...... 64, 78, 85 Jabeen Taj, R...... 73 Kaliora, S...... 27, 54, 76 Kihara, H...... 36 Hosakova, K...... 85 Jablensky, A...... 76 Kalkavoura, C...... 54, 68 Kikuchi, T...... 40 Hoschl, C...... 62 Jacobsen, M...... 81 Kalmady, S...... 35, 73 Kikuchi, Y...... 73 Hosoi, M...... 61, 87 Jacques, D...... 29 Kambeitz-Ilankovic, L...... 80, 89 Killackey, E...... 30, 40 Hototian, S. R...... 53, 71 Jaenner, M...... 53 Kambeitz, J...... 80 Kim, B...... 37 Houenou, J...... 41 Jagannathan, M...... 51 Kamei, N...... 73 Kim, C. E...... 54 Houivet, E...... 69, 71 Jagtap, P...... 38 Kaminski, J...... 73 Kim, C.-H...... 71 Hovhannisyan, L...... 79 Jain, S...... 30, 40, 73 Kamp, D...... 53 Kim, D...... 42 Ho, Y.-J...... 72 Jakobs, D...... 51 Kanaan, A. S...... 83 Kim, D.-J...... 35, 49, 63, 87 Hritcu, L...... 85 Jakovljevic, M...... 41 Kanagasundram, S...... 84 Kim, E. Y...... 36 Hsieh, H.-M...... 87 Jalali Sefid Dashti, M...... 56 Kanayama, Y...... 73 Kim, H...... 37, 53 Hsieh, J.-C...... 51 James, G. M...... 33 Kanba, S...... 28, 56, 60, 61, Kim, H.-C...... 40 Hsieh, M...... 57 Jang, M...... 68 ...... 70, 73, 83, 87 Kim, H. S...... 50 Hsu, P.-C...... 72 Jansone, B...... 73 Kandavel, T...... 73 Kim, J...... 54 Hsu, S.-H...... 37, 38 Janssen, P...... 87 Kanellos, P...... 67, 85 Kim, J. H...... 66 Huang, C.-C...... 39 Janssens, A...... 32 Kang, E.-S...... 51 Kim, J. J...... 53 Huang, M.-C...... 35, 39, 64, 65 Januel, D...... 40, 83 Kang, J.-H...... 50 Kim, J.-M...... 67 Huang, Q...... 31 Jarema, M...... 57 Kang, S.-H...... 67 Kim, J. W...... 41 Huang, S.-H...... 51 Jarkiewicz, M...... 57 Kang, U. G...... 35, 50 Kim, J.-W...... 87

101 WFSBP 2015 List of Chairpersons and Presenters

Kim, K.-S...... 40 Kraft, K...... 40 Lebedeva, E...... 67 Lin, R...... 56 Kim, K. w...... 51 Krähenmann, R...... 59 Leboyer, M...... 43 Lin, S.-H...... 38 Kim, K. W...... 41 Kranz, G...... 33, 40 Lebron-Milad, K...... 25 Lin-Shiau, S.-Y...... 37 Kim, S...... 36, 68 Kratz, O...... 34 Lechene, C...... 67 Lin, S.-K...... 64, 65, 80 Kim, S. H...... 36, 52, 69 Kraus, A...... 56 Ledesma Torres, L. A...... 81 Lin, W.-C...... 51 Kim, S.-H...... 50 Kraus, C...... 24 Lee, C...... 56 Lin, W.-H...... 66 Kim, S. M...... 66 Krebs, M.-O...... 25 Lee, C.-T...... 50 Lin, Y.-C...... 87 Kim, S.-W...... 38, 67 Krishnan, p...... 50 Lee, C. U...... 37, 56, 63 Li, S...... 56, 70, 72 Kim, T...... 78, 87 Krishnaswamy, S...... 82 Lee, C.-U...... 71 Lisanby, S...... 76 Kim, T. Y...... 67 Kristofikova, Z...... 86 Lee, C.-W...... 72 Lisowska, K...... 65 Kim, Y...... 36, 50, 66 Krivoy, A...... 68, 85 Lee, D...... 51 Li, T...... 41 Kim, Y. J...... 41 Król, A...... 87 Lee, H.-C...... 50, 51 Liu, C.-C...... 71 Kim, Y.-K...... 87 Kronbichler, M...... 55, 72 Lee, H. J...... 36, 70 Liu, C.-M...... 37, 71 Kim, Y. S...... 52, 69 Kruger, T...... 70 Lee, H.-K...... 50 Liu, C.-Y...... 46 Kindler, J...... 77 Ktonas, P...... 44 Lee, I...... 44 Liu, H.-C...... 36, 84 Kinoshita, A...... 30 Kubicki, M...... 44, 89 Lee, I.-J...... 50 Liu, K...... 32 Kiosterakis, G...... 35, 69 Küblböck, M...... 40 Lee, J...... 36 Liu, S.-I...... 36 Kiraly, L...... 57, 87 Kubo, H...... 70 Lee, J.-s...... 51 Li, W...... 51 Kircher, T...... 24 Kucukalic, A...... 41, 54, 87 Lee, K...... 53, 68 Li, X...... 50 Kirschbaum, C...... 64, 83 Kucukalic, S...... 87 Lee-Kardashyan, L...... 66 Li, X.-M...... 31 Kisielewski, J...... 65 Kudo, T...... 78, 80 Lee, K. J...... 53 Ljung, R...... 34 Kito, S...... 74, 88 Kuge, R...... 73 Lee, K.-S...... 71 Llorca, P.-M...... 24, 97 Kittel-Schneider, S...... 56 Kukuljan, M...... 52 Lee, K.-U...... 50 Lobaskova, M...... 41 Klasen, M...... 41 Kulkarni, K...... 73, 83 Lee, M.-S...... 63 Lof, E...... 25 Klauser, P...... 49 Kuloglu, M...... 53, 85 Lee, N. Y...... 52 Logotheti, M...... 51, 78 Klebe, S...... 56 Kumar, S...... 28 Lee, S...... 83 Lois, G...... 36 Klein, H...... 34 Kunchulia, M...... 88 Lee, S. J...... 50 Lopes, D. A...... 35 Klein, M...... 53 Kunjithapatham, G...... 57, 67 Lee, S.-M...... 50 Lopes, S...... 64 Kloiber, S...... 40 Kurtovic, B...... 52, 85 Lee, S. P...... 57 Lopez-Muñoz, F...... 35 Klöppel, S...... 77 Kushner, S...... 42 Lee, S. S...... 37 Lopez-Santin, J. M...... 87 Kloszewska, I...... 84, 87 Kusumi, I...... 26 Lee, S. W...... 41 Lopez, T...... 52 Klünemann, H.-H...... 65, 97 Kutalik, Z...... 82 Lee, S. Y...... 70 Lorenz, C...... 56 Klunk, W...... 32 Kuwano, M...... 73 Lee, Y.-H...... 67 Lorenzi, C...... 37, 38, 52 Klusa, V...... 73 Kuznetsova, O...... 86 Lee, Y. s...... 66 Lori, A...... 44 Knapp, R...... 76 Kwak, K...... 87 Lee, Y. S...... 52, 55, 88 Lortkipanidze, N...... 33 Knight, J...... 59 Kwan, Y...... 50 Lefter, R...... 53, 85, 87 Louzã, M. R...... 53 Knop, F. K...... 47 Kweon, Y.-S...... 50 Lehtimaki, T...... 44 Low, W.-Y...... 82 Kobori, A...... 52, 69 Kwon, Y...... 68 Lelental, N...... 37 Lublin, H...... 47 Kodama, T...... 37 Lemenager, T...... 72 Lucae, S...... 40 Kogkas, S...... 68 Lemes, J. A...... 35 Luikinga, S...... 66 Kogyna, A...... 84 L Leme Talib, L...... 53, 71 Lu, M.-K...... 38 Kohl, C...... 77 Lachance, I...... 54 Lenroot, R...... 76, 77 Lu, M.-L...... 36, 39 Koike, S...... 30 Lachmann, I...... 37 Lepage, M...... 34 Luna Muñoz, J...... 56 Kokras, N...... 64, 72, 73 Lagergren, J...... 34 Le Pen, G...... 25 Lutz, P.-E...... 60 Koks, S...... 41 Lagergren, K...... 34 Ler, S...... 54, 87 Lyall, A...... 89 Kolb, C...... 40, 51, 54 Lahaye, M...... 69 Lesch, K.-P...... 56 Lyketsos, C...... 30, 58 Kolb, S...... 88 Lai, C.-H...... 31 Lesch, O...... 64 Kolik, L. G...... 35 Lakshmi, V...... 79 Le Strat, Y...... 25 Kolisis, F...... 78 Lammert, F...... 64 Leszek, J...... 32 M Kolisis, R...... 51 Lammertz, S...... 39, 65 Levchuk, L...... 67 Maccarone, M...... 27 Kollmann, B...... 41 Lampit, A...... 48 Levinson, A...... 37 Macdonald, A...... 56 Komorowski, A...... 33 Lam, R. W...... 46 Levkovitz, H...... 65 Machado-Vieira, R...... 36, 65 Konadhod, R. R...... 33 Lamy, S...... 69, 71 Levkovitz, Y...... 60 Madsen, H...... 66 Konarzewska, B...... 37 Lancaster, S...... 89 Lewczuk, P...... 37, 45 Madurkar, A...... 38 Kong, J...... 31 Landgraf, R...... 79 Lhotkova, E...... 57 Maekawa, T...... 83 Konstantakopoulos, G...... 82 Landowski, J...... 65 Liapis, E...... 67, 85 Maeng, L...... 25 Konstantinidis, A...... 75 Lane, H.-Y...... 26 Liappas, I...... 63, 67, 82, 85 Maeng, S...... 54 Konstantinidou, A...... 48 Lange, E...... 41 Li, C...... 32 Maes, M...... 23, 36, 61 Konstantinopolsky, M...... 35 Lang, M...... 50, 64, 83 Licinio, J...... 58 Maestu, F...... 62 Kopelman, T...... 29 Lanna, C...... 38 Li, C.-T...... 51 Maggioni, E...... 51 Kornhuber, J...... 37 Lan, T.-H...... 66 Liddle, P...... 76 Magierski, R...... 84, 87 Koros, E...... 69 Lanzenberger, R...... 24, 27, 30, Li, H...... 32 Magno, L...... 71 Korostiy, V...... 67, 70, 83, 84, 88 ...... 31, 33, 40 Li, M...... 41 Mago, R...... 32, 54 Korostynski, M...... 35 Lara, C...... 64 Lim, C. K...... 77 Maher, M...... 36 Kostic, J...... 48 Larach, V...... 47, 61 Lim, H...... 84 Maisuradze, L...... 33 Kota, L. N...... 40 Larsson, H...... 64 Lim, H. K...... 32, 37 Maite, C.-S...... 38 Kotsioumpa, I...... 81 Lasalvia, A...... 72 Lim, H.-K...... 56 Maj, M...... 24 Kou, K...... 60 Last, D...... 68 Limouris, G...... 72 Makinodan, M...... 76 Koumoula, A...... 38, 48 László, P...... 34 Lim, S...... 50 Ma, L...... 32, 56, 86 Koutsouleris, N...... 76, 80, 89 Laucht, M...... 26 Li, M. S...... 35 Malafosse, A...... 72 Kovalenko, L...... 86 Lawrence, A...... 66 Lin, A...... 44, 49, 69 Malamou, R...... 67, 85 Kozhyna, H...... 67, 70, 83 Lazarevic, D...... 52 Lin, C.-H...... 26 Malan-Müller, S...... 56 Kraemer, B...... 41, 83 Le Bail, M...... 27 Lin, J.-J...... 38 Malan, S...... 50

102 WFSBP 2015 List of Chairpersons and Presenters

Malhadas Martins, J...... 49 Mayerova, M...... 82 Mkrtchyan, G...... 32, 79 Musliner, K. L...... 37 Malhotra, S...... 56, 57 Mayrhauser, L...... 55 Mlyniec, K...... 84 Mustapic, M...... 32, 71 Malla, A...... 34 Mays, J...... 79 Modi, M...... 57 Mutalik, N. R...... 30 Maller, J...... 36, 64 Mazella, J...... 31 Moehler, E...... 81 Muzik, O...... 33 Malm, J...... 71 Mazumdar, S...... 49, 69 Mogoanta, L...... 68, 73 Myint, A.-M...... 77 Malpighi, C...... 48 McCall, W. V...... 76 Mohamed, Z...... 84 Mykhailova, E...... 66 Malta Vacas, S...... 80 McCarley, R...... 44, 78, 89 Mohammadkhani Shali, S...... 33 Mykhaylov, V...... 84 Malus, A...... 37 McCarroll, S...... 59 Mohana Devi, S...... 89 Myung, W...... 66 Malykh, S...... 41 McClintock, S...... 76 Mohandas, E...... 80 Mamede, M...... 73 Mcdermott, K...... 73 Mohan, G...... 69 Mamo, D...... 39 McGorry, P...... 30, 38, 40, 41, Moha ou Maati, H...... 31 N Manchia, M...... 55, 88 ...... 44, 49, 69, 81 Moldovan, R...... 79 Naber, D...... 24 Mancke, F...... 33 McGuire, P...... 44 Molendijk, M. L...... 58 Na, C...... 36, 66 Mancuso, S...... 76 McIntosh, A...... 56 Molina-Andreu, O...... 49 Nachar, R...... 52 Mané, A...... 38 McIntyre, R. S...... 97 Mollenhauer, B...... 45 Nadella, R. K...... 40 Mann, J...... 75, 81 McKay, M...... 51, 68 Möller, H.-J...... 80 Nagpal, R...... 28 Mann, K...... 72, 78 McKenna, J...... 44, 78 Moll, G...... 34 Nagy, K...... 33 Manunta, P...... 37 McLoughlin, D...... 76 Molteni, M...... 38 Nahas, Z...... 55 Manzares Colín, M...... 56 McNally, J...... 44, 78 Mondelli, V...... 39 Najjar, F...... 68, 69, 72 Marazziti, D...... 35 Meaney, M. J...... 60 Montes, C...... 52, 70 Nakae, A...... 60 Marcel, S...... 54 Meinlschmidt, G...... 71 Montgomery, S...... 31 Nakajima, A...... 47 Marcolin, M...... 60 Meisenzahl, E...... 74, 80 Moons, T...... 32 Nakajima, S...... 39 Mardor, Y...... 68 Melicher, T...... 57 Moratalla, R...... 24, 48 Nakajima, T...... 88 Margaritis, D...... 81 Melle, I...... 33, 41, 81 Moreno, S...... 31 Nakamae, T...... 47 Margoob, M...... 47, 63 Mellos, E...... 82 Morera-Fumero, A. L...... 70 Nakamura, M...... 34, 60 Maria, L...... 54 Meltzer-Brody, S...... 42 Morgan, C...... 30, 55 Nakao, K...... 45, 54 Maric, N...... 32, 80 Memic, A...... 64, 83 Morgan, V...... 76 Nakao, T...... 47, 73 Marinelli, V...... 72 Mendlewicz, J...... 31 Mori, K...... 89 Nakazato, M...... 86 Marinescu, D...... 68, 73 Meneses Luna, O...... 81 Morinaga, S...... 60 Nakazawa, K...... 45, 54 Marinescu, I...... 68, 73 Menezes, A. K...... 53 Morino, Y...... 73 Nakovics, H...... 41 Marin Mayor, M...... 35 Mensi, R...... 68, 69 Mori, T...... 71 Na, K.-S...... 66 Markianos, M...... 52, 84 Meraner, V...... 77 Morita, K...... 89 Nalvarte, I...... 51 Markou, A...... 42, 50 Merz, C...... 25 Mörkl, S...... 36 Nam, B...... 86 Markulev, C...... 41 Mesholam-Gately, R...... 89 Morozova, A...... 51 Nam, J. Y...... 37 Maron, E...... 65 Messaoud, A...... 68, 69 Morozova, M...... 80 Napolitano, F...... 69 Marrag, I...... 51, 53, 67, 86, 87 Metzger, C...... 56 Mors, O...... 55 Narammalage, H...... 39 Marret, S...... 71 Meyer-Lindenberg, A...... 43 Mortensen, J. K...... 55, 64 Narayanaswamy, J...... 35, 73 Marta, T.-M...... 38 Meyyazhagan, A...... 38, 50, Mortensen, P. B...... 37, 53 Nasr, M...... 51, 53, 67, 86, 87 Martin, A...... 53 ...... 56, 69, 72 Moscato, P...... 56 Nathan, D...... 55 Martín Borreguero, P...... 86 Mhalla, A...... 68, 69, 72 Mosiolek, A...... 56 Navarro, G...... 77 Martínez-Díez, J...... 34 Miceli, M...... 83 Mosquera, F...... 67 Navarro, R...... 71 Martínez-García, O...... 34 Michael, B...... 34 Mota, C...... 66 Nawara, L. A...... 55 Martínez, I...... 35 Michaelis, S...... 60 Mothet, J.-P...... 27, 77 Nebes, R...... 32 Martinez, M...... 85 Michie, P...... 89 Motomura, K...... 56 Neffati, F...... 72 Martínez, M...... 67 Michilli, C...... 48 Mottaghy, F...... 33, 81 Nehra, R...... 79 Martini, N...... 84 Michopoulos, I...... 36, 54, 67, 88 Moulier, V...... 40 Neill, E...... 30, 55 Martin, L...... 35 Michopoulos, V...... 66, 79 Moussas, G...... 51, 80, 83 Nelson, B...... 44, 49, 69 Martín-Navarro, N...... 34 Mickuviene, N...... 52, 66 Mrad, A...... 68 Nenadic, I...... 30 Martins, J...... 49 Mielimaka, M...... 64, 82 Mucci, A...... 58 Nerland, S...... 33, 41 Martin-Subero, M...... 36 Mihaljevic, M...... 32, 80 Mudado, F...... 71 Nesvåg, R...... 33 Martynova, A...... 88 Miki, K...... 60 Mueller, J...... 54 Neufeld, N...... 27 Marusin, A...... 72 Mikoteit, T...... 71 Mueller, M...... 76 Neukel, C...... 81 Marzi, C...... 41, 53 Milad, M...... 25 Mukai, K...... 47 Neuner, I...... 57 Mascheretti, S...... 38 Milev, R...... 29, 43, 62 Mukherjee, S...... 83 Neves, F...... 81 Maselli, V...... 52 Militaru, F...... 68 Muldner-Nieckowski, L...... 64, 82 Neves, M...... 56, 81 Massimetti, G...... 35 Miller, B...... 32 Müller, D. J...... 47 Nevidimova, T...... 71 Mateu-Codina, G...... 38 Min, K...... 36 Müller, J...... 40 Niciu, M...... 45 Matheson, G...... 37 Minnai, G...... 88 Müller, U...... 27 Nickson, T...... 56 Mathiak, K...... 41 Miranda, D...... 38, 71, 73 Mullins, R...... 71 Nicola, B...... 55 Mathis, C...... 32 Miranda, E...... 72, 85 Mulsant, B...... 36, 39 Nicolas, Y...... 81 Matkovska, T...... 66 Miranda-Terres, E...... 40 Mumm, J...... 35 Nicolato, R...... 49, 56, 81 Matsoukas, T...... 37 Mirjanic, T...... 32, 80 Munk Laursen, T...... 37, 42 Nieber, K...... 40 Matsuda, Y...... 36 Miroshnichenko, I...... 80 Munk-Olsen, T...... 37, 42 Nielsen, R. E...... 47 Matsumoto, T...... 71 Mischoulon, D...... 51 Munoz, D...... 38 Nierenberg, A...... 51 Matsunaga, H...... 47, 51 Misra, A. K...... 86 Muñoz Lorenzo, L...... 84 Nieto, R...... 52 Matthews, P...... 65 Mital, A. K...... 30 Murayama, K...... 73 Nievergelt, C. M...... 79 Mattina, G...... 35 Mitchell, J...... 48 Muro, A...... 50, 70 Nikitin, S...... 86 Mattson, M...... 71 Mitelman, S...... 26 Murphy, M...... 79 Nikolaou, K...... 88 Mattsson, F...... 34 Mitterhauser, M...... 33 Murray, R...... 53, 72 Nikolic, G...... 48 Maudens, K...... 34 Miyamoto, T...... 26 Murthy, P...... 83 Nimatoudis, J...... 31, 85 Mavreas, V...... 34, 49, 68 Miyashita, M...... 52, 69 Musalek, M...... 61 Nimgaonkar, V...... 49, 69 Mavrikaki, M...... 30, 79 Mizuhara, H...... 78 Mushtaq, D...... 63 Nimroody, T...... 50 Ma, X...... 41 Mizuta, N...... 37 Mushtaq, H...... 63 Nishimura, Y...... 30

103 WFSBP 2015 List of Chairpersons and Presenters

Nizamie, S. H...... 31 P Pehlivanidis, A...... 36 Ponangi, C...... 39 Nobile, M...... 26, 38, 46, 57 Padberg, F...... 59 Pelayo-Terán, J. M...... 34 Pons, A...... 49 Noda, Y...... 34, 60 Padmanabhuni, S. S...... 41 Pelecanou, M...... 50 Ponseti, J...... 70 Nohara, I...... 52 Padurariu, M...... 85, 87 Peles, E...... 64 Ponsford, J...... 64, 85 Noh, J...... 68 Pae, C.-U...... 54 Pellicer-Graham, F...... 40 Popp, R...... 79 Norbury, R...... 65 Pagida, M...... 48 Pelluru, D...... 33 Pop, V...... 79 Nordbø Jørgensen, K...... 33 Paik, I. H...... 37 Penadés, R...... 49, 82 Porichi, E...... 81 Noskova, T...... 41 Paik, J.-W...... 41, 63 Penninx, B...... 31, 50 Porkka-Heiskanen, T...... 61 Nöthen, M...... 64, 83 Paik, Y...... 54 Penta, E...... 41 Porta, O. A...... 39 Nováková, P...... 57 Painold, A...... 36 Peralta Rodriguez, B...... 56 Port, J. D...... 46 Novakovic, I...... 32 Paiva, A...... 49 Pereira, P...... 38 Post, R...... 46 Novak Sarotar, B...... 68 Pajuste, K...... 73 Perets, R...... 54 Potanin, S...... 80 Nowak, G...... 68, 84 Palacios Escalona, S...... 56 Pérez Blanco, F...... 82 Potenza, M...... 25, 26, 62, 63 Numata, N...... 86 Palaniyappan, L...... 76 Perez Fominaya, M...... 84 Potik, D...... 64 Nussbaumer, M...... 79 Palenicek, T...... 57, 59 Pérez-Solà, V...... 38 Potvin, S...... 88 Nutt, D...... 65 Palma, H...... 66 Perlini, C...... 72, 83 Pouget, J...... 59 Panayotacopoulou, M...... 48, 55 Permoda-Osip, A...... 65 Poujol, R...... 60 Pandey, G...... 23, 75 Perret-Liaudet, A...... 37 Poulet, E...... 59, 79 O Panov, D...... 33 Peter, J...... 77 Poupon, C...... 41 Oakeley, E...... 56 Panteleakis, D...... 82 Petersen, L...... 53 Pourcher, E...... 64 Obata, N...... 52 Pantelis, C...... 23, 30, 38, Petersen, R...... 32 Power, B. D...... 76 Oberguggenberger, A...... 77 ...... 40, 41, 44, 49, 69, 74, 77 Petrasek, T...... 86 Prado, C...... 55 Ochoa Madrigal, M. G...... 81 Paoli, R. A...... 51 Petric, D...... 70 Prados, J...... 88 Ochoa-Sanchez, R...... 31 Papadimitriou, G. N...... 51, 61, 74 Petrides, G...... 27, 30, 76 Prasad, K...... 83 O´Connor, W. T...... 80 Papadodima, O...... 51, 78 Petrikis, P...... 34 Prasad, M...... 48 Odebrecht, H...... 36 Papadopoulou, A...... 52, 84 Petryshen, T...... 89 Preisig, M...... 82 Odebrecht, S...... 36 Papageorgiou, C...... 34, 52, 84, 88 Pettinelli, R...... 29 Preller, K...... 59 O´Donnell, L...... 89 Papageorgiou, G...... 39, 87 Pfister, H...... 40 Prenderville, J...... 31 O´Donovan, M. C...... 28 Papageorgiou, K...... 34, 75 Phassouliotis, C...... 30, 41, 49 Price, J...... 32 Ohashi, A...... 56 Papageorgiou, S...... 32, 56 Phillips, L...... 41, 44 Prinz, S...... 33 Ohgidani, M...... 70, 87 Papakostas, I...... 79 Piazza, P. V...... 62 Proietti, L...... 36, 51 Ohgi, Y...... 40 Papale, N...... 68 Picaza, U...... 73 Proloscic, J...... 70 Ohgodani, M...... 61 Paparrigopoulos, T. .. 35, 64, 65, 82 Picchioni, M...... 53 Proskurina, T...... 66 Oh, H. A...... 87 Papazahos, C...... 88 Piccin, S...... 38 Prout, T...... 50 Oh, H. J...... 68 Pappa, D...... 72, 85 Picciotto, M...... 45 Prudic, J...... 76 Ohi, K...... 60, 76 Paquet, Ph.D., J...... 36 Pick, C...... 56 Przewlocki, R...... 35 Oh, K...... 50 Paradis, I...... 54 Piekoszewski, W...... 84 Psarros, C...... 65 Oh, K. S...... 46 Pardo, M...... 38 Piel, M...... 81 Pühse, U...... 37 Okada, K...... 73 Parellada, E...... 24 Piervincenzi, C...... 33 Puljic, A...... 52 Okamura, H...... 51 Pariante, C...... 23, 43 Pietruczuk, K...... 65 Purdon, S...... 88 O´Keefe, G...... 49 Parikh, S...... 29, 43 Pigkou, A...... 86 Purushottam, M...... 40, 73 Okochi, M...... 37 Parisi, S. A...... 79 Pigoni, A...... 37, 38, 52 Puterman, E...... 50 Okpanyi, S. N...... 40 Park, C...... 67 Pilc, A...... 68, 84 Putkonen, N...... 48 Okruszek, L...... 57 Park, H.-J...... 52 Pillai, G...... 88 Puttick, D...... 79 Olazabal, N...... 73 Park, J.-I...... 51 Pinheiro, S...... 66 Pyrkosch, L...... 35 Olivas, O...... 73 Park, K...... 52 Pinna, M...... 88 Olivier, V...... 69 Park, S...... 36, 83 Pino, O...... 85 Oluyadi, F...... 50 Park, S. Y...... 66 Pinto, V...... 64, 66 Q Olver, J...... 49 Park, T. W...... 51 Piras, I. S...... 55 Quadri, A...... 86 O´Mara, S...... 31 Partyka, M...... 84 Pirovano, A...... 37, 38, 52 Quadri, M...... 86 Omari, A...... 68 Paschali, M...... 53 Pittman, B...... 45 Quartesan, R...... 29 Omezzine, A...... 72 Paschou, P...... 41, 83, 88 Pittman, J. O. E...... 79 Quattrocchi, C. C...... 33 Oniani, N...... 33 Passarelli Giroud, J. H...... 53, 71 P. John, J...... 30 Quteineh, L...... 82 Onitsuka, T...... 78, 83 Pasternak, O...... 44 Plag, J...... 35 Ookura, T...... 73 Patas, K...... 30, 71 Platova, A...... 80 Oquendo, M...... 81 Patel, J...... 67 Plaven Sigray, P...... 37 R Ordovás González, Pathak, S...... 28 Pletnikov, M...... 27 Rachel, W...... 84 M. D. Pino ...... 39, 64, 66, Patteet, L...... 34 Plewnia, C...... 65 Radziwon-Zaleska, M. ... 68, 71, 84 ...... 70, 82, 85, 86 Patterson Silver Wolf, D. A...... 66 Plotniece, A...... 73 Ragot, S...... 41 Ortiz-García de la Foz, V...... 34, 52 Paulet, M...... 53, 85 Pocivavsek, A...... 77 Rai, H...... 49, 68 Oruc, L...... 64, 83 Paul, I...... 35 Poczatek, C...... 67 Rajesh, J...... 57 O’Shea, S. D...... 80 Paul, P...... 40 Podea, D...... 82 Rajji, T...... 27, 36, 39 Os, J. van ...... 44 Paulus, W...... 24 Politis, A...... 30, 53, 65, 72 Rallis, G...... 34 Ospina-Duque, J...... 47 Paulzen, M...... 39, 65 Pollegioni, l...... 27 Ramalingam, J...... 56, 72 Ostojic, D...... 52 Pawlak, D...... 37 Pollock, B...... 39 Ramaseshan, K. . 41, 51, 53, 57, 68 Otaduy, M. C. Garcia ...... 36 Pawlowski, M...... 61 Polofinis, N...... 67, 85 Rambaldelli, G...... 72 Otte, D...... 85 Paz, R...... 54 Polunina, A...... 80 Rami-Mark, C...... 33 Otto, M...... 45 Peceliuniene, J...... 52 Polychronidis, C...... 83 Ramos Dunn, N...... 39, 83 Ozaki, J...... 73 Pedersen, C. B...... 53 Pomilio, A...... 52, 69 Ramoz, N...... 25, 27

104 WFSBP 2015 List of Chairpersons and Presenters

Ranasinghe, L. I...... 81 Rojo, E...... 85 Santonastaso, P...... 83 Seung, H...... 87 Ranganathan, M...... 45 Romano-Silva, M...... 38, 71, 73 Santos, A...... 88 Severus, E...... 46 Rapado-Castro, M...... 69 Romero, E...... 69 Sanz-Garcia, O...... 50, 70 Sforazzini, F...... 69 Raposo-Lima, C...... 82 Rosa, D...... 71, 73 Saperia, S...... 69 Shahar, H...... 60 Rasenick, M...... 42, 43, 68 Rosenbrock, H...... 69 Saraf, G...... 35, 40 Shah, N. J...... 57 Rashid, R...... 65 Roser, M.-R...... 38 Sarasola, A...... 73 Shah, R...... 32 Ratheesh, A...... 81 Rossella, V...... 52 Saricay, K...... 54 Shah, S...... 79 Rathi, P...... 86 Rossell, S. .... 30, 55, 64, 69, 85, 89 Sarno, T. A...... 53 Shalev, H...... 60 Ratz, J...... 51 Rössler, W...... 52, 69, 80 Sasikala, K...... 72, 89 Sham, P...... 72 Raveendranathan, D...... 73 Rostrup, E...... 47 Sason, A...... 64 Sham, P. C...... 53 Raventos, H...... 55 Rothbaum, A...... 66 Sato-Kasai, M...... 70 Shanaz, D...... 38 Ravichandran, N...... 88 Rothbaum, B...... 66 Sato, M...... 62, 89 Shanmugam, S. K...... 72 Ravindran, A...... 29, 39, 51, 68, Rothen, S...... 63 Satomura, Y...... 30 Shannon Weickert, C...... 27 ...... 71, 88 Rouine, J...... 31 Sauer, H...... 30 Shan, X...... 32, 56, 86 Ravindran, N...... 68 Roussidis, A...... 68 Saury, S...... 36 Sharma, D...... 83 Rebolledo, C...... 84 Röver, C...... 60 Savadjiev, P...... 44, 89 Sharma, P...... 40 Rebolledo, P...... 47, 84 Rowe, J...... 55 Savic, A...... 52 Shatsky, D...... 86 Reck, C...... 81 Rozin, A...... 64 Sayadi, M. A...... 72 Shayegan, L...... 73 Reddy, S...... 31 Rubesa, G...... 86 Scarone, S...... 83 Shbiro, L...... 52 Reddy, Y. C...... 35, 73 Rubio, G...... 35 Scarr, E...... 74, 75 Shearer, L...... 45 Reichmann, C...... 53 Rubovitch, V...... 56 Schabram, I...... 33 Sheen, S.-C...... 72 Reif, A...... 43, 56 Rudzki, L...... 37 Schafer, M. R...... 38 Shenton, M...... 44, 89 Reiser, M...... 80 Rueda, D...... 66 Schaffer, A...... 62 Sher, L...... 38, 47, 63, 70, 75, 81 Reitt, M...... 60 Ruggeri, M...... 72, 83 Schappi, J...... 68 Shetty, P. H...... 73 Rembao Bojórquez, D...... 56 Ruiz, A...... 72, 85 Schastnyy, E...... 64 Sheu, Y.-H...... 57 Remington, G...... 47, 69 Ruiz Feliu, M...... 35, 36, 39 Schatzberg, A...... 42 Shimizu, H...... 71 Renard, J...... 25 Rujescu, D...... 28, 30, 45, 60 Schelenz, P...... 41 Shin, C. y...... 87 Reniers, R...... 49 Rupprecht, R...... 42 Schenin-King Andrianisaina, P. ... 40 Shingaki, T...... 73 Rentero, D...... 35 Rutkowski, K...... 64, 82 Scheuer, S...... 40 Shin, H. W...... 53 Repetto, G...... 72 Rutledge, R...... 48 Schiffer, B...... 70 Shin, I.-S...... 67 Reshetovska, N...... 66 Rutz, W...... 75 Schlaepfer, T...... 42, 59, 79 Shiromani, P...... 33 Ressler, K...... 66, 74, 79 Ruxandra, P...... 54 Schlagenhauf, F...... 52, 73 Shivakumar, V...... 35 Révész, D...... 31 Rybakowski, J...... 65, 79 Schlüter, T...... 81 Shogo, H...... 83 Reyes, A...... 64 Ryszewska-Pokrasniewicz, B...... 68, Schmaljohann, J...... 33 Shohat, Y...... 54 Reyes-Resina, I...... 77 ...... 84 Schmitt, R...... 33 Shoji, Y...... 89 Reyes Santos, L...... 56 Schnell, T...... 80 Shreder, E...... 87 Reyes Zamorano, E...... 40 Scholz, V...... 41 Shreder, O...... 87 Reynaert, C...... 29 S Schreiber-Avissar, S...... 39 Shrinivasa, B...... 35 Rey, R...... 41 Saadaoui, M. H...... 72 Schreiber, G...... 39 Shriqui, C...... 54 Rezende, V...... 71 Sabau, A...... 82 Schreiber, S...... 56, 64 Shrot, S...... 68 Rezunenko, O...... 67 Sabbatini, D...... 36 Schreiner, A...... 53, 69 Shukla, T...... 73 Rho, J. H...... 54 Sacchi, S...... 27 Schultz, C. C...... 30 Shwedova, A...... 88 Ricardo Garcell, J...... 40 Sachs, G...... 64, 79 Schulze, L...... 65 Siarkos, C...... 72 Ricciardi, L...... 84 Saeki, T...... 60 Schulze, T...... 74, 76 Sibille, E...... 60 Rice, S...... 38 Sagata, N...... 70 Schüpbach, D...... 52 Siddiqui, I...... 69 Rice, T...... 38, 50, 70, 75, 83 Sagnou, M...... 50 Schuppe-Koistinen, I...... 36 Siedman, L. J...... 89 Rico Román, A...... 84 Sahakian, B...... 55 Schurz, M...... 55 Sienaert, P...... 76 Riederer, P...... 30, 43 Sahoo, S...... 57 Schutze, M...... 71, 73 Sigurdardottir, H. L...... 33 Riemenschneider, M...... 64 Said, M. A...... 65, 66 Schütze, T...... 81 Silic, A...... 52 Rietschel, M...... 50, 64, 83 Saigi-Morgui, N...... 82 Schwarcz, R...... 77 Silka, A...... 87 Rigonatti, L...... 55 Saito, T...... 37, 43 Schwartenbeck, P...... 72 Silva, H...... 47, 52, 70 Rigonatti, S...... 55 Saje, M...... 68 Schwartz, J...... 32 Silva, J...... 64, 66 Rihmer, Z...... 38, 75 Sakkas, P...... 38, 65 Schwarz, M...... 43 Silva Neves, F...... 56 Ripova, D...... 57, 86 Sales, A...... 31 Schweitzer, K...... 34 Simokawa, N...... 70 Ristow, I...... 70 Salinas, V...... 52 Schwieler, L...... 36 Simonsen, C...... 41 Riva, M. A...... 97 Salis, P...... 88 Scott, A...... 49 Simutkin, G...... 67 Rizos, E...... 68 Salomons, T...... 60 Scott, J...... 51 Singh, S...... 68 Robb, A...... 29 Sampson, S...... 46 Sedlak, T...... 27 Skafidas, E...... 77 Robbins, T...... 55 Samuelsson, M...... 36 Seedat, S...... 35, 50, 56, 63, 79 Skalski, M...... 68, 71, 84, 87 Roberto, S.-G...... 38 Sanchez, B...... 38 Seidman, L...... 44 Skandali, N...... 48, 55 Roberts, M...... 97 Sánchez Martínez, R...... 56 Seifritz, E...... 52, 59 Skarpa Usmiani, I...... 86 Rodrigues, S...... 64 Sanchez-Russi, C...... 79 Seligman, Z...... 64 Skrzeszewski, J...... 68, 71, 84 Rodriguez Aliste, A. B. ... 35, 36, 39 Sandhu, S...... 70 Selle, v...... 75 Skugarevsky, O...... 38, 55 Rodriguez Bambico, F...... 31 Sandrim, V...... 38 Semaoune, B...... 88 Skuhareuskaya, M...... 38, 55 Rodríguez Jiménez, E...... 39, 64, Sankaranarayanan, A...... 76 Semkovska, M...... 49, 67 Skurlova, M...... 86 ...... 66, 70, 82, 85, 86 San, L...... 38 Sen, S...... 40 Skuse, D...... 44 Rodzoch, R...... 71 Sano, S...... 37 Seo, J. S...... 86 Smeraldi, E...... 37, 38 Rofe, Y...... 82 Sanoudou, D...... 82 Serret, S...... 88 Smesny, S...... 30 Roiz-Santiáñez, R...... 52 Sant‘ana do Nascimento, A. B. ... 54 Serretti, A. ... 30, 31, 54, 62, 74, 82 Smyrnis, N...... 33, 56

105 WFSBP 2015 List of Chairpersons and Presenters

S.N., D...... 69, 72 Szulc, A...... 37, 56 Torres Martin, J...... 88 Valencia Granados, F. J...... 81 Snitz, B...... 32 Toto, S...... 75 Vales, K...... 86 Soares, J. C...... 26 Toulopoulou, T...... 53 Valim de Nicola, B...... 55 Sobanski, J...... 64, 82 T Touloumis, C...... 37, 49 Valmaggia, L...... 44 Sobów, T...... 51, 87 Tadevosyan, A...... 66 Tourjman, V...... 88 Van Assche, E...... 32 Söderpalm, B...... 25 Tagami, S...... 37 Tournikioti, K...... 36 van de Bilt, M...... 55 Sogou, K...... 66 Tagliaro, F...... 25 Toxto Guerrero, S...... 56 Vandenberghe, F...... 82 So, H...... 67 Takamiya, A...... 88 Toyomaki, A...... 26 van Den Heuvel, L...... 50 Soldatos, C. R...... 23, 36, 65 Takeda, M...... 32, 34, 37, 58, Trabjerg, B...... 37 Van den Noortgate, W...... 32 Soldatos, R...... 30, 53 ...... 60, 62, 73, 76, 97 Trakadis, Y...... 30, 48 Vanderhasselt, M.-A...... 65 Soldatovic, I...... 32 Takemoto, S...... 36 Traks, T...... 41 van Der Heijden, F...... 87 Soloff, P...... 33, 51, 70 Takizawa, R...... 30 Traub-Weidinger, T...... 33 van der Wee, N. J. A...... 60 Song, J...... 50 Talarowska, M...... 40 Trendafilova, R...... 83 van Groen, T...... 73 Sonobe, N...... 71 Taleb, M...... 88 Treutlein, J...... 50 Vanicek, T...... 33 Son, S...... 68 Taler, M...... 52, 68, 85 Treviranus, G. R. S...... 80, 84 van Oppen, P...... 31, 50 Sopterean, G. A...... 84 Talib, L...... 51, 53, 55 Tristán, M. F...... 56 van Os, J...... 32, 80 Sotiropoulos, I...... 25, 64, 66 Tallerova, A...... 86 Triulzi, F...... 51 Varela, L...... 47 Soto, A...... 85 Talreja, B...... 31, 79 Trivedi, M...... 25 Vargas Félix, G...... 56 Souery, D...... 31 Tanaka, T...... 62 Trofin, F...... 53 Vargas Pena, E...... 63 Sousa, N...... 64, 66 Tan, E...... 69 Tsai, H.-Y...... 37, 38 Vargas, W...... 81 Souza Costa, D...... 38 Taneli, B...... 49 Tsai, I.-N...... 38 Varrone, A...... 37 Soydas Akyol, E...... 53, 85 Tang, P. Y...... 32, 72 Tsai, S.-M...... 38 Varshney, M...... 51 Soyka, M...... 78 Tankaya, O...... 55 Tsai, S.-Y...... 51 Varsou, E...... 33 Spanagel, R...... 42 Tanus-Santos, J...... 38 Tsaklakidou, D...... 82 Vasconcelos, M...... 71 Spangaro, M...... 37, 38, 52 Taragano, F...... 67 Tsalamanios, E...... 83, 88 Vasilakopoulou, N...... 83 Spaniel, F...... 62 Tarasenko, I...... 85 Tsalta, E...... 72 Vasile, D...... 67, 84 Spariosu, M...... 39, 64 Tarasow, E...... 56 Tschernegg, M...... 55 Vasile, F...... 67, 84 Spencer, T...... 24 Tasdemir, A...... 53 Tse, D. H. Y...... 57 Vasiliu, D. G...... 67, 84 Sperner-Unterweger, B...... 77 Tatebayashi, Y...... 78 Tseng, L.-H...... 72 Vasiliu, O...... 67, 84 Spies, M...... 33, 40 Tateno, M...... 70 Tsetsos, F...... 88 Vaslamatzis, G...... 33 Squarcina, L...... 72 Tauber, S...... 39 Tsiolka, E...... 87 Vasquez, D...... 66 Squassina, A...... 40 Tavano, A...... 83 Tsou, H.-H...... 50 Vasquez, F...... 81 Squillace, M...... 69 Tavormina, G...... 29 Tsuchimoto, R...... 83 Vassaliliadou, M...... 67 Stamenkovic, M...... 67 Tayama, M...... 37 Tsuda, M...... 60 Vassiliadou, M...... 85 Staniute, M...... 66, 72 Tee, S. F...... 32, 72 Tubio-Arcos, E...... 39 Vazquez, G...... 67, 75 Stefanis, N...... 76 Tellez-Vargas, J...... 47 Tümer, Z...... 41 Vaz Silva, J...... 64, 66 Stefanis, N. C...... 30, 52, 76 Teo, A. R...... 70 Tundo, A...... 36, 51 Vejmola, C...... 57 Steiger, A...... 61 Teplytska, L...... 79, 85 Tu, P.-C...... 51 Velakoulis, D...... 30, 44, 49, 52, 74 Steiner, M...... 35, 42 Terada, M...... 62 Turck, C...... 67, 79, 85 Velez Aguirre, M. A...... 87 Stelzig-Schöler, R...... 55 Tesei, A...... 38 Turecki, G...... 60, 75 Vellingiri, B...... 38, 50, 56, 69, 72 Stepanov, V...... 72 Testa, R...... 77 Tyls, F...... 57 Veloso, A...... 66 Stiedl, O...... 32, 65 Teyssier, J.-R...... 41 Tzavara, C...... 65 Veloz, J...... 66 Stokes, C...... 64 Thankachan, S...... 44, 78 Tzavellas, E...... 48, 82 Vengoechea, J...... 63 Storvestre, G. B...... 81 Thase, M...... 74 Tzebelikos, E...... 54 Venizelos, N...... 30, 51, 71, 72, Strassmayr, C...... 55 Theleritis, C...... 39, 60, 65 Tziora, V...... 85 ...... 77, 78 Strecker, R...... 44, 78 Theodoridou, A...... 52, 69, 80 Venkatasubramanian, G...... 35, 73 Streit, F...... 50, 64, 83 Theodoropoulou, P...... 54 Verdolini, N...... 29 Ströhle, A...... 35 Theofilidis, A...... 85 U Vered, I...... 52 Strohmaier, J...... 64, 83 Theurer, C...... 54 Uchida, H...... 39 Verhoeven, J...... 31, 50 Stübner, S...... 75 Thibaut, F...... 25, 30, 42, Uchida, M...... 24 Verjee, S...... 54 Stuchlik, A...... 86 ...... 43, 46, 58, 62, 69, 71 Uchimura, N...... 89 Vernaleken, I...... 33, 81 Stupka, E...... 52 Thomas, M...... 40 Udristoiu, T...... 23, 30, 68, 73 Veselinovic, T...... 39, 65 Subramaniam, K...... 82 Thomas, N...... 64, 85, 89 Udupa, K...... 68 Vesperini, S...... 88 Sudo, N...... 87 Thompson, A...... 30, 40, 69 Ueno, S.-i...... 71 Vetter, S...... 52 Suh, H.-S...... 71 Thomson, L...... 36 Uhde, T...... 33 Veyssiere, J...... 31 Sulaiman, A. H...... 65, 66 Thon, N...... 72 Uhlhaas, P...... 61, 78 Vgonzas, A...... 80 Sulejmanpasic-Arslanagic, G. .... 54, Thonse, U...... 40 Uhr, M...... 40, 61 Viana Almeida Coelho, M...... 71 ...... 87 Thorens, G...... 63 Ulrike, K...... 40 Viana, M...... 35 Suliman, S...... 50 Thummler, S...... 88 Umesh, S...... 31 Vicente Forlenza, O...... 53, 71 Sullivan, G...... 81 Timofte, D...... 85 Upadhyaya, K. C...... 83 Víctor, C.-R...... 38 Sun, I.-W...... 36 Tizabi, Y...... 24 Urakami, K...... 62 Victoria, Z...... 87 Sun, Q...... 32, 56, 86 Tobimatsu, S...... 83 Urquijo, M. F...... 89 Vieta, E...... 28, 75 Supprian, T...... 53 Togao, O...... 73 Usiello, A...... 26, 69 Vignapiano, A...... 58 Suresh Kumar, S...... 72 Toh, W. L...... 64 Uttl, L...... 57 Vigod, S...... 42 Surrey, D...... 74 Tokarz, K...... 64, 82 Viji, P...... 72 Sussmann, J...... 56 Toll, A...... 38 Viktorin, A...... 42 Su, T.-P...... 51 Tomonaga, T...... 37 V Viktorinova, M...... 57 Suzuki, T...... 39 Tondo, L...... 75 Vahabi, S...... 66 Vila Nova, V...... 49 Swapna, V. K...... 85 Tononi, G...... 44 Vaidakis, N...... 64, 82 Vila-Rodriguez, F...... 36, 65 Szklarczyk-Smolana, K...... 35 Tordesillas-Gutiérrez, D...... 52 Valdez de Vuibert, V...... 30, 62, Vilela-Costa, H. H...... 54 Szlachta, P...... 37 Toriumi, K...... 52, 69 ...... 66, 80 Villarroel, J...... 70

106 WFSBP 2015 List of Chairpersons and Presenters

Viswanath, B...... 35, 40, 73 Weickert, C...... 76 X Z Vitale, A...... 52, 69 Weickert, C. S...... 77 Xiao, J...... 67 Zadorina, K...... 84 Vitale, M...... 52, 69 Weickert, T...... 76, 77 Xue, S...... 39 Zagato, L...... 37 Vite, V...... 81 Weidinger, E...... 43 Xu, H...... 31 Zai, C. C...... 55 Vitucci, D...... 69 Weiner, I...... 77 Xu, S...... 35 Zainal, N. Z...... 84 Vlissides, D...... 67, 85 Weiner, R...... 76 Zakharova, O...... 80 V. L., N...... 72 Weinstein, A...... 25, 26, 48 Zakharov, E...... 83 Vogl, S...... 67 Weinstein, Y...... 26 Y Zakharyan, R...... 32, 53 Voineskos, A...... 27, 46 Weissfeld, L...... 32 Yamada, S...... 73 Zakzanis, K...... 69 Voineskos, D...... 37 Weizman, A...... 52, 68, 85 Yamagisawa, Y...... 47 Zalesky, A...... 44, 49 Vollenweider, F...... 58, 59 Weller, A...... 52 Yamamori, H...... 60, 76 Zallo, E...... 73 Vollenweider, P...... 82 Wessa, M...... 36, 41 Yamamoto, M...... 37 Zamalloa, M. I...... 73 Vollstädt-Klein, S...... 41 Westlye, L. T...... 33, 81 Yamanishi, H...... 51 Zanetti, M. V...... 36 Volmer, D...... 64 Westrin, Å...... 37, 71 Yamanishi, K...... 47, 51 Zangen, A...... 60 von Düring, F...... 72 Whalley, H. C...... 56 Yamashita, Y...... 89 Zangrossi Junior, H...... 54 von Gunten, A...... 82 White, D...... 73 Yanagida, K...... 37 Zantomio, D...... 77 von Saldern, S...... 80 White, R...... 51, 68, 72 Yanagida, S...... 56 Zapico-Merayo, Y...... 34 Voon, V...... 55 Whittle, S...... 30, 40, 69 Yanagisawa, M...... 97 Zarate, C. A...... 28 Voskou, P...... 34, 83 Wichniak, A...... 57, 58 Yaneva, Z...... 83 Zarrouk, L...... 53, 86 Voudouri, N. M...... 83, 88 Wiedemann, K...... 32, 65, 71 Yang, C...... 78 Zarzycki, M...... 87 Vougiouklakis, T...... 34 Wielgos, M...... 71 Yang, D.-B...... 50 Zavitsanou, K...... 77 Vucic Peitl, M...... 70 Wild, K...... 82 Yang, J.-C...... 38, 51, 87 Zawadzki, J...... 69 Vumma, R...... 71, 78 Wilhelm, F...... 40 Yao, F...... 57 Zbukvic, I...... 66 Vyalova, N...... 67 Willeit, M...... 67 Yariv, S...... 54 Zdanowicz, N...... 29 Willette, A...... 71 Yasuda, Y...... 60, 76 Zelenska, K...... 70 Williams, S...... 39 Yatham, L...... 24, 28, 43, 48, 75 Zepf, F...... 41 W Willing, A...... 71 Yatham, S...... 88 Zerres, K...... 33, 41, 81 Wachtel, L...... 48 Windischberger, C...... 40 Yeh, Y.-W...... 39 Zervas, Y...... 73 Wadsak, W...... 33 Wingenfeld, K...... 29 Yelland, G...... 69 Zetterberg, H...... 45 Wagenpfeil, S...... 64 Winkler, D...... 40 Yi, J.-S...... 53 Zhang, B...... 56 Walitza, S...... 52, 69, 80 Winkler, S...... 56 Yokota, A...... 73 Zhang, H...... 31 Walker, C...... 68 Winter, C...... 78 Yolken, R...... 59 Zhang, J...... 32 Wall, M...... 65 Winterer, G...... 45 Yoo, h...... 51 Zhang, P...... 55 Waltereit, R...... 26 Winther Johannsen, B. M...... 42 Yoo, I...... 51, 54 Zhang, X...... 53 Walter, H...... 70, 74 Winz, O...... 33, 81 Yoo, J. H...... 41 Zhang, Y...... 27, 31 Walter, M...... 56, 70, 72 Witkowski, J...... 65 Yook, K.-H...... 50 Zhang, Z.-J...... 80 Walther, L...... 25 Witt, S...... 50 Yoon, D. H...... 36 Zhukova, I...... 72 Waltoft, B...... 37 Witt, S. H...... 64, 83 Yoon, H.-k...... 53 Zhukova, N...... 72 Wang, F...... 58 Wobrock, T...... 62 Yoon, J.-S...... 67 Zietlow, A.-L...... 81 Wang, J...... 31 Wojcik, J...... 89 Yoon, M...... 52 Zikic, O...... 48 Wang, L.-J...... 64 Wolf, D...... 41 Yoon, S...... 53 Zimmer, A...... 85 Wang, M...... 67 Wolf, O...... 25 Yoon, W...... 51 Zohar, J...... 31 Wang, Q...... 41 Wong, A...... 69 Yoshida, M...... 51 Zohsel, K...... 26 Wang, S.-C...... 50 Wong, J...... 27 Yoshida, T...... 71 Zois, E...... 41 Wang, S.-J...... 51 Won, W...... 66 Yoshiike, T...... 60 Zomorrodi, R...... 34 Wang, S.-M...... 50 Wood, J...... 49, 69 Yoshimi, N...... 40 Zompo, M. D...... 40 Waniek, J. Z...... 66 Wood, P...... 85 You, C. S...... 52 Zullino, D...... 63 Wassef, C...... 64 Wood, S...... 44, 49 Young, L...... 44 Zumárraga, M...... 73 Waszkiewicz, N...... 37, 56 Wood, S. J...... 30, 40, 69 Young, R...... 76 Zutshi, A...... 83 Watabe, M...... 70 Woods, W...... 89 Youn, T...... 52 Watanabe, K.-i...... 36 Wuan, E...... 67 Yow, K. L...... 85 Watanabe, Y...... 51, 73, 76 Wu, F...... 32, 56, 86 Yücel, M...... 44 Waterreus, A...... 76 Wurst, F. M...... 72 Yukioka, M...... 60 Webhofer, C...... 67 Wu, Y.-T...... 31 Yuko, O...... 83 Wedekind, D...... 60 Wysokinski, A...... 51, 84, 87 Yung, A...... 49 Wegener, G...... 80 Wyss, C...... 57 Yung, A. R...... 44, 69

107 www.wfsbp-congress.org Save the date

Welcome to coPenhagen

WFSBP Congress 2017 13th World congress of Biological Psychiatry 18 – 22 June 2017 Bella Center | Copenhagen, Denmark

www.wfsbp-congress.org organised by: World Federation of Societies of Biological Psychiatry

hosted by the danish Society of Biological Psychiatry The congress at your fingertips:

WFSBP Global Headquarters Zum Ehrenhain 34 22885 Barsbüttel, Germany Phone: +49 – 40 – 670 882 90 Fax: +49 – 40 – 670 328 82 91 Email: [email protected] www.wfsbp.org